false--08-31 FY 2020 0000898293 P3Y us-gaap:AccountingStandardsUpdate201602Member 0 0.001 0.001 500000000 500000000 260406796 263830270 153520380 150330358 0.05625 0.03950 0.04900 0.04700 0 0.001 0.001 10000000 10000000 0 0 0 0 P7Y P35Y P10Y P3Y P2Y P2Y 106886416 113499912 0000898293 2019-09-01 2020-08-31 0000898293 2020-10-14 0000898293 2020-02-29 0000898293 2020-08-31 0000898293 2019-08-31 0000898293 2018-09-01 2019-08-31 0000898293 2017-09-01 2018-08-31 0000898293 us-gaap:RetainedEarningsMember 2018-09-01 2019-08-31 0000898293 us-gaap:NoncontrollingInterestMember 2019-09-01 2020-08-31 0000898293 us-gaap:CommonStockMember 2017-09-01 2018-08-31 0000898293 us-gaap:CommonStockMember 2018-08-31 0000898293 us-gaap:RetainedEarningsMember 2019-08-31 0000898293 us-gaap:NoncontrollingInterestMember 2017-08-31 0000898293 us-gaap:AdditionalPaidInCapitalMember 2019-09-01 2020-08-31 0000898293 us-gaap:CommonStockMember 2018-09-01 2019-08-31 0000898293 us-gaap:CommonStockMember 2019-08-31 0000898293 us-gaap:RetainedEarningsMember 2017-09-01 2018-08-31 0000898293 us-gaap:TreasuryStockMember 2020-08-31 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-01 2018-08-31 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-08-31 0000898293 us-gaap:NoncontrollingInterestMember 2018-09-01 2019-08-31 0000898293 us-gaap:AdditionalPaidInCapitalMember 2018-08-31 0000898293 us-gaap:AdditionalPaidInCapitalMember 2020-08-31 0000898293 us-gaap:NoncontrollingInterestMember 2018-08-31 0000898293 us-gaap:CommonStockMember 2020-08-31 0000898293 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2018-08-31 0000898293 us-gaap:RetainedEarningsMember 2019-09-01 2020-08-31 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-08-31 0000898293 us-gaap:TreasuryStockMember 2019-08-31 0000898293 us-gaap:RetainedEarningsMember 2018-08-31 0000898293 us-gaap:TreasuryStockMember 2019-09-01 2020-08-31 0000898293 us-gaap:NoncontrollingInterestMember 2017-09-01 2018-08-31 0000898293 us-gaap:RetainedEarningsMember 2020-08-31 0000898293 us-gaap:CommonStockMember 2017-08-31 0000898293 us-gaap:AdditionalPaidInCapitalMember 2017-09-01 2018-08-31 0000898293 us-gaap:AdditionalPaidInCapitalMember 2018-09-01 2019-08-31 0000898293 us-gaap:CommonStockMember 2019-09-01 2020-08-31 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-08-31 0000898293 us-gaap:TreasuryStockMember 2018-08-31 0000898293 us-gaap:NoncontrollingInterestMember 2019-08-31 0000898293 us-gaap:TreasuryStockMember 2017-09-01 2018-08-31 0000898293 2018-08-31 0000898293 2017-08-31 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-08-31 0000898293 us-gaap:TreasuryStockMember 2017-08-31 0000898293 us-gaap:TreasuryStockMember 2018-09-01 2019-08-31 0000898293 us-gaap:NoncontrollingInterestMember 2020-08-31 0000898293 us-gaap:AdditionalPaidInCapitalMember 2017-08-31 0000898293 us-gaap:AdditionalPaidInCapitalMember 2019-08-31 0000898293 us-gaap:RetainedEarningsMember 2017-08-31 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-01 2019-08-31 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-01 2020-08-31 0000898293 us-gaap:InterestRateContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-09-01 2018-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2018-09-01 2019-08-31 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-09-01 2019-08-31 0000898293 us-gaap:InterestRateContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-09-01 2019-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2019-09-01 2020-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2018-09-01 2019-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-09-01 2018-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-09-01 2020-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-09-01 2019-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-09-01 2020-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-09-01 2019-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2017-09-01 2018-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2017-09-01 2018-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2019-09-01 2020-08-31 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-09-01 2018-08-31 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-09-01 2020-08-31 0000898293 us-gaap:InterestRateContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-09-01 2020-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-09-01 2018-08-31 0000898293 us-gaap:FurnitureAndFixturesMember 2019-09-01 2020-08-31 0000898293 us-gaap:TransportationEquipmentMember 2019-09-01 2020-08-31 0000898293 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-08-31 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2019-09-01 2020-08-31 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2019-09-01 2020-08-31 0000898293 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-08-31 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2020-08-31 0000898293 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-09-01 2020-08-31 0000898293 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-01 2020-08-31 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2020-08-31 0000898293 us-gaap:AccumulatedTranslationAdjustmentMember 2019-08-31 0000898293 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-09-01 2020-08-31 0000898293 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-08-31 0000898293 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-08-31 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2019-08-31 0000898293 us-gaap:AccumulatedTranslationAdjustmentMember 2020-08-31 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2019-08-31 0000898293 us-gaap:RestrictedStockMember 2017-09-01 2018-08-31 0000898293 us-gaap:RestrictedStockMember 2018-09-01 2019-08-31 0000898293 us-gaap:RestrictedStockMember 2019-09-01 2020-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-09-01 2018-08-31 0000898293 srt:MinimumMember 2020-08-31 0000898293 srt:MaximumMember 2020-08-31 0000898293 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-09-01 2020-08-31 0000898293 srt:MaximumMember jbl:BuildingsAndRealEstateMember 2020-08-31 0000898293 srt:MinimumMember jbl:BuildingsAndRealEstateMember 2020-08-31 0000898293 srt:MinimumMember jbl:ComputerHardwareAndSoftwareMember 2019-09-01 2020-08-31 0000898293 srt:MaximumMember jbl:ComputerHardwareAndSoftwareMember 2019-09-01 2020-08-31 0000898293 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2019-09-01 2020-08-31 0000898293 srt:MaximumMember us-gaap:BuildingMember 2019-09-01 2020-08-31 0000898293 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2019-09-01 2020-08-31 0000898293 jbl:TradeAccountsReceivableSaleProgramsMember 2019-09-01 2020-08-31 0000898293 jbl:TradeAccountsReceivableSaleProgramsMember 2018-09-01 2019-08-31 0000898293 jbl:TradeAccountsReceivableSaleProgramsMember 2017-09-01 2018-08-31 0000898293 jbl:OneHundredMillionDollarTradeAccountsReceivableSaleProgramExpiringAugust102021Member 2019-09-01 2020-08-31 0000898293 jbl:OneHundredFiftyMillionDollarTradeAccountsReceivableSaleProgramMember 2019-09-01 2020-08-31 0000898293 jbl:OnehundredThirtyFiveMillionDollarTradeAccountsReceivableSaleProgramDueApril112021Member 2019-09-01 2020-08-31 0000898293 jbl:OneHundredMillionDollarTradeAccountsReceivableSaleProgramExpiringJuly212021Member 2019-09-01 2020-08-31 0000898293 jbl:SixHundredFiftyMillionDollarTradeAccountsReceivableSaleProgramExpiringDecember42020Member 2019-09-01 2020-08-31 0000898293 jbl:SixHundredMillionDollarTradeAccountsReceivableSaleProgramDueDecember52020Member 2019-09-01 2020-08-31 0000898293 jbl:FiftyMillionDollarTradeAccountsReceivableSaleProgramExpiringFebruary232023Member 2019-09-01 2020-08-31 0000898293 jbl:OneHundredFiftyMillionDollarTradeAccountsReceivableSaleProgramExpiringMay42023Member 2019-09-01 2020-08-31 0000898293 jbl:OneHundredFiftyMillionDollarTradeAccountsReceivableSaleProgramExpiringJanuary252021Member 2019-09-01 2020-08-31 0000898293 jbl:OnehundredMillionDollarTradeAccountsReceivableSaleProgramExpiringOnDecember52020Member 2020-08-31 0000898293 jbl:OneHundredFiftyMillionDollarTradeAccountsReceivableSaleProgramExpiringJanuary252021Member 2020-08-31 0000898293 jbl:OneHundredMillionDollarTradeAccountsReceivableSaleProgramExpiringJuly212021Member 2020-08-31 0000898293 jbl:OneHundredMillionDollarTradeAccountsReceivableSaleProgramExpiringAugust102021Member 2020-08-31 0000898293 jbl:OneHundredFiftyMillionDollarTradeAccountsReceivableSaleProgramExpiringMay42023Member 2020-08-31 0000898293 jbl:FourHundredMillionCNYTradeAccountsReceivableSaleProgramMember 2020-08-31 0000898293 jbl:OnehundredThirtyFiveMillionDollarTradeAccountsReceivableSaleProgramDueApril112021Member 2020-08-31 0000898293 jbl:SixHundredFiftyMillionDollarTradeAccountsReceivableSaleProgramExpiringDecember42020Member 2020-08-31 0000898293 jbl:FiftyMillionDollarTradeAccountsReceivableSaleProgramExpiringFebruary232023Member 2020-08-31 0000898293 jbl:OneHundredFiftyMillionDollarTradeAccountsReceivableSaleProgramMember 2020-08-31 0000898293 jbl:SixHundredMillionDollarTradeAccountsReceivableSaleProgramDueDecember52020Member 2020-08-31 0000898293 us-gaap:ConstructionInProgressMember 2019-08-31 0000898293 us-gaap:TransportationEquipmentMember 2020-08-31 0000898293 us-gaap:MachineryAndEquipmentMember 2019-08-31 0000898293 us-gaap:LandAndLandImprovementsMember 2020-08-31 0000898293 us-gaap:TransportationEquipmentMember 2019-08-31 0000898293 us-gaap:MachineryAndEquipmentMember 2020-08-31 0000898293 jbl:ComputerHardwareAndSoftwareMember 2020-08-31 0000898293 us-gaap:ConstructionInProgressMember 2020-08-31 0000898293 us-gaap:FurnitureAndFixturesMember 2019-08-31 0000898293 us-gaap:LandAndLandImprovementsMember 2019-08-31 0000898293 us-gaap:BuildingMember 2020-08-31 0000898293 us-gaap:LeaseholdImprovementsMember 2019-08-31 0000898293 jbl:ComputerHardwareAndSoftwareMember 2019-08-31 0000898293 us-gaap:BuildingMember 2019-08-31 0000898293 us-gaap:FurnitureAndFixturesMember 2020-08-31 0000898293 us-gaap:LeaseholdImprovementsMember 2020-08-31 0000898293 us-gaap:AccountingStandardsUpdate201602Member 2019-09-01 0000898293 jbl:DmsMember 2018-08-31 0000898293 jbl:EmsMember 2018-08-31 0000898293 jbl:EmsMember 2018-09-01 2019-08-31 0000898293 jbl:DmsMember 2019-09-01 2020-08-31 0000898293 jbl:DmsMember 2019-08-31 0000898293 jbl:EmsMember 2019-08-31 0000898293 jbl:DmsMember 2020-08-31 0000898293 jbl:EmsMember 2020-08-31 0000898293 jbl:DmsMember 2018-09-01 2019-08-31 0000898293 jbl:EmsMember 2019-09-01 2020-08-31 0000898293 us-gaap:IntellectualPropertyMember 2019-09-01 2020-08-31 0000898293 jbl:ContractualAgreementsAndCustomerRelationshipsMember 2020-08-31 0000898293 us-gaap:IntellectualPropertyMember 2019-08-31 0000898293 us-gaap:TradeNamesMember 2019-08-31 0000898293 us-gaap:TradeNamesMember 2020-08-31 0000898293 jbl:ContractualAgreementsAndCustomerRelationshipsMember 2019-08-31 0000898293 us-gaap:TradeNamesMember 2020-08-31 0000898293 us-gaap:IntellectualPropertyMember 2020-08-31 0000898293 jbl:ContractualAgreementsAndCustomerRelationshipsMember 2019-09-01 2020-08-31 0000898293 us-gaap:TradeNamesMember 2019-08-31 0000898293 2020-06-01 2020-08-31 0000898293 jbl:DebtRatingOneMember srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2019-09-01 2020-08-31 0000898293 jbl:SeniorNotesDueJanuary2030Member us-gaap:SeniorNotesMember 2020-01-15 0000898293 jbl:DebtRatingTwoMember srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:EurodollarMember 2019-09-01 2020-08-31 0000898293 jbl:SeniorNotesDueJuly2023Member us-gaap:SeniorNotesMember 2020-08-31 0000898293 us-gaap:RevolvingCreditFacilityMember jbl:A364DayRevolvingCreditAgreementMember us-gaap:LineOfCreditMember 2020-08-31 0000898293 us-gaap:RevolvingCreditFacilityMember jbl:A364DayRevolvingCreditAgreementMember us-gaap:LineOfCreditMember 2020-04-24 2020-04-24 0000898293 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-09-01 2020-08-31 0000898293 srt:MaximumMember us-gaap:MediumTermNotesMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2019-09-01 2020-08-31 0000898293 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-01-22 0000898293 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2019-09-01 2020-08-31 0000898293 srt:MinimumMember jbl:TermLoanFacilityMember jbl:TermLoanFacilityAMember us-gaap:LineOfCreditMember 2020-08-31 0000898293 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2019-09-01 2020-08-31 0000898293 us-gaap:RevolvingCreditFacilityMember jbl:A364DayRevolvingCreditAgreementMember us-gaap:LineOfCreditMember 2020-04-24 0000898293 srt:MaximumMember jbl:TermLoanFacilityMember jbl:TermLoanFacilityAMember us-gaap:LineOfCreditMember 2020-08-31 0000898293 us-gaap:RevolvingCreditFacilityMember jbl:CreditFacilityDueJanuary2023Member us-gaap:LineOfCreditMember 2020-01-22 0000898293 jbl:SeniorNotesDueJanuary2031Member us-gaap:SeniorNotesMember 2020-07-13 0000898293 us-gaap:RevolvingCreditFacilityMember jbl:A364DayRevolvingCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:EurodollarMember 2019-09-01 2020-08-31 0000898293 jbl:SeniorNotesDueDecember2020Member us-gaap:SeniorNotesMember 2020-07-13 2020-07-13 0000898293 jbl:SeniorNotesDueJanuary2028Member us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:SeniorNotesDueDecember2020Member us-gaap:SeniorNotesMember 2020-07-13 0000898293 jbl:DebtRatingThreeMember srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2019-09-01 2020-08-31 0000898293 jbl:DebtRatingOneMember srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:EurodollarMember 2019-09-01 2020-08-31 0000898293 us-gaap:RevolvingCreditFacilityMember jbl:CreditFacilityDueJanuary2025Member us-gaap:LineOfCreditMember 2020-01-22 0000898293 srt:MinimumMember us-gaap:MediumTermNotesMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2019-09-01 2020-08-31 0000898293 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:FederalFundsEffectiveSwapRateMember 2019-09-01 2020-08-31 0000898293 jbl:SeniorNotesDueJanuary2031Member us-gaap:SeniorNotesMember 2020-08-31 0000898293 us-gaap:RevolvingCreditFacilityMember jbl:A364DayRevolvingCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-09-01 2020-08-31 0000898293 jbl:DebtRatingTwoMember srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2019-09-01 2020-08-31 0000898293 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-08-31 0000898293 jbl:SeniorNotesDueSeptember2022Member us-gaap:SeniorNotesMember 2020-08-31 0000898293 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember jbl:RevolvingCreditFacilityAMember us-gaap:LineOfCreditMember 2020-08-31 0000898293 srt:MaximumMember us-gaap:MediumTermNotesMember us-gaap:LineOfCreditMember us-gaap:EurodollarMember 2019-09-01 2020-08-31 0000898293 us-gaap:RevolvingCreditFacilityMember jbl:A364DayRevolvingCreditAgreementMember us-gaap:LineOfCreditMember 2020-05-29 0000898293 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:EurodollarMember 2019-09-01 2020-08-31 0000898293 jbl:DebtRatingThreeMember srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:EurodollarMember 2019-09-01 2020-08-31 0000898293 jbl:SeniorNotesDueJanuary2030Member us-gaap:SeniorNotesMember 2020-08-31 0000898293 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember jbl:RevolvingCreditFacilityAMember us-gaap:LineOfCreditMember 2020-08-31 0000898293 us-gaap:MediumTermNotesMember us-gaap:LineOfCreditMember 2020-01-22 0000898293 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:EurodollarMember 2019-09-01 2020-08-31 0000898293 srt:MinimumMember us-gaap:MediumTermNotesMember us-gaap:LineOfCreditMember us-gaap:EurodollarMember 2019-09-01 2020-08-31 0000898293 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-08-31 0000898293 jbl:SeniorNotesDueJanuary2031Member us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueJuly2023Member us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueJanuary2030Member us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueSeptember2022Member us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueDecember2020Member us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:TermLoanFacilityMember us-gaap:LineOfCreditMember 2020-08-31 0000898293 jbl:SeniorNotesDueJanuary2028Member us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:TermLoanFacilityMember us-gaap:LineOfCreditMember 2019-08-31 0000898293 jbl:SeniorNotesDueDecember2020Member us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:AssetBackedSecuritizationsMember 2018-09-01 2019-08-31 0000898293 jbl:AssetBackedSecuritizationsMember 2017-09-01 2018-08-31 0000898293 jbl:AssetBackedSecuritizationsMember 2020-08-31 0000898293 jbl:AssetBackedSecuritizationsMember 2019-08-31 0000898293 jbl:AssetBackedSecuritizationsMember 2018-08-31 0000898293 jbl:AssetBackedSecuritizationsMember 2019-09-01 2020-08-31 0000898293 us-gaap:NonUsMember us-gaap:AssetBackedSecuritiesMember 2020-08-31 0000898293 jbl:AssetBackedSecuritizationsMember 2018-09-01 2018-11-30 0000898293 jbl:AssetBackedSecuritizationsMember 2018-11-30 0000898293 jbl:ForeignAssetBackedSecuritizationProgramMember 2020-08-31 0000898293 jbl:NorthAmericanAssetBackedSecuritizationProgramMember 2020-08-31 0000898293 jbl:DefinedBenefitPlanInsuranceContractsMember us-gaap:FairValueInputsLevel3Member 2019-08-31 0000898293 jbl:DefinedBenefitPlanInsuranceContractsMember us-gaap:FairValueInputsLevel3Member 2020-08-31 0000898293 us-gaap:DefinedBenefitPlanEquitySecuritiesMember us-gaap:FairValueInputsLevel2Member 2019-08-31 0000898293 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member 2020-08-31 0000898293 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel2Member 2020-08-31 0000898293 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member 2019-08-31 0000898293 us-gaap:DefinedBenefitPlanEquitySecuritiesMember us-gaap:FairValueInputsLevel2Member 2020-08-31 0000898293 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member 2019-08-31 0000898293 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel2Member 2019-08-31 0000898293 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member 2020-08-31 0000898293 us-gaap:DefinedBenefitPlanDebtSecurityMember 2020-08-31 0000898293 jbl:SwitzerlandPlanMember us-gaap:ForeignPlanMember 2019-09-01 2020-08-31 0000898293 us-gaap:DefinedBenefitPlanEquitySecuritiesMember 2020-08-31 0000898293 us-gaap:ForeignPlanMember 2019-09-01 2020-08-31 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:ForwardContractsMember 2019-08-31 0000898293 jbl:SeniorNotesDueJanuary2031Member us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2020-08-31 0000898293 us-gaap:CashFlowHedgingMember us-gaap:ForwardContractsMember 2019-08-31 0000898293 us-gaap:CashFlowHedgingMember us-gaap:ForwardContractsMember 2020-08-31 0000898293 us-gaap:CostOfSalesMember 2017-09-01 2018-08-31 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:ForwardContractsMember 2020-08-31 0000898293 us-gaap:CostOfSalesMember 2018-09-01 2019-08-31 0000898293 us-gaap:CostOfSalesMember 2019-09-01 2020-08-31 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2017-09-01 2018-08-31 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2018-09-01 2019-08-31 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2019-09-01 2020-08-31 0000898293 us-gaap:StockAppreciationRightsSARSMember 2019-09-01 2020-08-31 0000898293 us-gaap:StockAppreciationRightsSARSMember 2019-08-31 0000898293 us-gaap:StockAppreciationRightsSARSMember 2020-08-31 0000898293 us-gaap:StockAppreciationRightsSARSMember 2018-09-01 2019-08-31 0000898293 jbl:TimeBasedRestrictedStockUnitsMember 2019-09-01 2020-08-31 0000898293 jbl:A2011EmployeeStockPurchasePlanMember 2019-09-01 2020-08-31 0000898293 2019-09-30 0000898293 2020-08-31 2020-08-31 0000898293 jbl:MarketBasedRestrictedStockUnitsMember 2019-09-01 2020-08-31 0000898293 jbl:A2011EmployeeStockPurchasePlanMember 2020-08-31 0000898293 jbl:TimeBasedRestrictedStockUnitsMember 2019-09-01 2020-08-31 0000898293 us-gaap:EmployeeStockMember jbl:A2011EmployeeStockPurchasePlanMember 2020-08-31 0000898293 jbl:MarketBasedRestrictedStockUnitsMember 2019-09-01 2020-08-31 0000898293 us-gaap:PerformanceSharesMember 2019-09-01 2020-08-31 0000898293 us-gaap:EmployeeStockMember jbl:A2011EmployeeStockPurchasePlanMember 2019-09-01 2020-08-31 0000898293 srt:MaximumMember us-gaap:PerformanceSharesMember 2019-09-01 2020-08-31 0000898293 us-gaap:PerformanceSharesMember 2019-09-01 2020-08-31 0000898293 us-gaap:RestrictedStockUnitsRSUMember 2017-09-01 2018-08-31 0000898293 jbl:PlanTwoThousandElevenMember 2020-08-31 0000898293 2020-07-16 0000898293 2019-04-18 0000898293 2020-01-23 0000898293 2019-10-17 0000898293 2019-01-24 0000898293 2019-07-18 0000898293 2018-10-18 0000898293 2020-04-15 0000898293 jbl:OtherAwardsMember 2019-09-01 2020-08-31 0000898293 us-gaap:EmployeeStockMember 2018-09-01 2019-08-31 0000898293 jbl:OtherAwardsMember 2017-09-01 2018-08-31 0000898293 us-gaap:EmployeeStockMember 2019-09-01 2020-08-31 0000898293 us-gaap:RestrictedStockUnitsRSUMember 2019-09-01 2020-08-31 0000898293 us-gaap:RestrictedStockUnitsRSUMember 2018-09-01 2019-08-31 0000898293 us-gaap:EmployeeStockMember 2017-09-01 2018-08-31 0000898293 jbl:OtherAwardsMember 2018-09-01 2019-08-31 0000898293 2019-09-01 2019-09-30 0000898293 jbl:EmsMember us-gaap:TransferredAtPointInTimeMember 2019-09-01 2020-08-31 0000898293 us-gaap:TransferredOverTimeMember 2018-09-01 2019-08-31 0000898293 jbl:EmsMember us-gaap:TransferredOverTimeMember 2019-09-01 2020-08-31 0000898293 us-gaap:TransferredAtPointInTimeMember 2018-09-01 2019-08-31 0000898293 us-gaap:TransferredOverTimeMember 2019-09-01 2020-08-31 0000898293 jbl:DmsMember us-gaap:TransferredAtPointInTimeMember 2019-09-01 2020-08-31 0000898293 jbl:EmsMember us-gaap:TransferredOverTimeMember 2018-09-01 2019-08-31 0000898293 jbl:DmsMember us-gaap:TransferredAtPointInTimeMember 2018-09-01 2019-08-31 0000898293 jbl:EmsMember us-gaap:TransferredAtPointInTimeMember 2018-09-01 2019-08-31 0000898293 jbl:DmsMember us-gaap:TransferredOverTimeMember 2018-09-01 2019-08-31 0000898293 jbl:DmsMember us-gaap:TransferredOverTimeMember 2019-09-01 2020-08-31 0000898293 us-gaap:TransferredAtPointInTimeMember 2019-09-01 2020-08-31 0000898293 jbl:OtherNonAllocatedAssetsMember 2020-08-31 0000898293 jbl:OtherNonAllocatedAssetsMember 2019-08-31 0000898293 country:VN 2018-09-01 2019-08-31 0000898293 country:CN 2018-09-01 2019-08-31 0000898293 country:MX 2017-09-01 2018-08-31 0000898293 jbl:OtherCountriesMember 2019-09-01 2020-08-31 0000898293 country:MY 2017-09-01 2018-08-31 0000898293 us-gaap:NonUsMember 2018-09-01 2019-08-31 0000898293 country:VN 2017-09-01 2018-08-31 0000898293 country:SG 2019-09-01 2020-08-31 0000898293 country:VN 2019-09-01 2020-08-31 0000898293 country:SG 2018-09-01 2019-08-31 0000898293 country:US 2019-09-01 2020-08-31 0000898293 country:MX 2019-09-01 2020-08-31 0000898293 country:MX 2018-09-01 2019-08-31 0000898293 us-gaap:NonUsMember 2017-09-01 2018-08-31 0000898293 country:US 2018-09-01 2019-08-31 0000898293 country:MY 2018-09-01 2019-08-31 0000898293 jbl:OtherCountriesMember 2018-09-01 2019-08-31 0000898293 country:US 2017-09-01 2018-08-31 0000898293 country:SG 2017-09-01 2018-08-31 0000898293 country:MY 2019-09-01 2020-08-31 0000898293 jbl:OtherCountriesMember 2017-09-01 2018-08-31 0000898293 country:CN 2019-09-01 2020-08-31 0000898293 country:CN 2017-09-01 2018-08-31 0000898293 us-gaap:NonUsMember 2019-09-01 2020-08-31 0000898293 jbl:AppleIncMember us-gaap:SalesRevenueNetMember 2017-09-01 2018-08-31 0000898293 jbl:AmazonComMember us-gaap:SalesRevenueNetMember 2019-09-01 2020-08-31 0000898293 jbl:AppleIncMember us-gaap:SalesRevenueNetMember 2019-09-01 2020-08-31 0000898293 jbl:AppleIncMember us-gaap:SalesRevenueNetMember 2018-09-01 2019-08-31 0000898293 us-gaap:OperatingSegmentsMember 2017-09-01 2018-08-31 0000898293 us-gaap:MaterialReconcilingItemsMember 2019-09-01 2020-08-31 0000898293 us-gaap:MaterialReconcilingItemsMember 2017-09-01 2018-08-31 0000898293 us-gaap:OperatingSegmentsMember jbl:DmsMember 2019-09-01 2020-08-31 0000898293 us-gaap:MaterialReconcilingItemsMember 2018-09-01 2019-08-31 0000898293 us-gaap:OperatingSegmentsMember jbl:EmsMember 2017-09-01 2018-08-31 0000898293 us-gaap:OperatingSegmentsMember jbl:DmsMember 2018-09-01 2019-08-31 0000898293 us-gaap:OperatingSegmentsMember 2018-09-01 2019-08-31 0000898293 us-gaap:OperatingSegmentsMember 2019-09-01 2020-08-31 0000898293 us-gaap:OperatingSegmentsMember jbl:DmsMember 2017-09-01 2018-08-31 0000898293 us-gaap:OperatingSegmentsMember jbl:EmsMember 2018-09-01 2019-08-31 0000898293 us-gaap:OperatingSegmentsMember jbl:EmsMember 2019-09-01 2020-08-31 0000898293 country:SG 2020-08-31 0000898293 jbl:OtherCountriesMember 2019-08-31 0000898293 country:CN 2019-08-31 0000898293 country:CH 2019-08-31 0000898293 country:TW 2019-08-31 0000898293 country:US 2019-08-31 0000898293 country:HU 2020-08-31 0000898293 us-gaap:NonUsMember 2019-08-31 0000898293 country:MY 2019-08-31 0000898293 country:CH 2020-08-31 0000898293 country:VN 2019-08-31 0000898293 country:HU 2019-08-31 0000898293 country:US 2020-08-31 0000898293 country:MX 2020-08-31 0000898293 country:CN 2020-08-31 0000898293 country:SG 2019-08-31 0000898293 jbl:OtherCountriesMember 2020-08-31 0000898293 country:MY 2020-08-31 0000898293 country:MX 2019-08-31 0000898293 country:VN 2020-08-31 0000898293 country:TW 2020-08-31 0000898293 us-gaap:NonUsMember 2020-08-31 0000898293 jbl:CayeyPuertoRicoMember 2017-09-01 2018-08-31 0000898293 jbl:CayeyPuertoRicoMember 2018-09-01 2019-08-31 0000898293 us-gaap:AccountingStandardsUpdate201409Member 2018-09-01 2018-09-01 0000898293 jbl:FiveLargestCustomersThatAccountForAPercentageOfNetRevenueMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-09-01 2020-08-31 0000898293 jbl:GroupOfCustomersThatAccountFor90PercentOfTotalNetRevenueMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-09-01 2020-08-31 0000898293 jbl:DmsMember 2017-09-01 2018-08-31 0000898293 jbl:EmsMember 2017-09-01 2018-08-31 0000898293 jbl:AmazonComMember us-gaap:AccountsReceivableMember 2019-09-01 2020-08-31 0000898293 jbl:AmazonComMember us-gaap:SalesRevenueNetMember 2018-09-01 2019-08-31 0000898293 jbl:AppleIncMember us-gaap:AccountsReceivableMember 2019-09-01 2020-08-31 0000898293 jbl:AmazonComMember us-gaap:SalesRevenueNetMember 2017-09-01 2018-08-31 0000898293 jbl:AppleIncMember us-gaap:AccountsReceivableMember 2018-09-01 2019-08-31 0000898293 jbl:AmazonComMember us-gaap:AccountsReceivableMember 2018-09-01 2019-08-31 0000898293 jbl:AssetWriteOffMember jbl:A2020RestructuringPlanMember 2018-09-01 2019-08-31 0000898293 jbl:AssetWriteOffMember jbl:A2020RestructuringPlanMember 2018-08-31 0000898293 us-gaap:OtherRestructuringMember jbl:A2020RestructuringPlanMember 2018-09-01 2019-08-31 0000898293 jbl:LeaseCostsMember jbl:A2020RestructuringPlanMember 2019-09-01 2020-08-31 0000898293 jbl:A2020RestructuringPlanMember 2019-08-31 0000898293 us-gaap:EmployeeSeveranceMember jbl:A2020RestructuringPlanMember 2020-08-31 0000898293 us-gaap:EmployeeSeveranceMember jbl:A2020RestructuringPlanMember 2018-09-01 2019-08-31 0000898293 jbl:A2020RestructuringPlanMember 2019-09-01 2020-08-31 0000898293 jbl:AssetWriteOffMember jbl:A2020RestructuringPlanMember 2019-08-31 0000898293 us-gaap:EmployeeSeveranceMember jbl:A2020RestructuringPlanMember 2019-09-01 2020-08-31 0000898293 us-gaap:OtherRestructuringMember jbl:A2020RestructuringPlanMember 2019-08-31 0000898293 us-gaap:OtherRestructuringMember jbl:A2020RestructuringPlanMember 2019-09-01 2020-08-31 0000898293 jbl:A2020RestructuringPlanMember 2018-09-01 2019-08-31 0000898293 us-gaap:OtherRestructuringMember jbl:A2020RestructuringPlanMember 2018-08-31 0000898293 jbl:AssetWriteOffMember jbl:A2020RestructuringPlanMember 2019-09-01 2020-08-31 0000898293 jbl:LeaseCostsMember jbl:A2020RestructuringPlanMember 2018-09-01 2019-08-31 0000898293 us-gaap:OtherRestructuringMember jbl:A2020RestructuringPlanMember 2020-08-31 0000898293 jbl:AssetWriteOffMember jbl:A2020RestructuringPlanMember 2020-08-31 0000898293 jbl:LeaseCostsMember jbl:A2020RestructuringPlanMember 2020-08-31 0000898293 jbl:LeaseCostsMember jbl:A2020RestructuringPlanMember 2018-08-31 0000898293 jbl:A2020RestructuringPlanMember 2018-08-31 0000898293 us-gaap:EmployeeSeveranceMember jbl:A2020RestructuringPlanMember 2019-08-31 0000898293 us-gaap:EmployeeSeveranceMember jbl:A2020RestructuringPlanMember 2018-08-31 0000898293 jbl:A2020RestructuringPlanMember 2020-08-31 0000898293 jbl:LeaseCostsMember jbl:A2020RestructuringPlanMember 2019-08-31 0000898293 jbl:LeaseCostsMember 2017-09-01 2018-08-31 0000898293 jbl:LeaseCostsMember 2018-09-01 2019-08-31 0000898293 jbl:LeaseCostsMember 2019-09-01 2020-08-31 0000898293 jbl:OtherNonAllocatedChargesMember 2019-09-01 2020-08-31 0000898293 jbl:AssetWriteOffMember 2018-09-01 2019-08-31 0000898293 jbl:AssetWriteOffMember 2017-09-01 2018-08-31 0000898293 jbl:OtherNonAllocatedChargesMember 2018-09-01 2019-08-31 0000898293 us-gaap:EmployeeSeveranceMember 2017-09-01 2018-08-31 0000898293 us-gaap:EmployeeSeveranceMember 2018-09-01 2019-08-31 0000898293 jbl:AssetWriteOffMember 2019-09-01 2020-08-31 0000898293 jbl:OtherNonAllocatedChargesMember 2017-09-01 2018-08-31 0000898293 us-gaap:EmployeeSeveranceMember 2019-09-01 2020-08-31 0000898293 us-gaap:EmployeeSeveranceMember jbl:ReductionofWorldwideWorkforceMember 2019-09-01 2020-08-31 0000898293 us-gaap:CorporateAndOtherMember 2019-09-01 2020-08-31 0000898293 us-gaap:EmployeeSeveranceMember jbl:ReductionofWorldwideWorkforceMember 2020-08-31 0000898293 us-gaap:CorporateAndOtherMember 2018-09-01 2019-08-31 0000898293 us-gaap:CorporateAndOtherMember 2017-09-01 2018-08-31 0000898293 us-gaap:ForeignCountryMember 2020-08-31 0000898293 us-gaap:StateAndLocalJurisdictionMember 2020-08-31 0000898293 us-gaap:DomesticCountryMember 2020-08-31 0000898293 us-gaap:DomesticCountryMember us-gaap:CapitalLossCarryforwardMember 2020-08-31 0000898293 jbl:TruetechmemberMember 2017-09-01 0000898293 jbl:JohnsonAndJohnsonMedicalDevicesCompaniesMember 2019-09-30 0000898293 jbl:JohnsonAndJohnsonMedicalDevicesCompaniesMember 2019-04-29 0000898293 jbl:JohnsonAndJohnsonMedicalDevicesCompaniesMember 2019-02-25 2019-04-29 0000898293 jbl:TruetechmemberMember 2017-09-01 2017-09-01 0000898293 jbl:JohnsonAndJohnsonMedicalDevicesCompaniesMember 2019-09-30 2019-09-30 0000898293 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-08-31 0000898293 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-08-31 0000898293 jbl:SeniorNotesDueJanuary2028Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueDecember2020Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:SeniorNotesDueSeptember2022Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:SeniorNotesDueJuly2023Member us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:SeniorNotesDueJanuary2028Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:SeniorNotesDueSeptember2022Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueDecember2020Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:SeniorNotesDueJuly2023Member us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:SeniorNotesDueSeptember2022Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueJanuary2031Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueSeptember2022Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:SeniorNotesDueJanuary2031Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:SeniorNotesDueJanuary2030Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:SeniorNotesDueDecember2020Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueJanuary2028Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueJanuary2030Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueJanuary2031Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueJuly2023Member us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueJanuary2031Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:SeniorNotesDueJanuary2028Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:SeniorNotesDueDecember2020Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueJuly2023Member us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-08-31 0000898293 jbl:SeniorNotesDueJanuary2030Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2020-08-31 0000898293 jbl:SeniorNotesDueJanuary2030Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-08-31 0000898293 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-08-31 0000898293 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-08-31 0000898293 us-gaap:CashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-08-31 0000898293 us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2020-08-31 0000898293 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-08-31 0000898293 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2020-08-31 0000898293 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-08-31 0000898293 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-08-31 0000898293 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-08-31 0000898293 us-gaap:CashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-08-31 0000898293 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2020-08-31 0000898293 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2020-08-31 0000898293 us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-08-31 0000898293 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-08-31 0000898293 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-08-31 0000898293 us-gaap:AccruedLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2020-08-31 0000898293 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-08-31 0000898293 us-gaap:OtherLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2020-08-31 0000898293 us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-08-31 0000898293 us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-08-31 0000898293 us-gaap:OtherLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-08-31 0000898293 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-08-31 0000898293 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-08-31 0000898293 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-08-31 0000898293 us-gaap:AccruedLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-08-31 0000898293 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-08-31 0000898293 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-01 2020-08-31 0000898293 us-gaap:FairValueMeasurementsNonrecurringMember 2020-08-31 0000898293 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2020-08-31 0000898293 us-gaap:InventoryValuationReserveMember 2017-09-01 2018-08-31 0000898293 us-gaap:InventoryValuationReserveMember 2018-09-01 2019-08-31 0000898293 us-gaap:InventoryValuationReserveMember 2018-08-31 0000898293 us-gaap:InventoryValuationReserveMember 2019-09-01 2020-08-31 0000898293 us-gaap:InventoryValuationReserveMember 2019-08-31 0000898293 us-gaap:InventoryValuationReserveMember 2017-08-31 0000898293 us-gaap:InventoryValuationReserveMember 2020-08-31 0000898293 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-08-31 0000898293 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-09-01 2019-08-31 0000898293 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-08-31 0000898293 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-09-01 2018-08-31 0000898293 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-08-31 0000898293 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-09-01 2020-08-31 0000898293 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-08-31 0000898293 us-gaap:AllowanceForCreditLossMember 2017-09-01 2018-08-31 0000898293 us-gaap:AllowanceForCreditLossMember 2018-09-01 2019-08-31 0000898293 us-gaap:AllowanceForCreditLossMember 2018-08-31 0000898293 us-gaap:AllowanceForCreditLossMember 2019-08-31 0000898293 us-gaap:AllowanceForCreditLossMember 2020-08-31 0000898293 us-gaap:AllowanceForCreditLossMember 2019-09-01 2020-08-31 0000898293 us-gaap:AllowanceForCreditLossMember 2017-08-31 iso4217:CNY iso4217:USD iso4217:CHF iso4217:USD xbrli:shares xbrli:pure xbrli:shares jbl:customer jbl:segment jbl:country
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

(Mark One)

☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended August 31, 2020
or

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to
Commission file number 001-14063

JABIL INC.
(Exact name of registrant as specified in its charter)

Delaware |  | 38-1886260
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)

10560 Dr. Martin Luther King, Jr. Street North, St. Petersburg, Florida 33716
(Address of principal executive offices) (Zip Code)
(727) 577-9749
Registrant’s telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, $0.001 par value per share | JBL | New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☒ |  | Accelerated filer | ☐
Non-accelerated filer | ☐ |  | Smaller reporting company | ☐
|  |  | Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
The aggregate market value of the voting common stock held by non-affiliates of the registrant based on the closing sale price of the Common Stock as reported on the New York Stock Exchange on February 29, 2020 was approximately $4.7 billion. For purposes of this determination, shares of Common Stock held by each officer and director and by each person who owns 10% or more of the outstanding Common Stock have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes. The number of outstanding shares of the registrant’s Common Stock as of the close of business on October 14, 2020, was 149,550,360. The registrant does not have any non-voting stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
We have incorporated by reference portions of our Proxy Statement for our annual meeting of shareholders expected to be held on January 21, 2021 into Part III hereof, to the extent indicated herein.

Table of Contents
JABIL INC. AND SUBSIDIARIES
2020 FORM 10-K ANNUAL REPORT
TABLE OF CONTENTS

Part I. |
Item 1. | Business | 2
Item 1A. | Risk Factors | 9
Item 1B. | Unresolved Staff Comments | 23
Item 2. | Properties | 23
Item 3. | Legal Proceedings | 23
Item 4. | Mine Safety Disclosures | 23
Part II. |
Item 5. | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 24
Item 6. | Selected Financial Data | 26
Item 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 27
Item 7A. | Quantitative and Qualitative Disclosures About Market Risk | 44
Item 8. | Financial Statements and Supplementary Data | 45
Item 9. | Changes in and Disagreements With Accountants on Accounting and Financial Disclosure | 45
Item 9A. | Controls and Procedures | 46
Item 9B. | Other Information | 46
Part III. |
Item 10. | Directors, Executive Officers and Corporate Governance | 48
Item 11. | Executive Compensation | 48
Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 48
Item 13. | Certain Relationships and Related Transactions, and Director Independence | 48
Item 14. | Principal Accounting Fees and Services | 48
Part IV. |
Item 15. | Exhibits and Financial Statement Schedules | 49
Item 16. | Form 10-K Summary | 94
Signatures |  | 95

Table of Contents
This Annual Report on Form 10-K (“Form 10-K”) contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Many of the forward-looking statements are located in Part II, Item 7 of this Form 10-K under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as “future,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “will,” “would,” “should,” “could,” “can,” “may,” and similar terms. Forward-looking statements are not guarantees of future performance and the Company’s actual results may differ significantly from the results discussed in the forward-looking statements. Achievement of anticipated results is subject to substantial risks, uncertainties and inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from past results and those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements, and you are cautioned not to put undue reliance on forward-looking statements. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. You are advised, however, to consult any further disclosures we make on related subjects. Factors that might cause such differences include, but are not limited to, those discussed in Part I, Item 1A of this Form 10-K under the heading “Risk Factors,” which are incorporated herein by reference. References in this report to “the Company,” “Jabil,” “we,” “our,” or “us” mean Jabil Inc. together with its subsidiaries, except where the context otherwise requires.
1

Table of Contents
PART I
Item 1. Business
The Company
We are one of the leading providers of worldwide manufacturing services and solutions. We provide comprehensive electronics design, production and product management services to companies in various industries and end markets. Our services enable our customers to reduce manufacturing costs, improve supply-chain management, reduce inventory obsolescence, lower transportation costs and reduce product fulfillment time. Our manufacturing and supply chain management services and solutions include innovation, design, planning, fabrication and assembly, delivery and managing the flow of resources and products.
We serve our customers primarily through dedicated business units that combine highly automated, continuous flow manufacturing with advanced electronic design and design for manufacturability. We depend, and expect to continue to depend, upon a relatively small number of customers for a significant percentage of our net revenue, which in turn depends upon their growth, viability and financial stability. Based on net revenue, for the fiscal year ended August 31, 2020, our largest customers include Amazon.com, Inc., Apple, Inc., Cisco Systems, Inc., Hewlett-Packard Company, Ingenico Group, Johnson and Johnson, LM Ericsson Telephone Company, NetApp, Inc., SolarEdge Technologies Inc., and Tesla, Inc. For the fiscal year ended August 31, 2020, we had net revenues of $27.3 billion and net income attributable to Jabil Inc. of $53.9 million.
We conduct our operations in facilities that are located worldwide, including but not limited to, China, Malaysia, Mexico, Singapore, the United States and Vietnam. Our global manufacturing production sites allow customers to manufacture products simultaneously in the optimal locations for their products. Our global presence is key to assessing and executing on our business opportunities.
We have two reporting segments: Electronics Manufacturing Services (“EMS”) and Diversified Manufacturing Services (“DMS”), which are organized based on the economic profiles of the services performed, including manufacturing capabilities, market strategy, margins, return on capital and risk profiles. Our EMS segment is focused around leveraging IT, supply chain design and engineering, technologies largely centered on core electronics, utilizing our large-scale manufacturing infrastructure and our ability to serve a broad range of end markets. Our EMS segment includes customers primarily in the automotive and transportation, capital equipment, cloud, networking and storage, defense and aerospace, industrial and energy, print and retail, and smart home and appliances industries. Our DMS segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies and healthcare. Our DMS segment includes customers primarily in the connected devices, healthcare, mobility and packaging industries.
As of September 1, 2020, certain customers have been realigned within our operating segments. Our operating segments, which are the reporting segments, continue to consist of the DMS and EMS segments. Beginning in fiscal year 2021, customers within the automotive and transportation and smart home and appliances industries will be presented within the DMS segment.
Additional financial information regarding our reportable operating segments is included in Item 7 of this report and Note 13 – “Concentration of Risk and Segment Data” to the Consolidated Financial Statements.
Industry Background
The industry in which we operate has historically been composed of companies that provide a range of design and manufacturing services to companies that utilize electronics components in their products.
We monitor the current economic environment and its potential impact on both the customers we serve as well as our end markets and closely manage our costs and capital resources so that we can respond appropriately as circumstances change. Over the long term we believe the factors driving our customers and potential customers to use our industry’s services include:

• | Efficient Manufacturing. Manufacturing service providers are often able to manufacture products at a reduced total cost to companies. These cost advantages result from higher utilization of capacity and efficiencies of scale because of diversified product demand and, generally, a greater focus on the components of manufacturing cost. Companies are increasingly seeking to reduce their investment in inventory, facilities and equipment used in manufacturing and prioritizing capital investments in other activities such as sales and marketing and research and development (“R&D”). This strategic shift in capital deployment has contributed to increased demand for and interest in outsourcing to external manufacturing service providers.

2

Table of Contents

• | Accelerated Product Time-to-Market and Time-to-Volume. Manufacturing service providers are often able to deliver accelerated production start-ups and achieve high efficiencies in bringing new products to production. Providers are also able to more rapidly scale production for changing markets and to position themselves in global locations that serve the leading world markets. With increasingly shorter product life cycles, these key services allow new products to be sold in the marketplace in an accelerated time frame.

• | Access to Advanced Design and Manufacturing Technologies. By utilizing manufacturing service providers, customers gain access to additional advanced technologies in manufacturing processes, as well as to product and production design, which can offer customers significant improvements in the performance, quality, cost, time-to-market and manufacturability of their products.

• | Improved Inventory Management and Purchasing Power. Manufacturing service providers are often able to more efficiently manage both procurement and inventory, and have demonstrated proficiency in purchasing components at improved pricing due to the scale of their operations and continuous interaction with the materials marketplace.

Our Strategy
Our vision for the future is to become the world’s most technologically advanced manufacturing services and solutions provider. As we work to achieve our vision, we continue to pursue the following strategies:

• | Establish and Maintain Long-Term Customer Relationships. An important element of our strategy is to establish and maintain long-term relationships with leading companies in expanding industries with size and growth characteristics that can benefit from highly automated, continuous flow manufacturing on a global scale. We focus on maintaining long-term relationships with our customers and seek to expand these relationships to include additional product lines and services. In addition, we focus on identifying and developing relationships with new customers that meet our targeted profile, which includes financial stability, the need for technology-driven turnkey manufacturing, anticipated unit volume and long-term relationship stability.

• | Product Diversification. We focus on balancing our portfolio of products and product families to those that align with higher return areas of our business, including manufacturing, supply chain management services, comprehensive electronics design, production and product management services. We have made concentrated efforts to diversify our industry sectors and customer base. Because of these efforts, we have experienced business growth from both existing and new customers as well as from acquisitions.

• | Utilize Customer-Centric Business Units. Most of our business units are dedicated to serve one customer each and operate by primarily utilizing dedicated production equipment, production workers, supervisors, buyers, planners and engineers to provide comprehensive manufacturing solutions that are customized to each customer’s needs. We believe our customer-centric business units promote increased responsiveness to our customers’ needs, particularly for customer relationships that extend across multiple production locations.

• | Leverage Global Production. We believe that global production is a key strategy to reduce obsolescence risk and secure the lowest possible landed costs while simultaneously supplying products of equivalent or comparable quality throughout the world. Consistent with this strategy, we have established or acquired operations in the Americas, Europe, Asia and Africa. Our extensive global footprint positions us well to implement safe and practical solutions in order to select production locations which best serve the needs of our customers.

• | Offer Systems Assembly, Direct-Order Fulfillment and Configure-to-Order Services. Our systems assembly, direct-order fulfillment and configure-to-order services allow our customers to reduce product cost and risk of product obsolescence by reducing total work-in-process and finished goods inventory. These services are available at all of our manufacturing locations.

• | Offer Design Services. We offer a wide spectrum of value-add design services to achieve improvements in performance, cost, time-to-market and manufacturability.

• | Pursue Acquisition Opportunities Selectively. Traditionally, electronics manufacturing service companies have acquired manufacturing capacity from their customers to drive growth, expand their footprint and gain new customers. In recent years, our acquisition strategy has expanded to include opportunities to acquire competitors who are focused on our key growth areas, which include specialized manufacturing in key markets, materials technology and design operations, as well as other acquisition opportunities complementary to our services offerings. The primary goals of

3

Table of Contents
our acquisition strategy are to complement our current capabilities, diversify our business into new industry sectors and with new customers and expand the scope of the services we can offer to our customers.
Our Approach to Manufacturing
To achieve high levels of manufacturing performance, we have adopted the following approaches:

• | Decentralized Business Unit Model. Most of our business units are dedicated to serve one customer each and are empowered to formulate strategies tailored to individual customer’s needs. Our business units generally have dedicated production lines consisting of equipment, production workers, supervisors, buyers, planners and engineers. Under certain circumstances, a production line may serve more than one business unit to maximize resource utilization. Business units have direct responsibility for manufacturing results and time-to-volume production, thereby promoting a sense of individual commitment and ownership. The business unit approach is modular and enables us to grow incrementally without disrupting the operations of other business units. Business unit management reviews the customer financial information to assess whether the business units are meeting their designated responsibilities and to ensure that the daily execution of manufacturing activities is being effectively managed. The business units aggregate into operating segments based on the economic profiles of the services performed, including manufacturing capabilities, market share strategy, margins, return on capital and risk profiles.

• | Automated Continuous Flow. We use a highly automated, continuous flow approach to manufacturing, whereby different pieces of equipment are joined directly or by conveyor to create an in-line assembly process. This process contrasts with a batch approach, whereby individual pieces of assembly equipment are operated as freestanding work-centers. The elimination of waiting time prior to sequential operations results in faster manufacturing, which improves production efficiencies and quality control, and reduces inventory work-in-process. We believe continuous flow manufacturing provides cost reductions and quality improvement when applied to high volumes of product.

• | Computerized Control and Monitoring. We support all aspects of our manufacturing activities with advanced computerized control and monitoring systems. Component inspection and vendor quality are monitored electronically in real-time. Materials planning, purchasing, stockroom and shop floor control systems are supported through a computerized manufacturing resource planning system, which provides customers with the ability to continuously monitor material availability and track work-in-process on a real-time basis. In addition, manufacturing processes are supported by a computerized statistical process control system, whereby customers can remotely access our computer systems to monitor real-time yields, inventory positions, work-in-process status and vendor quality data.

• | Electronic Supply Chain Management. We make available to our customers and suppliers an electronic commerce system/electronic data interchange and web-based tools to implement a variety of supply chain management programs. Our customers use these tools to share demand and product forecasts and deliver purchase orders, and we use these tools with our suppliers for just-in-time delivery, supplier-managed inventory and consigned supplier-managed inventory.

Our Design Services
We offer a wide spectrum of value-add design services to enhance our relationships with current customers and to help develop relationships with our new customers. Our teams are strategically staffed to support Jabil customers for all development projects, including turnkey system design and design for manufacturing activities. These design services include:

• | Electronic Design. Our Electronic Design team provides electronic circuit design services, including application-specific integrated circuit design, firmware development and rapid prototyping services. These services have been used by our customers for a variety of products including smart phones and accessory products, notebook and personal computers, servers, radio frequency products, video set-top boxes, optical communications products, communication and broadband products, and automotive and consumer appliance controls.

• | Industrial Design. Our Industrial Design team designs the “look and feel” of the plastic and metal enclosures that house the products’ electro-mechanics, including the printed circuit board assemblies (“PCBA”).

• | Mechanical Design. Our Mechanical Design team specializes in three-dimensional mechanical design with the analysis of electronic, electro-mechanical and optical assemblies using state of the art modeling and analytical tools. This team has extended Jabil’s product design offering capabilities to include all aspects of industrial design, advance mechanism development and tooling management.

4

Table of Contents

• | Computer-Assisted Design. Our Computer-Assisted Design (“CAD”) team provides PCBA design services using advanced CAD engineering tools, PCBA design validation and verification services, and other consulting services, which include generating a bill of materials, approved vendor list and assembly equipment configuration for a particular PCBA design. We believe that our CAD services result in PCBA designs that are optimized for manufacturability and cost efficiencies and accelerate a product’s time-to-market and time-to-volume production.

• | Product Validation. Our Product Validation team provides complete product and process validation. This includes product system tests, product safety, regulatory compliance and reliability tests.

• | Manufacturing Test Solution Development. Our Manufacturing Test Solution Development team provides integral support to the design teams to embed design with testability and to promote efficient capital and resource investment in the manufacturing process. The use of software driven instrumentation and test process design and management has enhanced our product quality and reduced our operating costs relative to human dependent test processes. The full electronic test data-log of customer products has allowed customer product test traceability and visibility throughout the manufacturing test process.

Fabrication and Assembly
We offer systems assembly, test, direct-order fulfillment and configure-to-order services to our customers. Our systems assembly services extend our range of assembly activities to include assembly of higher-level sub-systems and systems incorporating multiple PCBAs. In addition, based on quality assurance programs developed with our customers, we provide testing services for our PCBAs, sub-systems and systems products. Our quality assurance programs include circuit testing under various environmental conditions to ensure that our products meet or exceed required customer specifications. We also offer direct-order fulfillment and configure-to-order services for delivery of final products.
Technology and Research and Development
We believe that our manufacturing and testing technologies are among the most advanced in our industry. To meet our customers’ increasingly sophisticated needs, we continuously engage in R&D activities designed to create new and improved products and manufacturing solutions for our customers. Through our R&D efforts, we intend to continue to offer our customers highly automated, continuous flow manufacturing process technologies for precise and aesthetic mechanical components and system assembly. These technologies and R&D activities include:

• | Automation, including automated tooling

• | Electronic interconnection

• | Advanced polymer and metal material science

• | Single/multi-shot injection molding, stamping and in-mold labeling

• | Multi-axis computer numerical control

• | Vacuum metallization

• | Physical vapor deposition

• | Digital printing

• | Anodization

• | Thermal-plastic composite formation

• | Plastic with embedded electronics

• | Metal and plastic covers with insert-molded or dies-casting features for assembly

• | Display cover with integrated touch sensor

• | Material processing research (including plastics, metal, glass and ceramic)

• | Additive manufacturing

We engage in R&D activities for many products including mobile internet devices and associated accessories, multi-media tablets, two-way radios, health care and life science products, server and storage products, set-top and digital home products and printing products.
Customers and Marketing
A key tenet of our strategy is to establish and maintain long-term relationships with leading companies in expanding industries with the size and growth characteristics that can benefit from highly automated, continuous flow manufacturing on a global scale. A small number of customers and significant industry sectors have historically comprised a major portion of our net revenue. We also market our services and solutions through our website and our Blue Sky Innovation Centers.
5

Table of Contents
In fiscal year 2020, our five largest customers accounted for approximately 47% of our net revenue and 73 customers accounted for approximately 90% of our net revenue. The table below sets forth the respective portion of net revenue attributable to the customers that accounted for approximately 10% or more of our net revenue during the periods indicated:

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Apple, Inc. | 20 | % |  | 22 | % |  | 28 | %
Amazon.com | 11 | % |  | * |  |  | * |

* Amount was less than 10% of total.
Competition
Our business is highly competitive. We compete against numerous domestic and foreign electronic manufacturing service providers, diversified manufacturing service providers and design providers. We also face competition from the manufacturing operations of our current and potential customers, who are continually evaluating the merits of manufacturing products internally against the advantages of outsourcing.
We compete with different companies depending on the type of service we are providing or the geographic area in which an activity takes place. We believe that the principal competitive factors in the manufacturing services market are: cost; accelerated production time-to-market; higher efficiencies; global locations; rapid scale production; advanced technologies; quality; and improved pricing of components. We believe we are extremely competitive with regard to all of these factors.
Backlog
Our order backlog as of August 31, 2020 and 2019 was valued at approximately $7.4 billion and $6.2 billion, respectively. Our order backlog is expected to be filled within the current fiscal year. Although our backlog consists of firm purchase orders, the level of backlog at any particular time may not be necessarily indicative of future sales. Given the nature of our relationships with our customers, and the fact that we generally do not enter into long-term purchase commitments with our customers, we frequently allow our customers to cancel or reschedule deliveries, and therefore, backlog is often not a meaningful indicator of future financial results.
Components Procurement
We procure components from a broad group of suppliers, determined on an assembly-by-assembly basis. Our global sourcing and purchasing locations are strategically placed in various countries throughout the world along with our global commodity management and supplier relationship teams. These locations manage our end-to-end procurement lifecycle. This regionalized expertise along with our supplier relationships provide efficient procurement operations.
Some of the products we manufacture contain one or more components that are only available from a single source. Some of these components are allocated from time to time in response to supply shortages. In some cases, supply shortages will substantially curtail production of all assemblies using a particular component.
Proprietary Rights
We regard certain aspects of our design, production and product management services as proprietary intellectual property. To protect our trade secrets, manufacturing know-how and other proprietary rights, we rely largely upon a combination of intellectual property laws, non-disclosure agreements with our customers, employees, and suppliers and our internal security systems, policies and procedures. We currently have a relatively modest number of patents for various innovations. We believe that our research and design activities, along with developments relating thereto, may result in growth of our patent portfolio and its importance to us, particularly as we expand our business activities. Other factors significant to our proprietary rights include the knowledge and experience of our management and personnel and our ability to develop, enhance and market manufacturing services.
We license some technology and intellectual property rights from third parties that we use in providing some of our design, production and product management services to our customers. Generally, the license agreements that govern such third-party technology and intellectual property rights grant us the right to use the subject technology anywhere in the world and terminate upon a material breach by us.
Employees
6

Table of Contents
As of August 31, 2020, we employed approximately 240,000 people worldwide. None of our U.S. domestic employees have chosen to be represented by a labor union. In certain international locations, our employees are represented by labor unions and by works councils. We have never experienced a significant work stoppage or strike and promote a culture of positive employee relations.
Environmental
We are subject to a variety of federal, state, local and foreign environmental, health and safety, product stewardship and producer responsibility laws and regulations, including those relating to the use, storage, discharge and disposal of hazardous chemicals used during our manufacturing process, those governing worker health and safety, those requiring design changes, supply chain investigation or conformity assessments or those relating to the recycling or reuse of products we manufacture.
Information about our Executive Officers
Executive officers are appointed by the Board of Directors and serve at the discretion of the Board. Except as otherwise noted below, each executive officer is a full-time employee of Jabil. There are no family relationships among our executive officers and directors. There are no arrangements or understandings between any of our executive officers and any other persons pursuant to which any of such executive officers were selected. Below is a list of our executive officers:
Steven D. Borges (age 52) was named Executive Vice President, Chief Executive Officer, Regulated Industries in September 2020 with additional responsibility for Additive Manufacturing. Mr. Borges served as Executive Vice President, Chief Executive Officer, Healthcare from September 2016 through August 2020. Mr. Borges joined Jabil in 1993 and has global experience in positions of increasing responsibility in Operations, Business Development, Manufacturing Operations and Supply Chain Management. He holds a Bachelor’s Degree in Business Administration and Management from Fitchburg State University.
Sergio A. Cadavid (age 64) was named Senior Vice President, Treasurer in September 2013. Mr. Cadavid joined Jabil in 2006 as Treasurer. Prior to joining Jabil, Mr. Cadavid was Corporate Assistant Treasurer for Owens-Illinois, Inc. in Toledo, Ohio. He has also held various positions with The Quaker Oats Company, Arthur Andersen & Co. and J.M. Family Enterprises, Inc. He holds an M.B.A. from the University of Florida and a B.B.A. from Florida International University.
Michael Dastoor (age 55) was named Executive Vice President, Chief Financial Officer effective September 2018. Mr. Dastoor joined Jabil in 2000 as Regional Controller – Asia Pacific and was named Controller in June 2004 and Senior Vice President, Controller in July 2010. Prior to joining Jabil, Mr. Dastoor was a Regional Financial Controller for Inchcape PLC. He holds a degree in Finance and Accounting from the University of Bombay. Mr. Dastoor is a Chartered Accountant from the Institute of Chartered Accountants in England and Wales.
Bruce A. Johnson (age 64) was named Executive Vice President, Chief Human Resources Officer in January 2019. Mr. Johnson joined Jabil in 2015 as Vice President, Human Resources and was promoted to Senior Vice President, Chief Human Resources Officer in 2017. Prior to joining Jabil, Mr. Johnson was Chief Organizational Effectiveness Officer/Executive Vice President, Human Resources for C&S Wholesale Grocers, Inc., a wholesale distributor of food and grocery items with headquarters in Keene, New Hampshire from 2007 to 2014. Mr. Johnson also served in senior roles at The Timberland Company, a footwear and apparel designer, retailer and manufacturer in New Hampshire, and E.I. Du Pont De Nemours and Company (Du Pont) in Delaware. He holds a Bachelor of Arts in History from Middlebury College in Vermont.
Robert L. Katz (age 58) joined Jabil in March 2016 and was named Executive Vice President, General Counsel and Corporate Secretary in September 2016. Mr. Katz transitioned the Corporate Secretary role to a member of his staff in April 2017. In April 2019 he was named Chief Ethics & Compliance Officer. Prior to joining Jabil, Mr. Katz served as Executive Vice President, General Counsel and Secretary of SharkNinja, a vacuum and kitchen appliance manufacturer. He was previously Senior Vice President and General Counsel of Ingersoll Rand plc, a diversified industrial manufacturer, from 2010 to 2015. Mr. Katz served as Senior Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer of Federal-Mogul Corporation from 2007 to 2010. From 1999 to 2007 he was General Counsel—EMEA for Delphi Corporation in Paris, France. He began his career with Milbank, Tweed, Hadley & McCloy working in the Mergers and Acquisitions and General Corporate Group in New York and London. He earned a Bachelor of Laws (LL.B.) and a Bachelor of Civil Law (B.C.L.) from McGill University. He is a member of the New York Bar.
Michael J. Loparco (age 49) was named Executive Vice President, Chief Executive Officer, Electronic Manufacturing Services (EMS) in September 2020; and currently also has responsibility for Jabil’s Enterprise Supply Chain Strategies and Global IT. Previously, Mr. Loparco served as Executive Vice President, Chief Executive Officer. Engineered Solutions Group since January 2016; and also had responsibility for Jabil’s Enterprise Supply Chain, Procurement and
7

Table of Contents
certain strategic investments. Prior to that, Mr. Loparco served as President, Chief Executive Officer of Jabil’s High Velocity and Energy & Industrial Division and held a variety of global management positions. Before joining Jabil in 1999, Mr. Loparco was an attorney at Holland & Knight, LLP, practicing corporate and commercial litigation and serving as a certified mediator. He holds a Juris Doctorate from Stetson University College of Law. He holds a Bachelor of Arts in International Business, with minor degrees in Business Management and Spanish, from Eckerd College.
Mark Mondello (age 56) has served as Chief Executive Officer and a member of the Board of Directors since March 2013. Mr. Mondello served as Chief Operating Officer from 2002 to 2013. Mr. Mondello joined Jabil in 1992 as a manufacturing supervisor and has held various leadership roles, including SVP, Business Development. Prior to joining Jabil, Mr. Mondello was a commercial and defense-related aerospace project manager for Moog, Inc. He holds a B.S. in Mechanical Engineering from the University of South Florida.
Daryn Smith (age 50) was named Senior Vice President, Enterprise & Commercial Controller effective September 2018. Mr. Smith served as Chief Financial Officer of EMS from June 2013 through June 2018. Mr. Smith joined Jabil in 2002 and he has held various leadership roles in Risk and Assurance, Financial Planning and Analysis, and Controllership for Jabil. Prior to joining Jabil, Mr. Smith was with the Assurance and Advisory Services practice for Arthur Andersen. He holds a Bachelor’s degree in Accounting from the University of South Florida and an MBA from the University of Florida.
Kenneth S. Wilson (age 55) was named Executive Vice President and CEO of Jabil Green Point in 2017 and assumed responsibility for Consumer Packaging and Corporate Procurement in September 2020. Prior to that, Mr. Wilson was Senior Vice President of the Telecommunications Infrastructure Sector within Jabil’s Enterprise & Infrastructure group. He first joined Jabil in 2000 as a business unit manager; and has held various leadership roles, including VP of Global Business Units, running businesses such as consumer electronics and telecommunications. Prior to Jabil, he spent 8 years at Motorola, where he served as Operations Director in their Handset Division. Mr. Wilson has a Bachelor’s degree in Manufacturing Engineering and a MBA from Edinburgh Business School.
Additional Information
Our principal executive offices are located at 10560 Dr. Martin Luther King, Jr. Street North, St. Petersburg, Florida 33716, and our telephone number is (727) 577-9749. We were incorporated in Delaware in 1992. Our website is located at http://www.jabil.com. Through a link on the “Investors” section of our website, we make available our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, our Current Reports on Form 8-K and any amendments to those reports, free of charge, as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. The “Investors” section of our website contains a significant amount of information about our Company, including financial and other information for investors. The information that we post on the “Investors” section of our website could be deemed to be material information. We encourage investors, the media and others interested in Jabil to visit our website. Information on our website, however, is not a part of this report.
8

Table of Contents
Item 1A. Risk Factors
Operational Risks
The effect of COVID-19 on our operations and the operations of our customers, suppliers and logistics providers has, and is expected to continue to have, a material and adverse impact on our financial condition and results of operations.
Our global operations expose us to the COVID-19 pandemic, which has had and will continue to have an adverse impact on our employees, operations, supply chain and distribution system. While we have taken numerous steps to mitigate the impact of the pandemic on our results of operations, there can be no assurance that these efforts will be successful. To date, COVID-19 has increased our expenses, primarily related to additional labor costs and the procurement of personal protection equipment for our employees globally, and has caused a reduction in factory utilization due to travel disruptions and restrictions. COVID-19 has now spread across the globe and is impacting worldwide economic activity, including our global manufacturing production sites. Public and private sector policies and initiatives to reduce the transmission of COVID-19, including travel restrictions and quarantines, are impacting our operations, including affecting the ability of our employees to get to our facilities, reducing capacity utilization levels, causing certain facility or intermittent business closures, and interrupting the movement or increasing the cost of moving components and products through our supply chain. If additional factory closures are required or reductions in capacity utilization levels occur, we expect to incur additional direct costs and lost revenue. If our suppliers experience additional closures or reductions in their capacity utilization levels in the future, we may have difficulty sourcing materials necessary to fulfill production requirements. COVID-19 has also impacted our customers and may create unpredictable reductions or increases in demand for our manufacturing services. Our ability to continue to manufacture products is highly dependent on our ability to maintain the safety and health of our factory employees. The ability of our employees to work may be significantly impacted by individuals contracting or being exposed to COVID-19. While we are following the requirements of governmental authorities and taking preventative and protective measures to prioritize the safety of our employees, these measures may not be successful, and we may be required to temporarily close facilities or take other measures. In addition, responding to the continuing pandemic could divert management’s attention from our key strategic priorities, cause us to reduce, delay, alter or abandon initiatives that may otherwise increase our long-term value or otherwise disrupt our business operations. While we are staying in close communication with our sites, employees, customers, suppliers and logistics partners and acting to mitigate the impact of this dynamic and evolving situation, the duration and extent of the effect of COVID-19 on Jabil is not determinable. We believe COVID-19 will continue to have a material and adverse impact on our consolidated financial position, results of operations and cash flows in the near term. In addition, the impact of the COVID-19 pandemic could exacerbate the other risks we face.
If we do not manage our growth effectively, our profitability could decline.
Our business at times experiences periods of rapid growth which can place considerable demands upon our management team and our operational, financial and management information systems. Our ability to manage growth effectively requires us to continue to implement and improve these systems; avoid cost overruns; maintain customer, supplier and other favorable business relationships during transition periods; efficiently and effectively dedicate resources to existing customers as well as new projects; acquire or construct additional facilities; occasionally transfer operations to different facilities; acquire equipment in anticipation of demand; continue to develop the management skills of our managers and supervisors; adapt relatively quickly to new markets or technologies and continue to hire, train, motivate and manage our employees. Our failure to effectively manage growth, as well as our failure to realize the anticipated benefits of the actions we take to try to manage our growth, could have a material adverse effect on our results of operations. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
Because we depend on a limited number of customers, a reduction in sales to any one of those customers could cause a significant decline in our revenue.
We currently depend, and expect to continue to depend for the foreseeable future, upon a relatively small number of customers for a significant percentage of our net revenue and upon their growth, viability and financial stability. See “Business – The Company.” In some instances, particular manufacturing services we provide for a customer represent a significant portion of the overall revenue we receive from that customer. As a result of this concentration, a reduction in business from one or more of our largest customers could have a material adverse effect on our results of operations. In addition, if one or more of our significant customers were to become insolvent or otherwise become unable to pay us on a timely basis, or at all, our operating results and financial condition could be adversely affected.
Consolidation among our customers exposes us to increased risks, including reduced revenue and dependence on a smaller number of customers. Increasing consolidation in industries that utilize our services may occur as companies combine to achieve further economies of scale and other synergies, which could result in an increase in excess manufacturing capacity as
9

Table of Contents
companies seek to divest manufacturing operations or eliminate duplicative product lines. Excess manufacturing capacity may increase pricing and competitive pressures for our industry as a whole and for us in particular. Such consolidation among our customers may further reduce the number of customers that generate a significant percentage of our net revenue and expose us to increased risks relating to dependence on a small number of customers.
Our customers face numerous competitive challenges, which may materially adversely affect their business and ours.
Factors adversely affecting our customers may also adversely affect us. These factors include:

• | recessionary periods in our customers’ markets;

• | the inability of our customers to adapt to rapidly changing technology and evolving industry standards, which may contribute to short product life cycles or shifts in our customers’ strategies;

• | the inability of our customers to develop, market or gain commercial acceptance of their products, some of which are new and untested;

• | the potential that our customers’ products become commoditized or obsolete;

• | loss of business or a reduction in pricing power experienced by our customers;

• | the emergence of new business models or more popular products and shifting patterns of demand; and

• | a highly-competitive consumer products industry, which is often subject to shorter product lifecycles, shifting end-user preferences and higher revenue volatility.

If our customers are unsuccessful in addressing these competitive challenges, their businesses may be materially adversely affected, reducing the demand for our services, decreasing our revenues or altering our production cycles and inventory management, each of which could adversely affect our ability to cover fixed costs and our gross profit margins and results of operations.
Most of our customers do not commit to long-term production schedules, and they may cancel their orders, change production quantities, delay production or change their sourcing strategy, which makes it difficult for us to schedule production and manage capital expenditures and to maximize the efficiency of our manufacturing capacity.
Most of our customers do not commit to firm production schedules for more than one quarter. We make significant decisions, including determining the levels of business that we will seek and accept, production schedules and locations, component procurement commitments, personnel needs and other resource requirements, based on our estimate of customer requirements. Our inability to forecast the level of customer orders with certainty makes it difficult to schedule production and maximize utilization of our manufacturing capacity. In the past, we have been required to increase staffing and other expenses in order to meet the anticipated demand. On occasion, customers may require rapid increases in production for one or more of their products or request that we relocate our manufacturing operations or transfer manufacturing from one facility to another, which can stress our resources and reduce operating margins.
Customers have canceled their orders, changed production quantities or designs, delayed production, changed their sourcing strategy and terminated their relationships with us. We cannot assure you that present or future customers will not terminate their service arrangements with us or significantly change, reduce, cancel or delay the amount of services ordered. Such changes, delays and cancellations have led to, and may lead in the future to a decline in our production and our possession of excess or obsolete inventory that we may not be able to sell to customers or third parties. This may result in write downs of inventories, reduction in the number of products that we sell, delays in payment for inventory that we purchased, and reductions in the use of our manufacturing facilities. As many of our costs and operating expenses are relatively fixed, a reduction in customer demand, particularly a reduction in demand for a product that represents a significant amount of revenue, can harm our gross profit margins and results of operations.
In addition, we sometimes experience difficulty forecasting the timing of our receipt of payment from customers. The necessary process to begin manufacturing can be lengthy. Because we make capital expenditures during this ramping-up process and do not receive payment until after we produce and ship the customer’s products, any delays or unanticipated costs in the ramping-up process may have a significant adverse effect on our cash flows and our results of operations. Servicing our largest customers may also require us to increase our capital expenditures.
Customer relationships with emerging companies may present more risks than with established companies.
10

Table of Contents
Customer relationships with emerging companies present special risks because we do not have an extensive product or customer relationship history. There is less demonstration of market acceptance of their products making it harder for us to anticipate requirements than with established customers. Our credit risk on these customers, especially in trade accounts receivable and inventories, and the risk that these customers will be unable to fulfill indemnification obligations to us are potentially increased. We sometimes offer these customers extended payment terms, loans and other support and financial accommodations which may increase our financial exposure.
The success of our business is dependent on our ability to keep pace with technological changes and competitive conditions in our industry, and our ability to effectively adapt our services as our customers react to technological changes and competitive conditions in their respective industries.
If we are unable to offer technologically advanced, cost effective, quick response manufacturing services that are differentiated from our competition and adapt those services as our customers’ requirements change, demand for our services will decline.
Introducing new business models or programs requiring implementation of new competencies, such as new process technologies and our development of new products or services for customers, could affect our operations and financial results.
The introduction of new business models or programs requiring implementation or development of new competencies, such as new process technology within our operations and our independent development of new products or services for customers, presents challenges in addition to opportunities. The success of new business models or programs depends on a number of factors including, but not limited to, a sufficient understanding of the new business or markets, timely and successful product development (by us and/or our customer), market acceptance, our ability to manage the risks associated with new product production ramp-up, the effective management of purchase commitments and inventory levels in line with anticipated product demand, our development or acquisition of appropriate intellectual property, the availability of supplies in adequate quantities and at appropriate costs to meet anticipated demand, and the risk that new products may have quality or other defects in the early stages of introduction. Accordingly, we cannot determine in advance the ultimate result of new business models or programs.
As a result, we must make long-term investments, develop or obtain appropriate intellectual property and commit significant resources before knowing whether our assumptions will accurately reflect customer demand for our services or for our customer’s products. After the development of a new business model or program, we must be able to manufacture appropriate volumes quickly and at low cost. To accomplish this, we endeavor to accurately forecast volumes, mixes of products and configurations that meet customer requirements; however, we may not succeed at doing so.
We compete with numerous other diversified manufacturing service providers, electronic manufacturing services and design providers and others.
Our business is highly competitive and our manufacturing processes are generally not subject to significant proprietary protection. We compete against numerous domestic and foreign electronic manufacturers, manufacturing service providers and design providers. The significant purchasing power and market power of these large companies could increase pricing and competitive pressures for us. Most of our competitors have international operations and significant financial resources and some have substantially greater manufacturing, research and development (R&D) and marketing resources. These competitors may:

• | respond more quickly to new or emerging technologies or changes in customer requirements;

• | have technological expertise, engineering capabilities and/or manufacturing resources that are greater than ours;

• | have greater name recognition, critical mass and geographic market presence;

• | be better able to take advantage of acquisition opportunities;

• | devote greater resources to the development, promotion and sale of their services and execution of their strategy;

• | be better positioned to compete on price for their services;

• | have excess capacity, and be better able to utilize such excess capacity;

• | have greater direct buying power from component suppliers, distributors and raw material suppliers;

• | have lower cost structures as a result of their geographic location or the services they provide;

• | be willing or able to make sales or provide services at lower margins than we do;

11

Table of Contents

• | have increased vertical capabilities providing them greater cost savings.

We also face competition from the manufacturing operations of our current and potential customers, who are continually evaluating the merits of manufacturing products internally against the advantages of outsourcing. In the past, some of our customers moved a portion of their manufacturing from us in order to more fully utilize their excess internal manufacturing capacity.
The actions of competitors and current and potential customers could cause a decline in our sales and/or compression of our profits.
Our business could be adversely affected by any delays, or increased costs, resulting from common carrier or transportation issues.
We rely on a variety of common carriers to transport our materials from our suppliers and to our customers. Problems suffered by any of these common carriers, including natural disaster, pandemic, labor problems, increased energy prices, or criminal activity, could result in shipping delays for products or materials, increased costs or other supply chain disruptions, and could therefore have a negative impact on our ability to receive products from suppliers and deliver products to customers, resulting in a material adverse effect on our operations.
We may not be able to maintain our engineering, technological and manufacturing expertise.
Many of the markets for our manufacturing and engineering services are characterized by rapidly changing technology and evolving process development. The continued success of our business will depend upon our ability to:

• | hire, retain and expand our pool of qualified engineering and technical personnel;

• | maintain and continually improve our technological expertise;

• | develop and market manufacturing services that meet changing customer needs; and

• | anticipate and respond to technological changes in manufacturing processes on a cost-effective and timely basis.

Although we use the assembly and testing technologies, equipment and processes that are currently required by our customers, we cannot be certain that we will be able to maintain or develop the capabilities required by our customers in the future. The emergence of new technology, industry standards or customer requirements may render our equipment, inventory or processes obsolete or noncompetitive. The acquisition and implementation of new technologies and equipment and the offering of new or additional services to our customers may require significant expense or capital investment, which could reduce our operating margins and our operating results. In facilities that we newly establish or acquire, we may not be able to insert or maintain our engineering, technological and manufacturing process expertise. Our failure to anticipate and adapt to our customers’ changing technological needs and requirements or to hire sufficient personnel to maintain our engineering, technological and manufacturing expertise could have a material adverse effect on our results of operations.
We depend on attracting and retaining officers, managers and skilled personnel.
Our success depends to a large extent upon the continued services of our officers, managers and skilled personnel. These employees are not generally bound by employment or non-competition agreements, and we cannot assure you that we will retain them. To aid in managing our growth and strengthening our pool of management and skilled personnel, we will need to internally develop, recruit and retain skilled management personnel. If we are not able to do so, our business and our ability to continue to grow could be harmed.
Efficient component and material purchasing is critical to our manufacturing processes and contractual arrangements. A shortage of components or an increase in price could interrupt our operations and reduce our profit, increase our inventory carrying costs, increase our risk of exposure to inventory obsolescence and cause us to purchase components of a lesser quality.
Strategic and efficient component and materials purchasing is an aspect of our strategy. When prices rise, they may impact our margins and results of operations if we are not able to pass the increases through to our customers or otherwise offset them. Most of our significant long-term customer contracts permit quarterly or other periodic prospective adjustments to pricing based on decreases and increases in component prices and other factors; however, we typically bear the risk of component price increases that occur between any such re-pricings or, if such re-pricing is not permitted, during the balance of the term of the particular customer contract. There can be no assurance that we will continue to be able to purchase the
12

Table of Contents
components and materials needed to manufacture customer products at favorable prices. Accordingly, certain component price increases could adversely affect our gross profit margins and results of operations.
Some of the products we manufacture require one or more components that are only available from a single source. Some of these components are subject to supply shortages from time to time. In some cases, supply shortages will substantially curtail production of all assemblies using a particular component. A supply shortage can also increase our cost of goods sold if we have to pay higher prices for components in limited supply, or cause us to have to redesign or reconfigure products to accommodate a substitute component. In the past there have been industry wide conditions, natural disasters and global events that have caused material shortages. Our production of a customer’s product could be negatively impacted by any quality, reliability or availability issues with any of our component suppliers. The financial condition of our suppliers could affect their ability to supply us with components and their ability to satisfy any warranty obligations they may have, which could have a material adverse effect on our results of operations.
If a component shortage is threatened or anticipated, we may purchase such components early to avoid a delay or interruption in our operations. Purchasing components early may cause us to incur additional inventory carrying costs and may cause us to experience inventory obsolescence, both of which may not be recoverable from our customers and could adversely affect our gross profit margins and net income. A component shortage may also require us to look to second tier vendors or to procure components through brokers with whom we are not familiar. These components may be of lesser quality than those we have historically purchased and could cause us to incur costs to bring such components up to our quality levels or to replace defective ones. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business – Components Procurement.”
We derive a substantial majority of our revenues from our international operations, which may be subject to a number of different risks and often require more management time and expense than our domestic operations.
Our international operations are subject to a number of risks, including:

• | difficulties in staffing and managing foreign operations and attempting to ensure compliance with our policies, procedures, and applicable local laws;

• | less flexible employee relationships that can be difficult and expensive to terminate due to, among other things, labor laws and regulations;

• | rising labor costs (including the introduction or expansion of certain social programs), in particular within the lower-cost regions in which we operate, due to, among other things, demographic changes and economic development in those regions;

• | labor unrest and dissatisfaction, including potential labor strikes or claims;

• | increased scrutiny by the media and other third parties of labor practices within our industry (including working conditions, compliance with employment and labor laws and compensation) which may result in allegations of violations, more stringent and burdensome labor laws and regulations, higher labor costs and/or loss of revenues if our customers become dissatisfied with our labor practices and diminish or terminate their relationship with us;

• | burdens of complying with a wide variety of foreign laws, including those relating to export and import duties, domestic and foreign import and export controls, trade barriers (including tariffs and quotas), environmental policies and privacy issues, and local statutory corporate governance rules;

• | risk of non-compliance with the U.S. Foreign Corrupt Practices Act (the “FCPA”) or similar regulations in other jurisdictions;

• | less favorable, less predictable, or relatively undefined, intellectual property laws;

• | lack of sufficient or available locations from which to operate or inability to renew leases on terms that are acceptable to us or at all;

• | unexpected changes in regulatory requirements and laws or government or judicial interpretations of such regulatory requirements and laws and adverse trade policies, and adverse changes to any of the policies of either the U.S. or any of the foreign jurisdictions in which we operate;

• | adverse changes in tax rates or accounting rules and the manner in which the U.S. and other countries tax multinational companies or interpret their tax laws or accounting rules or restrictions on the transfer of funds to us from our operations outside the U.S.;

• | limitations on imports or exports of components or products, or other trade sanctions;

13

Table of Contents

• | political and economic instability and unsafe working conditions;

• | risk of governmental expropriation of our property;

• | inadequate infrastructure for our operations (e.g., lack of adequate power, water, transportation and raw materials);

• | legal or political constraints on our ability to maintain or increase prices;

• | health concerns, epidemics and related government actions;

• | increased travel costs and difficulty in coordinating our communications and logistics across geographic distances and multiple time zones;

• | longer customer payment cycles and difficulty collecting trade accounts receivable;

• | fluctuations in currency exchange rates;

• | economies that are emerging or developing or that may be subject to greater currency volatility, negative growth, high inflation, limited availability of foreign exchange and other risks; and

• | international trade disputes could result in tariffs and other protectionist measures that could adversely affect our business. Tariffs could increase the costs of the components and raw materials we use in the manufacturing process as well as import and export costs for finished products. Countries could adopt other protectionist measures that could limit our ability to manufacture products or provide services. Increased costs to our U.S. customers who use our non-U.S. manufacturing sites and components may adversely impact demand for our services and our results of operation and financial condition. Additionally, international trade disputes may cause our customers to decide to relocate the manufacturing of their products to another location, either within country, or into a new country. Relocations may require considerable management time as well as expenses related to market, personnel and facilities development before any significant revenue is generated, which may negatively affect our margin. Furthermore, there can be no assurance that all customer manufacturing needs can be met in available locations within the desired timeframe, or at all, which may cause us to lose business, which may negatively affect our financial condition and results of operation.

In particular, a significant portion of our manufacturing, design, support and storage operations are conducted in our facilities in China, and revenues associated with our China operations are important to our success. Therefore, our business, financial condition and results of operations may be materially adversely affected by economic, political, legal, regulatory, competitive and other factors in China. International trade disputes with China could result in tariffs and other measures that could adversely affect the Company’s business. The Chinese economy differs from the economies of most developed countries in many respects, including the level of government involvement and control over economic growth. In addition, our operations in China are governed by Chinese laws, rules and regulations, some of which are relatively new. The Chinese legal system continues to rapidly evolve, which may result in uncertainties with respect to the interpretation and enforcement of Chinese laws, rules and regulations that could have a material adverse effect on our business. China experiences high turnover of direct labor in the manufacturing sector due to the intensely competitive and fluid market for labor, and the retention of adequate labor is a challenge. If our labor turnover rates are higher than we expect, or we otherwise fail to adequately manage our labor needs, then our business and results of operations could be adversely affected. We are also subject to risks associated with our subsidiaries organized in China. For example, regulatory and registration requirements and government approvals affect the financing that we can provide to our subsidiaries. If we fail to receive required registrations and approvals to fund our subsidiaries organized in China, or if our ability to remit currency out of China is limited, then our business and liquidity could be adversely affected.
These factors may harm our results of operations. Also, any measures that we may implement to reduce risks of our international operations may not be effective, may increase our expenses and may require significant management time and effort. Entry into new international markets requires considerable management time as well as start-up expenses related to market, personnel and facilities development before any significant revenue is generated. As a result, initial operations in a new market may operate at low margins or may be unprofitable.
Although we have implemented policies and procedures designed to cause compliance with the FCPA and similar laws, there can be no assurance that all of our employees and agents, as well as those companies to which we outsource certain of our business operations, will not take actions in violation of our policies which could have a material adverse effect on our operations.
We have on occasion not achieved, and may not in the future achieve, expected profitability from our acquisitions.
We have in the past and will continue to seek and complete acquisitions. We cannot assure you that we will be able to successfully integrate the operations and management of our recent acquisitions. Similarly, we cannot assure you that we will
14

Table of Contents
be able to identify future strategic acquisitions and adequately conduct due diligence, consummate these potential acquisitions on favorable terms, if at all, or if consummated, successfully integrate the operations and management of future acquisitions. Acquisitions involve significant risks, which could have a material adverse effect on us including:

• | Financial risks, such as: (1) overpayment; (2) an increase in our expenses and working capital requirements; (3) exposure to liabilities of the acquired businesses, with contractually-based time and monetary limitations on a seller’s obligation to indemnify us; (4) integration costs or failure to achieve synergy targets; (5) incurrence of additional debt; (6) valuation of goodwill and other intangible assets; (7) possible adverse tax and accounting effects; (8) the risk that we acquire manufacturing facilities and assume significant contractual and other obligations with no guaranteed levels of revenue; (9) the risk that, in the future, we may have to close or sell acquired facilities at our cost, which may include substantial employee severance costs and asset write-offs, which have resulted, and may result, in our incurring significant losses; and (10) costs associated with environmental risks including fines, remediation and clean-up.

• | Operating risks, such as: (1) the diversion of management’s attention and resources to the integration of the acquired businesses and their employees and to the management of expanding operations; (2) the risk that the acquired businesses will fail to maintain the quality of services that we have historically provided; (3) the need to implement financial and other systems and add management resources; (4) the need to maintain customer, supplier or other favorable business relationships of acquired operations and restructure or terminate unfavorable relationships; (5) the potential for deficiencies in internal controls of the acquired operations; (6) the inability to attract and retain the employees necessary to support the acquired businesses; (7) potential inexperience in a line of business that is either new to us or that has become materially more significant to us as a result of the transaction; (8) unforeseen difficulties (including any unanticipated liabilities) in the acquired operations; (9) the impact on us of any unionized work force we may acquire or any labor disruptions that might occur; (10) the possibility that the acquired business’s past transactions or practices before our acquisition may lead to future commercial or regulatory risks; (11) the difficulty of presenting a unified corporate image; (12) the possibility that we will have unutilized capacity due to our acquisition activity; (13) when acquiring an operation from a customer and continuing or entering into a supply arrangement, our inability to meet the expectations of the customer as to volume, product quality, timeliness and cost reductions.

Although we conduct what we believe to be a prudent level of due diligence regarding the businesses we purchase, in light of the circumstances of each transaction, an unavoidable level of risk remains regarding the actual condition of these businesses. Until we actually assume operating control of such businesses and their assets and operations, we may not be able to ascertain the actual value or understand the potential liabilities of the acquired entities and their operations.
Most of our acquisitions involve operations outside of the U.S., which are subject to various risks including those described in “Risk Factors – We derive a substantial majority of our revenue from our international operations, which may be subject to a number of risks and often require more management time and expense than our domestic operations.”
We have acquired and may continue to pursue the acquisition of manufacturing and supply chain management operations from our customers (or potential customers). In these acquisitions, the divesting company will typically enter into a supply arrangement with the acquirer. Therefore, our competitors often also pursue these acquisitions. In addition, certain divesting companies may choose not to offer to sell their operations to us because of our current supply arrangements with other companies or may require terms and conditions that may impact our profitability. If we are unable to attract and consummate some of these acquisition opportunities at favorable terms, our growth and profitability could be adversely impacted.
We have expanded the primary scope of our acquisitions strategy beyond focusing on acquisition opportunities presented by companies divesting internal manufacturing operations. As we continue to pursue acquisitions that diversify our business into new industry sectors with new customers and services, the amount and scope of the risks associated may extend beyond those that we have traditionally faced in making acquisitions. These risks include greater uncertainties in the financial benefits and potential liabilities associated with this expanded base of acquisitions.
We face risks arising from the restructuring of our operations.
Over the past several years, we have undertaken initiatives to restructure our business operations with the intention of improving utilization and realizing cost savings. These initiatives have included changing the number and location of our production facilities, largely to align our capacity and infrastructure with current and anticipated customer demand. The process of restructuring entails, among other activities, moving production between facilities, transferring programs from higher cost geographies to lower cost geographies, closing facilities, reducing the level of staff, realigning our business processes and reorganizing our management.
15

Table of Contents
Restructurings could adversely affect us, including a decrease in employee morale, delays encountered in finalizing the scope of, and implementing, the restructurings, failure to achieve targeted cost savings, and failure to meet operational targets and customer requirements due to the restructuring process. These risks are further complicated by our extensive international operations, which subject us to different legal and regulatory requirements that govern the extent and speed of our ability to reduce our manufacturing capacity and workforce.
Any delay in the implementation of our information systems could disrupt our operations and cause unanticipated increases in our costs.
We are currently in the process of completing the installation of an enterprise resource planning system in certain of our manufacturing facilities, which will replace the existing planning and financial information systems. Any delay in the implementation of these information systems could result in material adverse consequences, including disruption of operations, loss of information and unanticipated increases in costs.
Disruptions to our information systems, including security breaches, losses of data or outages, and other security issues, could adversely affect our operations.
We rely on information systems, some of which are owned and operated by third parties, to store, process and transmit confidential information, including financial reporting, inventory management, procurement, invoicing and electronic communications, belonging to our customers, our suppliers, our employees and/or us. We attempt to monitor and mitigate our exposure and modify our systems when warranted and we have implemented certain business continuity items including data backups at alternative sites. Nevertheless, these systems are vulnerable to, and at times have suffered from, among other things, damage from power loss or natural disasters, computer system and network failures, loss of telecommunication services, physical and electronic loss of data, terrorist attacks, security breaches, cyberattacks and computer viruses. We regularly face attempts by others to access our information systems in an unauthorized manner, to introduce malicious software to such systems or both. The increased use of mobile technologies and the internet of things can heighten these and other operational risks. If we, or the third parties who own and operate certain of our information systems, are unable to prevent such breaches, losses of data and outages, our operations could be disrupted. Also, the time and funds spent on monitoring and mitigating our exposure and responding to breaches, including the training of employees, the purchase of protective technologies and the hiring of additional employees and consultants to assist in these efforts could adversely affect our financial results. The increasing sophistication of cyberattacks requires us to continually evaluate the threat landscape and new technologies and processes intended to detect and prevent these attacks. There can be no assurance that the security measures and systems configurations we choose to implement will be sufficient to protect the data we manage. Any theft or misuse of information resulting from a security breach could result in, among other things, loss of significant and/or sensitive information, litigation by affected parties, financial obligations resulting from such theft or misuse, higher insurance premiums, governmental investigations, negative reactions from current and potential future customers (including potential negative financial ramifications under certain customer contract provisions) and poor publicity and any of these could adversely affect our financial results. In addition, we must comply with increasingly complex regulations intended to protect business and personal data in the U.S. and elsewhere. Compliance with these regulations can be costly and any failure to comply could result in legal and reputational risks as well as penalties, fines and damages that could adversely affect our financial results.
Regulatory Risks
We are subject to extensive government regulations and industry standards and the terms of complex contracts; a failure to comply with current and future regulations and standards, or the terms of our contractual arrangements, could have an adverse effect on our business, customer relationships, reputation and profitability.
We are subject to extensive government regulation and industry standards relating to the products we design and manufacture as well as how we conduct our business, including regulations and standards relating to labor and employment practices, workplace health and safety, the environment, sourcing and import/export practices, the market sectors we support, privacy and data protection, the regulations that apply to government contracts, and many other facets of our operations. The regulatory climate in the U.S. and other countries has become increasingly complex and fragmented, and regulatory activity has increased in recent periods. Failure or noncompliance with such regulations or standards could have an adverse effect on our reputation, customer relationships, profitability and results of operations. In addition, we regularly enter into a large number of complex contractual arrangements as well as operate pursuant to the terms of a significant number of ongoing intricate contractual arrangements. Our failure or our customers’ failure to comply with the terms of such arrangements could expose us to claims or other demands and could have an adverse effect on our reputation, customer relationships, profitability and results of operations.
16

Table of Contents
If we manufacture products containing design or manufacturing defects, demand for our services may decline, our reputation may be damaged and we may be subject to liability claims.
Our customers’ products and the manufacturing processes and design services that we use to produce them often are highly complex. Defects in the products we manufacture or design, whether caused by a design, manufacturing or component failure or error, or deficiencies in our manufacturing processes, may result in delayed shipments to customers or reduced or canceled customer orders. If these defects or deficiencies are significant, our business reputation may also be damaged. The failure of the products that we manufacture or of our manufacturing processes or facilities may subject us to regulatory enforcement, fines or penalties and, in some cases, require us to shut down, temporarily halt operations or incur considerable expense to correct a manufacturing process or facility. In addition, these defects may result in liability claims against us, expose us to liability to pay for the recall or remanufacture of a product or adversely affect product sales or our reputation. Even if our customers are responsible for the defects or defective specifications, they may not, or may not have resources to, assume responsibility for any costs or liabilities arising from these defects, which could expose us to additional liability claims. Any of these actions could increase our expenses, reduce our revenue or damage our reputation as a supplier to these customers.
We may face heightened liability risks specific to our medical device business as a result of additional healthcare regulatory related compliance requirements and the potential severe consequences (e.g., death or serious injury) that could result from manufacturing defects or malfunctions of the medical devices we manufacture or design.
As a service provider engaged in the business of designing and manufacturing medical devices for our customers, we have compliance requirements in addition to those relating to other industries we serve within our business. We are required to register with the U.S. Food and Drug Administration (“FDA”) and are subject to periodic inspection by the FDA for compliance with the FDA’s Quality System Regulation (“QSR”), including current Good Manufacturing Practices (cGMPs). This regulation establishes requirements for manufacturers of medical devices to implement design and process manufacturing controls, quality control, labeling, handling and documentation procedures. The FDA, through periodic inspections and post-market surveillance, continuously and rigorously monitors compliance with these QSR requirements and other applicable regulatory requirements. If any FDA inspection reveals noncompliance, and we do not address the FDA’s concerns to its satisfaction, the FDA may elect to take enforcement action against us, including issuing inspection observations or a notice of violation or a warning letter, imposing fines, bringing an action against the Company and its officers, requiring a recall of the products we manufactured, issuing an import detention on products entering the U.S. from an offshore facility or temporarily halting operations at or shutting down a manufacturing facility.
Beyond the FDA, our medical device business is also subject to applicable state and foreign regulatory requirements. Within the European Union (“EU”), we are required to fulfill certain internationally recognized standards and must undergo periodic inspections to obtain and maintain certifications to these standards. Continued noncompliance to the EU regulations could stop the flow of products into the EU from us or from our customers. In China, the Safe Food and Drug Administration controls and regulates the manufacture and commerce of healthcare products. We must comply with the regulatory laws applicable to medical device manufactures or our ability to manufacture products in China could be impacted. In Japan, the Pharmaceutical Affairs Laws regulate the manufacture and commerce of healthcare products. These regulations also require that subcontractors manufacturing products intended for sale in Japan register with authorities and submit to regulatory audits. Other foreign countries where we operate have similar laws regarding the regulation of medical device manufacturing. In the event of any noncompliance with these requirements, interruption of our operations and/or ability to allow commerce in these markets could occur, which in turn could cause our reputation and business to suffer.
Compliance or the failure to comply with current and future environmental, health and safety, product stewardship and producer responsibility laws or regulations could cause us significant expense.
We are subject to a variety of federal, state, local and foreign environmental, health and safety, product stewardship and producer responsibility laws and regulations, including those arising from global pandemics or relating to the use, generation, storage, discharge and disposal of hazardous chemicals used during our manufacturing process, those governing worker health and safety, those requiring design changes, supply chain investigation or conformity assessments and those relating to the recycling or reuse of products we manufacture. If we fail to comply with any present or future regulations or timely obtain any needed permits, we could become subject to liabilities, and we could face fines or penalties, the suspension of production, or prohibitions on sales of products we manufacture. In addition, such regulations could restrict our ability to expand our facilities or could require us to acquire costly equipment, or to incur other significant expenses, including expenses associated with the recall of any non-compliant product or with changes in our operational, procurement and inventory management activities.
Certain environmental laws impose liability for the costs of investigation, removal and remediation of hazardous or toxic substances on an owner, occupier or operator of real estate, or on parties who arranged for hazardous substance treatment or disposal, even if such person or company was unaware of, or not responsible for, contamination at the affected site. Soil and
17

Table of Contents
groundwater contamination may have occurred at or near, or may have arisen from, some of our facilities. From time to time we investigate, remediate and monitor soil and groundwater contamination at certain of our operating sites. In certain instances where contamination existed prior to our ownership or occupation of a site, landlords or former owners have retained some contractual responsibility for contamination and remediation. However, failure of such persons to perform those obligations could result in us being required to address such contamination. As a result, we may incur clean-up costs in such potential removal or remediation efforts. In other instances, we may be responsible for clean-up costs and other liabilities, including the possibility of claims due to health risks by both employees and non-employees, as well as other third-party claims in connection with contaminated sites.
In addition, there is an increasing governmental focus around the world on global warming and environmental impact issues, which may result in new environmental, health and safety regulations that may affect us, our suppliers and our customers. This could cause us to incur additional direct costs for compliance, as well as increased indirect costs resulting from our customers, suppliers or both incurring additional compliance costs that get passed on to us. These costs may adversely impact our operations and financial condition.
We have limited insurance coverage for potential environmental liabilities associated with current operations and we do not anticipate increasing such coverage in the future.
Our manufacturing, production and design processes and services may result in exposure to intellectual property infringement and other claims.
Providing manufacturing services can expose us to potential claims that products, designs or manufacturing processes we use infringe third party intellectual property rights. Even though many of our manufacturing services contracts require our customers to indemnify us for infringement claims relating to their products, including associated product specifications and designs, a particular customer may not, or may not have the resources to, assume responsibility for such claims. In addition, we may be responsible for claims that our manufacturing processes or components used in manufacturing infringe third party intellectual property rights. Providing turnkey design solutions, and design and other services can expose us to different or greater potential liabilities than those we face providing just manufacturing services, including an increase in exposure to potential claims that products we design or supply, or materials or components we use, infringe third party intellectual property rights. Infringement claims could subject us to significant liability for damages, potential injunctive action, or hamper our normal operations such as by interfering with the availability of components. Regardless of the merits of any such claim, it could be time-consuming and expensive to resolve, and have a material adverse effect on our results of operations and financial position. In the event of such a claim, we may spend significant amounts of money and effort to develop non-infringing alternatives or obtain and maintain licenses. We may not be successful in developing such alternatives or obtaining and maintaining such licenses on reasonable terms or at all. Our customers may be required to or decide to discontinue products that are alleged to be infringing, and such discontinuance may result in a significant decrease in our business and/or could have a material adverse effect on our results of operations and financial position. These risks may be heightened in connection with our customer relationships with emerging companies.
Components we purchase, products we design and/or manufacture and/or services we provide may infringe the intellectual property rights of third parties, some of whom may hold key intellectual property rights in areas in which we operate. Our customers or suppliers could also become subject to infringement claims. Patent clearance or licensing activities, if any, may be inadequate to anticipate and avoid third party claims. Additionally, customers for our services in which we have significant technology contributions, typically require that we indemnify them against the risk of intellectual property infringement. If any claims are brought against our customers, our suppliers or us for such infringement, regardless of their merits, we could be required to expend significant resources in the defense or settlement of such claims, or in the defense or settlement of related indemnification claims. In the event of a claim, we may be required to spend significant amounts of money and effort to develop non-infringing alternatives or obtain and maintain licenses. We may not be successful in developing such alternatives or obtaining or maintaining such licenses on reasonable terms or at all. We, our suppliers or our customers may be required to or decide to discontinue products, and such discontinuance may result in a significant decrease in our business, and could have a material adverse effect on our results of operations and financial position.
The success of certain aspects of our business depends in part on our ability to obtain, protect and leverage intellectual property rights.
In certain circumstances, we strive to obtain and protect certain intellectual property rights related to solutions, designs, processes and products that we create. We believe that obtaining a significant level of protected proprietary technology may give us a competitive advantage. In addition to selectively relying on patent rights, we rely on unpatented proprietary know-how and trade secrets, and employ various methods, including non-disclosure agreements with our customers, employees and suppliers and our internal security systems, policies and procedures to protect our know-how and trade secrets. However, we
18

Table of Contents
cannot be certain the measures we employ will result in protected intellectual property rights or will result in the prevention of unauthorized use of our technology. If we are unable to obtain and protect intellectual property rights embodied within our solutions, designs, processes and products, this could reduce or eliminate competitive advantages of our proprietary technology, which would harm our business and could have a material adverse effect on our results of operations and financial position.
Even if we take steps to protect certain intellectual property rights, these mechanisms may not afford complete or sufficient protection, and misappropriation may still occur. Further, there can be no assurance that we will be able to acquire or enforce our patent or other rights, if any, and that others will not independently develop similar know-how and trade secrets, or develop better solutions, designs, processes and products than us. We have not historically sought patent protection for many of our proprietary processes, designs or other patentable intellectual property. Further, we may not be able to prevent current and former employees, contractors and other parties from breaching non-disclosure agreements and misappropriating proprietary information. If any of the foregoing occur, it could impair our ability to compete with others in our industry, result in a significant decrease in our business and/or could have material adverse effect on our results of operations and financial position.
Financial Risks
Exposure to financially troubled customers or suppliers may adversely affect our financial results.
We provide manufacturing services to companies and industries that have in the past, and may in the future, experience financial difficulty. If our customers experience financial difficulty, we could have difficulty recovering amounts owed to us from these customers, or demand for our products from these customers could decline. Additionally, if our suppliers experience financial difficulty, we could have difficulty sourcing supplies necessary to fulfill production requirements. If one or more of our customers were to become insolvent or otherwise were unable to pay for the services provided by us on a timely basis, or at all, our operating results and financial condition could be adversely affected. Such adverse effects could include one or more of the following: an increase in our provision for doubtful accounts, a charge for inventory writeoffs, an impairment of contract assets, a reduction in revenue, and an increase in our working capital requirements due to higher inventory levels and increases in days our accounts receivable are outstanding. In addition, because we securitize certain of our accounts receivable, our securitization programs could be negatively affected by customer financial difficulty affecting the recovery of a significant amount of receivables.
When financial markets experience significant turmoil, the financial arrangements we may need to enter into, refinance or repay and our customers may be adversely affected.
Credit market turmoil could negatively impact the counterparties and lenders to our forward foreign exchange contracts, trade accounts receivable securitization and sale programs, unsecured credit and term loan facilities, commercial paper program, various foreign subsidiary credit facilities and other debt facilities. These potential negative impacts could limit our ability to borrow under these financing agreements, contracts, facilities and programs or renew or obtain future additional financing. Credit market turmoil could also negatively impact certain of our customers and certain of their respective customers, which could cause them to reduce or cancel their orders and have a negative effect on our results of operations.
We can offer no assurance under the uncommitted trade accounts receivable sales programs that if we attempt to sell receivables through such programs in the future that we will receive funding from the associated banks, which would require us to utilize other available sources of liquidity, including our revolving credit facilities.
We are subject to the risk of increased taxes.
We base our tax position upon the anticipated nature and conduct of our business and upon our understanding of the tax laws of the various countries in which we have assets or conduct activities. Our tax position, however, is subject to review and possible challenge by taxing authorities and to possible changes in law (including adverse changes to the manner in which the U.S. and other countries tax multinational companies or interpret their tax laws). We cannot determine in advance the extent to which some jurisdictions may assess additional tax or interest and penalties on such additional taxes. In addition, our effective tax rate may be increased by changes in the mix of earnings between jurisdictions, changes in the valuation of deferred tax assets and liabilities, changes in our cash management strategies, changes in local tax rates or countries adopting more aggressive interpretations of tax laws, or other legislative changes, including the Tax Cuts and Jobs Act of 2017 (“Tax Act”).
Several countries in which we are located allow for tax incentives to attract and retain business. We have obtained incentives where available and practicable. Our taxes could increase if certain tax incentives are retracted, which could occur if we are unable to satisfy the conditions on which such incentives are based, if they are not renewed upon expiration, or if tax rates applicable to us in such jurisdictions otherwise increase. Due to the possibility of changes in existing tax law and our
19

Table of Contents
operations, we are unable to predict how any expirations will impact us in the future. In addition, acquisitions may cause our effective tax rate to increase, depending on the jurisdictions in which the acquired operations are located.
Certain of our subsidiaries provide financing, products and services to, and may undertake certain significant transactions with, other subsidiaries in different jurisdictions. Several jurisdictions in which we operate have tax laws with detailed transfer pricing rules that require that all transactions with non-resident related parties be priced using arm’s length pricing principles, and that contemporaneous documentation must exist to support such pricing. There is a risk that the taxing authorities may not deem our transfer pricing documentation acceptable. In addition, the Organization for Economic Cooperation and Development continues to issue guidelines and proposals related to Base Erosion and Profit Shifting which may result in legislative changes that could reshape international tax rules in numerous countries and negatively impact our effective tax rate.
Our credit rating may be downgraded.
Our credit is and certain of our financial instruments and our commercial paper are rated by credit rating agencies. Any potential future negative change in our credit ratings may make it more expensive for us to raise additional capital on terms that are acceptable to us, if at all; negatively impact the price of our common stock; increase our interest payments under existing debt agreements; cause us to lose the ability to utilize our commercial paper program; and have other negative implications on our business, many of which are beyond our control. In addition, the interest rate payable under the Credit Facility (as such terms are defined in Note 7 – “Notes Payable and Long-Term Debt” to the Consolidated Financial Statements) is subject to adjustment from time to time if our credit ratings change. Thus, any potential future negative change in our credit rating may increase the interest rate payable on the Credit Facility and certain of our other borrowings.
Our amount of debt could significantly increase in the future.
The Company has a number of debt facilities. Refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources” and Note 7 – “Notes Payable and Long-Term Debt” to the Consolidated Financial Statements for further details.
Should we desire to consummate significant additional acquisition opportunities, undertake significant additional expansion activities, or make substantial investments in our infrastructure or in support of customer opportunities, our capital needs would increase and could result in our need to increase available borrowings under our revolving credit facilities or access public or private debt and equity markets. There can be no assurance, however, that we would be successful in raising additional debt or equity on terms that we would consider acceptable. An increase in the level of our indebtedness, among other things, could:

• | make it difficult for us to obtain any necessary financing in the future for other acquisitions, working capital, capital expenditures, debt service requirements or other purposes;

• | limit our flexibility in planning for, or reacting to changes in, our business;

• | make us more vulnerable in the event of a downturn in our business; and

• | impact certain financial covenants that we are subject to in connection with our debt and asset-backed securitization programs.

There can be no assurance that we will be able to meet future debt service obligations.
An adverse change in the interest rates for our borrowings could adversely affect our financial condition.
We pay interest on outstanding borrowings under our revolving credit facilities and certain other long term debt obligations at interest rates that fluctuate based upon changes in various base interest rates. An adverse change in the base rates upon which our interest rates are determined could have a material adverse effect on our financial position, results of operations and cash flows. If certain economic or fiscal issues occur, interest rates could rise, which would increase our interest costs and reduce our net income. Also, increased interest rates could make any future fixed interest rate debt obligations more expensive.
In addition, the U. K.’s Financial Conduct Authority, which regulates LIBOR, announced that it intends to phase out LIBOR by the end of 2021. The alternative reference rates for U.S. dollar LIBOR and other currencies have been announced. At this time, we cannot predict how markets will respond to these proposed alternative rates or the effect of any changes to LIBOR or the discontinuation of LIBOR. If LIBOR is no longer available or if our lenders have increased costs due to changes in LIBOR, we may experience potential increases in interest rates on our variable rate debt, which could adversely impact our interest expense, results of operations and cash flows.
20

Table of Contents
We are subject to risks of currency fluctuations and related hedging operations.
Although a significant number of our operations are located outside the United States, the majority of our business is conducted in U.S. dollars. Changes in exchange rates will affect our net revenue, cost of sales, operating margins and net income. We cannot predict the impact of future exchange rate fluctuations. We use financial instruments, primarily forward contracts, to hedge our exposure to exchange rate fluctuations. We believe that our hedging activities enable us to largely protect ourselves from future exchange rate fluctuations. If, however, these hedging activities are not successful, if the counterparties to these hedging activities default on their obligations to us or if we change or reduce these hedging activities in the future, we may experience significant unexpected expenses from fluctuations in exchange rates. In addition, certain countries in which we operate have adopted, or may adopt, currency controls requiring that local transactions be settled only in local currency. Such controls could require us to hedge larger amounts of local currency than we have in the past.
Energy price increases may negatively impact our results of operations.
Certain of the components that we use in our manufacturing activities are petroleum-based. In addition, we, along with our suppliers and customers, rely on various energy sources (including oil) in our facilities and transportation activities. An increase in energy prices, which have been volatile historically, could cause an increase in our raw material costs and transportation costs. In addition, increased transportation costs of certain of our suppliers and customers could be passed along to us. We may not be able to increase our product prices enough to offset these increased costs. In addition, any increase in our product prices may reduce our future customer orders and profitability.
An impairment in the value of our assets would reduce the value of our assets and reduce our net income in the year in which the write-off occurs.
We have recorded intangible assets, including goodwill, in connection with business acquisitions. We perform a goodwill impairment analysis on an annual basis and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If the carrying amount of the reporting unit exceeds its fair value, goodwill is considered impaired. Refer to note 6 to the consolidated financial statements for further discussion of the impairment testing of goodwill and identifiable intangible assets. A decline in general economic conditions or global equity valuations could impact the judgments and assumptions about the fair value of our businesses and we could be required to record impairment charges on our goodwill or other identifiable intangible assets in the future, which could impact our consolidated balance sheet, as well as our consolidated statement of operations.
General Risk Factors
Changes in financial accounting standards or policies have affected, and in the future may affect, our reported financial condition or results of operations.
We prepare our financial statements in conformity with U.S. GAAP. These principles are subject to interpretation by the Financial Accounting Standards Board (FASB), the American Institute of Certified Public Accountants, the SEC and various bodies formed to interpret and create appropriate accounting policies. A change in these policies can have a significant effect on our reported results and may affect our reporting of transactions that are completed before a change is announced. Changes to those rules or questions as to how we interpret or implement them may have a material adverse effect on our reported financial results or on the way we conduct business. For example, significant changes to revenue recognition rules have been adopted and first applied to us in fiscal year 2019.
We are subject to risks associated with natural disasters, climate change and global events.
Our operations and those of our customers and suppliers may be subject to natural disasters, climate change-related events, or other business disruptions, which could seriously harm our results of operation and increase our costs and expenses. We are susceptible to losses and interruptions caused by hurricanes (including in Florida, where our headquarters are located), earthquakes, power shortages, telecommunications failures, water or other natural resource shortages, tsunamis, floods, typhoons, drought, fire, extreme weather conditions, rising sea level, geopolitical events such as direct or indirect terrorist acts or acts of war, other natural or manmade disasters, boycotts and sanctions or widespread criminal activities. Such events could make it difficult or impossible to manufacture or to deliver products to our customers, receive production materials from our suppliers, or perform critical functions, which could adversely affect our business globally or in certain regions. While we maintain similar manufacturing capacities at different locations and coordinate multi-source supplier programs on many of our materials, which we believe better enables us to respond to these types of events, we cannot be sure that our plans will fully protect us from all such disruptions. Our insurance coverage with respect to natural disasters is limited and is subject to deductibles and coverage limits. Such coverage may not be adequate, or may not continue to be available at commercially reasonable rates and terms.
21

Table of Contents
While we manufacture our products in a large number of diversified facilities and maintain insurance covering our facilities, including business interruption insurance, a catastrophic loss of the use of all or a portion of one of our key manufacturing facilities due to accident, labor issues, weather conditions, natural disaster or otherwise, whether short- or long-term, could have a material adverse effect on us.
22

Table of Contents
Item 1B. Unresolved Staff Comments
There are no unresolved written comments from the SEC staff regarding our periodic or current reports.
Item 2. Properties
We own or lease facilities located primarily in the geographies listed below. We believe that our properties are generally in good condition, are well maintained and are generally suitable and adequate to carry out our business at expected capacity for the foreseeable future. The majority of the square footage is active manufacturing space and are reported in both the EMS and DMS operating segments, as both use these properties. Our corporate headquarters is located in St. Petersburg, Florida.
The table below lists the approximate square footage for our facilities as of August 31, 2020 (in thousands):

Location | Approximate Square Footage
Asia | 33,161 |
Americas | 15,645 |
Europe | 5,052 |
Total as of August 31, 2020 (1)(2) | 53,858 |

(1) | Approximately 14% of our total square footage is not currently used in business operations.

(2) | Consists of 18.2 million square feet in facilities that we own with the remaining 35.7 million square feet in leased facilities.

Our manufacturing facilities are ISO certified to ISO 9001:2008 standards and most are also certified to ISO-14001:2004 environmental standards.
Item 3. Legal Proceedings
We are party to certain lawsuits in the ordinary course of business. We do not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on our financial position, results of operations or cash flows.
Item 4. Mine Safety Disclosures
Not applicable.
23

Table of Contents
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market Information and Dividends
Our common stock trades on the New York Stock Exchange under the symbol “JBL.” See discussion of our cash dividends declared to common shareholders in Note 12 - “Stockholders’ Equity” to the Consolidated Financial Statements.
We expect to continue to declare and pay quarterly dividends of an amount similar to our past declarations. However, the declaration and payment of future dividends are discretionary and will be subject to determination by our Board of Directors each quarter following its review of our financial performance and global economic conditions.
On October 14, 2020, the closing sales price for our common stock as reported on the New York Stock Exchange was $35.63. As of October 14, 2020, there were 1,266 holders of record of our common stock. A substantially greater number of holders of our common stock are “street name” or beneficial holders, whose shares are held of record by banks, brokers, and other financial institutions.
Information regarding equity compensation plans is incorporated by reference to the information set forth in Item 12 of Part III of this report.
Stock Performance Graph
The performance graph and table show a comparison of cumulative total stockholder return, assuming the reinvestment of dividends, from a $100 investment in the common stock of Jabil over the five-year period ending August 31, 2020, with the cumulative stockholder return of the (1) S&P MidCap 400 Index and (2) peer group which includes Celestica Inc., Catcher Technology Co., Ltd, Flex Ltd., Hon-Hai Precision Industry Co. Ltd, Plexus Corp., and Sanmina Corp.

August 31 | 2015 |  | 2016 |  | 2017 |  | 2018 |  | 2019 |  | 2020
Jabil Inc. | $ | 100 |  |  | $ | 111 |  |  | $ | 167 |  |  | $ | 159 |  |  | $ | 157 |  |  | $ | 188 |
S&P MidCap 400 Index – Total Returns | 100 |  |  | 112 |  |  | 126 |  |  | 151 |  |  | 142 |  |  | 148 |
Peer Group | 100 |  |  | 104 |  |  | 165 |  |  | 125 |  |  | 94 |  |  | 107 |

Issuer Purchases of Equity Securities
24

Table of Contents
The following table provides information relating to our repurchase of common stock during the three months ended August 31, 2020:

Period | Total Number of Shares Purchased(1) |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Program(2) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (in thousands)(2)
June 1, 2020 - June 30, 2020 | 80,750 |  |  | $ | 31.52 |  |  | 80,750 |  |  | $ | 408,525 |
July 1, 2020 - July 31, 2020 | 457,212 |  |  | $ | 32.23 |  |  | 455,893 |  |  | $ | 393,829 |
August 1, 2020 - August 31, 2020 | 223,628 |  |  | $ | 34.67 |  |  | 223,628 |  |  | $ | 386,076 |
Total | 761,590 |  |  | $ | 32.87 |  |  | 760,271 |  |  |

(1) | The purchases include amounts that are attributable to 1,319 shares surrendered to us by employees to satisfy, in connection with the vesting of restricted stock units and the exercise of stock options and stock appreciation rights, their tax withholding obligations.

(2) | In September 2019, our Board of Directors authorized the repurchase of up to $600.0 million of our common stock as publicly announced in a press release on September 24, 2019 (the “2020 Share Repurchase Program”).

25

Table of Contents
Item 6. Selected Financial Data
The following selected data is derived from our Consolidated Financial Statements. This data should be read in conjunction with the Consolidated Financial Statements and notes thereto incorporated into Item 8, “Financial Statements and Supplementary Data” and with Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018 |  | 2017 |  | 2016
| (in thousands, except for per share data)
Consolidated Statement of Operations Data: |  |  |  |  |  |  |  |  |
Net revenue | $ | 27,266,438 |  |  | $ | 25,282,320 |  |  | $ | 22,095,416 |  |  | $ | 19,063,121 |  |  | $ | 18,353,086 |
Operating income | 499,846 |  |  | 701,356 |  |  | 542,153 |  |  | 410,230 |  |  | 522,833 |
Income before income tax | 260,738 |  |  | 450,704 |  |  | 373,401 |  |  | 256,233 |  |  | 387,045 |
Net income | 56,779 |  |  | 289,474 |  |  | 87,541 |  |  | 127,167 |  |  | 254,896 |
Net income attributable to Jabil Inc. | $ | 53,912 |  |  | $ | 287,111 |  |  | $ | 86,330 |  |  | $ | 129,090 |  |  | $ | 254,095 |
Earnings per share attributable to the stockholders of Jabil Inc.: |  |  |  |  |  |  |  |  |
Basic | $ | 0.36 |  |  | $ | 1.85 |  |  | $ | 0.50 |  |  | $ | 0.71 |  |  | $ | 1.33 |
Diluted | $ | 0.35 |  |  | $ | 1.81 |  |  | $ | 0.49 |  |  | $ | 0.69 |  |  | $ | 1.32 |

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018 |  | 2017 |  | 2016
| (in thousands)
Consolidated Balance Sheets Data: |  |  |  |  |  |  |  |  |
Working capital(1) | $ | 75,402 |  |  | $ | (187,020 | ) |  | $ | 319,050 |  |  | $ | (243,910 | ) |  | $ | 280,325 |
Total assets | $ | 14,397,416 |  |  | $ | 12,970,475 |  |  | $ | 12,045,641 |  |  | $ | 11,095,995 |  |  | $ | 10,322,677 |
Current installments of notes payable and long-term debt | $ | 50,194 |  |  | $ | 375,181 |  |  | $ | 25,197 |  |  | $ | 444,255 |  |  | $ | 44,689 |
Notes payable and long-term debt, less current installments | $ | 2,678,288 |  |  | $ | 2,121,284 |  |  | $ | 2,493,502 |  |  | $ | 1,606,017 |  |  | $ | 2,046,655 |
Total Jabil Inc. stockholders’ equity | $ | 1,811,384 |  |  | $ | 1,887,443 |  |  | $ | 1,950,257 |  |  | $ | 2,353,514 |  |  | $ | 2,438,171 |
Common stock shares outstanding | 150,330 |  |  | 153,520 |  |  | 164,588 |  |  | 177,728 |  |  | 186,998 |

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018 |  | 2017 |  | 2016
| (in thousands)
Consolidated Cash Flow Data: |  |  |  |  |  |  |  |  |
Investing activities: |  |  |  |  |  |  |  |  |
Acquisition of property, plant and equipment | $ | (983,035 | ) |  | $ | (1,005,480 | ) |  | $ | (1,036,651 | ) |  | $ | (716,485 | ) |  | $ | (924,239 | )
Proceeds and advances from sale of property, plant and equipment | $ | 186,655 |  |  | $ | 218,708 |  |  | $ | 350,291 |  |  | $ | 175,000 |  |  | $ | 26,031 |
Financing activities: |  |  |  |  |  |  |  |  |
Payments to acquire treasury stock | $ | (214,510 | ) |  | $ | (350,323 | ) |  | $ | (450,319 | ) |  | $ | (306,640 | ) |  | $ | (148,340 | )

(1) | Working capital is defined as current assets minus current liabilities.

26

Table of Contents
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Overview
We are one of the leading providers of worldwide manufacturing services and solutions. We provide comprehensive electronics design, production and product management services to companies in various industries and end markets. We derive substantially all of our revenue from production and product management services (collectively referred to as “manufacturing services”), which encompass the act of producing tangible components that are built to customer specifications and are then provided to the customer.
We have two reporting segments: Electronics Manufacturing Services (“EMS”) and Diversified Manufacturing Services (“DMS”), which are organized based on the economic profiles of the services performed, including manufacturing capabilities, market strategy, margins, return on capital and risk profiles. Our EMS segment is focused around leveraging IT, supply chain design and engineering, technologies largely centered on core electronics, utilizing our large-scale manufacturing infrastructure and our ability to serve a broad range of end markets. Our EMS segment includes customers primarily in the automotive and transportation, capital equipment, cloud, networking and storage, defense and aerospace, industrial and energy, print and retail, and smart home and appliances industries. Our DMS segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies and healthcare. Our DMS segment includes customers primarily in the connected devices, healthcare, mobility and packaging industries.
As of September 1, 2020, certain customers have been realigned within our operating segments. Our operating segments, which are the reporting segments, continue to consist of the DMS and EMS segments. Beginning in fiscal year 2021, customers within the automotive and transportation and smart home and appliances industries will be presented within the DMS segment.
Our cost of revenue includes the cost of electronic components and other materials that comprise the products we manufacture; the cost of labor and manufacturing overhead; and adjustments for excess and obsolete inventory. As a provider of turnkey manufacturing services, we are responsible for procuring components and other materials. This requires us to commit significant working capital to our operations and to manage the purchasing, receiving, inspecting and stocking of materials. Although we bear the risk of fluctuations in the cost of materials and excess scrap, our ability to purchase components and materials efficiently may contribute significantly to our operating results. While we periodically negotiate cost of materials adjustments with our customers, rising component and material prices may negatively affect our margins. Net revenue from each product that we manufacture consists of an element based on the costs of materials in that product and an element based on the labor and manufacturing overhead costs allocated to that product. Our gross margin for any product depends on the mix between the cost of materials in the product and the cost of labor and manufacturing overhead allocated to the product.
Our operating results are impacted by the level of capacity utilization of manufacturing facilities; indirect labor costs; and selling, general and administrative expenses. Operating income margins have generally improved during periods of high production volume and high capacity utilization. During periods of low production volume, we generally have reduced operating income margins.
We monitor the current economic environment and its potential impact on both the customers we serve as well as our end markets and closely manage our costs and capital resources so that we can try to respond appropriately as circumstances change.
We have consistently utilized advanced circuit design, production design and manufacturing technologies to meet the needs of our customers. To support this effort, our engineering staff focuses on developing and refining design and manufacturing technologies to meet specific needs of specific customers. Most of the expenses associated with these customer-specific efforts are reflected in our cost of revenue. In addition, our engineers engage in research and development (“R&D”) of new technologies that apply generally to our operations. The expenses of these R&D activities are reflected in the research and development line item within our Consolidated Statement of Operations.
An important element of our strategy is the expansion of our global production facilities. The majority of our revenue and materials costs worldwide are denominated in U.S. dollars, while our labor and utility costs in operations outside the U.S. are denominated in local currencies. We economically hedge certain of these local currency costs, based on our evaluation of the potential exposure as compared to the cost of the hedge, through the purchase of foreign currency exchange contracts. Changes in the fair market value of such hedging instruments are reflected within the Consolidated Statement of Operations and the Consolidated Statement of Comprehensive Income.
27

Table of Contents
See Note 13 – “Concentration of Risk and Segment Data” to the Consolidated Financial Statements.
COVID-19
The COVID-19 pandemic, which began to impact us in January 2020, has continued to affect our business and the businesses of our customers and suppliers into our fiscal fourth quarter. Travel and business operation restrictions arising from virus containment efforts of governments around the world have continued to impact our operations in Asia, Europe and the Americas. With the exception of certain jurisdictions, essential activity exceptions from these restrictions have allowed us to continue to operate. Nevertheless, virus containment efforts during the fiscal year ended August 31, 2020, led to a disruption in operations and certain facility or intermittent business closures in areas such as China, Malaysia, India, Mexico and California, which resulted in additional direct costs and a reduction in revenue in certain end markets.
Our first priority has been the health and safety of our employees and so we have incurred additional costs in order to procure the necessary equipment, including face masks, thermometers, hand sanitizers and personal protection equipment, to keep our employees safe. We have implemented risk-mitigation activities including travel restrictions, social distancing practices, additional cleaning procedures within our facilities, contact tracing, COVID-19 testing, restricting the number of visitors to our sites and requiring employees and visitors to have their temperatures taken and wear masks when they are at our sites. During the fiscal year ended August 31, 2020, we incurred approximately $141.9 million in direct costs associated with the COVID-19 outbreak, primarily due to incremental and idle labor costs leading to a reduction in factory utilization as a result of the travel disruptions and governmental restrictions and the procurement of personal protection equipment for our employees globally. This increase in costs was partially offset by governmental subsidies, such as lower payroll taxes or social insurance in certain countries, related to COVID-19 incentives.
Additionally, certain of the Company’s suppliers were similarly impacted by the COVID-19 pandemic, leading to supply chain constraints, including difficulty sourcing materials necessary to fulfill customer production requirements and challenges in transporting completed products to our end customers.
We have implemented efforts across the organization to enhance our financial position, increase liquidity and reduce costs. During the fiscal year ended August 31, 2020, we added incremental short-term committed revolving credit agreements of $625.0 million. We also issued $600.0 million of 10-year Senior Notes in July 2020, which was used to: (i) pay $400.0 million of Senior Notes due in December 2020 and (ii) increase our cash on hand.
In addition, we have taken aggressive steps to reduce expenses, including suspending base salary increases for Fiscal Year 2021. Our Chief Executive Officer, Chief Financial Officer and other executive vice presidents will reduce their base salaries by 25% from June 1, 2020 through November 30, 2020 and will forego any bonus that would otherwise be due to them under Jabil’s Fiscal Year 2020 short-term incentive program. Members of Jabil’s Board of Directors will also reduce by 25% their annual cash retainers that would otherwise be payable during the period from June 1, 2020 through November 30, 2020.
In order to further decrease operating expenses and better align with the needs of the business, we have reduced our worldwide workforce and implemented voluntary early retirement programs. In connection with reducing our worldwide workforce, we incurred $56.6 million of severance and benefit costs during the fiscal year ended August 31, 2020. Following this reduction in headcount, we expect annual savings beginning in Fiscal Year 2021 of approximately $40.0 million to $50.0 million. We continue to focus on prioritizing spending related to future business.
We do not expect any material impairments or adjustments to the fair value of our assets as a result of the COVID-19 pandemic. In addition, we completed our annual impairment test for goodwill and indefinite-lived intangible assets during the fourth quarter of fiscal year 2020 and determined there was no impairment of our goodwill, intangible assets or long-lived assets.
Our performance is subject to global economic conditions, as well as their impacts on levels of consumer spending and the production of goods. These current conditions are significantly impacted by COVID-19, have had a negative impact on our results of operations during the fiscal year ended August 31, 2020 and will continue to have a negative impact on our operations over the next fiscal year and likely beyond.
Summary of Results
The following table sets forth, for the periods indicated, certain key operating results and other financial information (in thousands, except per share data):
28

Table of Contents

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Net revenue | $ | 27,266,438 |  |  | $ | 25,282,320 |  |  | $ | 22,095,416 |
Gross profit | $ | 1,930,813 |  |  | $ | 1,913,401 |  |  | $ | 1,706,792 |
Operating income | $ | 499,846 |  |  | $ | 701,356 |  |  | $ | 542,153 |
Net income attributable to Jabil Inc. | $ | 53,912 |  |  | $ | 287,111 |  |  | $ | 86,330 |
Earnings per share – basic | $ | 0.36 |  |  | $ | 1.85 |  |  | $ | 0.50 |
Earnings per share – diluted | $ | 0.35 |  |  | $ | 1.81 |  |  | $ | 0.49 |

Key Performance Indicators
Management regularly reviews financial and non-financial performance indicators to assess the Company’s operating results. Changes in our operating assets and liabilities are largely affected by our working capital requirements, which are dependent on the effective management of our sales cycle as well as timing of payments. Our sales cycle measures how quickly we can convert our manufacturing services into cash through sales. We believe the metrics set forth below are useful to investors in measuring our liquidity as future liquidity needs will depend on fluctuations in levels of inventory, accounts receivable and accounts payable.
The following table sets forth, for the quarterly periods indicated, certain of management’s key financial performance indicators:

| Three Months Ended
| August 31, 2020 |  | May 31, 2020 |  | February 29, 2020 |  | November 30, 2019
Sales cycle(1) | 16 days |  | 27 days |  | 30 days |  | 23 days
Inventory turns (annualized)(2) | 6 turns |  | 5 turns |  | 5 turns |  | 6 turns
Days in accounts receivable(3) | 35 days |  | 37 days |  | 34 days |  | 43 days
Days in inventory(4) | 56 days |  | 67 days |  | 70 days |  | 57 days
Days in accounts payable(5) | 75 days |  | 77 days |  | 74 days |  | 77 days
| Three Months Ended
| August 31, 2019 |  | May 31, 2019 |  | February 28, 2019 |  | November 30, 2018
Sales cycle(1) | 19 days |  | 27 days |  | 25 days |  | 16 days
Inventory turns (annualized)(2) | 6 turns |  | 6 turns |  | 6 turns |  | 6 turns
Days in accounts receivable(3) | 38 days |  | 39 days |  | 38 days |  | 38 days
Days in inventory(4) | 58 days |  | 64 days |  | 65 days |  | 60 days
Days in accounts payable(5) | 77 days |  | 76 days |  | 78 days |  | 82 days

(1) | The sales cycle is calculated as the sum of days in accounts receivable and days in inventory, less the days in accounts payable; accordingly, the variance in the sales cycle quarter over quarter is a direct result of changes in these indicators.

(2) | Inventory turns (annualized) are calculated as 360 days divided by days in inventory.

(3) | Days in accounts receivable is calculated as accounts receivable, net, divided by net revenue multiplied by 90 days. During the three months ended May 31, 2020 and November 30, 2019, the increase in days in accounts receivable from the prior sequential quarter was primarily due to an increase in accounts receivable, primarily driven by higher sales and timing of collections. During the three months ended February 29, 2020, the decrease in days in accounts receivable from the prior sequential quarter is primarily driven by lower sales and the timing of collections in the second quarter.

(4) | Days in inventory is calculated as inventory and contract assets divided by cost of revenue multiplied by 90 days. During the three months ended August 31, 2020, May 31, 2020 and August 31, 2019, the decrease in days in inventory from the prior sequential quarter was primarily due to increased sales activity during the quarter. During the three months ended February 29, 2020, the increase in days in inventory from the prior sequential quarter is primarily driven by idle capacity and supply chain constraints, largely in China due to COVID-19. During the three months ended February 28, 2019, days in inventory increased from the prior sequential quarter to support anticipated ramps and expected sales levels in the second half of fiscal year 2019 and due to the acquisition of certain assets of Johnson & Johnson Medical Devices Companies (“JJMD”) facilities at the end of February.

(5) | Days in accounts payable is calculated as accounts payable divided by cost of revenue multiplied by 90 days. During the three months ended May 31, 2019, the decrease in days in accounts payable from the prior sequential quarter was primarily due to timing of purchases and cash payments for purchases during the quarter. During the three months ended February 28, 2019, the decrease in days in accounts payable from the prior sequential quarter was primarily due

29

Table of Contents
to lower materials purchases during the quarter and timing of purchases and cash payments for purchases during the quarter.
Critical Accounting Policies and Estimates
The preparation of our Consolidated Financial Statements and related disclosures in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and judgments that affect our reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and assumptions based upon historical experience and various other factors and circumstances. Management believes that our estimates and assumptions are reasonable under the circumstances; however, actual results may vary from these estimates and assumptions under different future circumstances. We have identified the following critical accounting policies that affect the more significant judgments and estimates used in the preparation of our Consolidated Financial Statements. For further discussion of our significant accounting policies, refer to Note 1 – “Description of Business and Summary of Significant Accounting Policies” to the Consolidated Financial Statements.
Revenue Recognition
For our over time customers, we believe the measure of progress which best depicts the transfer of control is based on costs incurred to date, relative to total estimated cost at completion (i.e., an input method). This method is a faithful depiction of the transfer of goods or services because it results in the recognition of revenue on the basis of our to-date efforts in the satisfaction of a performance obligation relative to the total expected efforts in the satisfaction of the performance obligation. We believe that the use of an input method best depicts the transfer of control to the customer, which occurs as we incur costs on our contracts. The transaction price of each performance obligation is generally based upon the contractual stand-alone selling price of the product or service.
Certain contracts with customers include variable consideration, such as periodic cost of materials adjustments, rebates, discounts, or returns. We recognize estimates of this variable consideration that are not expected to result in a significant revenue reversal in the future, primarily based on the most likely level of consideration to be paid to the customer under the specific terms of the underlying programs.
Allowance for Doubtful Accounts
We maintain an allowance for doubtful accounts related to receivables not expected to be collected from our customers. This allowance is based on management’s assessment of specific customer balances after considering the age of receivables and financial stability of the customer. If there is an adverse change in the financial condition and circumstances of our customers, or if actual defaults are higher than provided for, an addition to the allowance may be necessary.
Inventory Valuation
We purchase inventory based on forecasted demand and record inventory at the lower of cost and net realizable value. Management regularly assesses inventory valuation based on current and forecasted usage, customer inventory-related contractual obligations and other lower of cost and net realizable value considerations. If actual market conditions or our customers’ product demands are less favorable than those projected, additional valuation adjustments may be necessary.
Long-Lived Assets
We review property, plant and equipment and amortizable intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of property, plant and equipment is measured by comparing its carrying value to the undiscounted projected cash flows that the asset(s) or asset group(s) are expected to generate. If the carrying amount of an asset or an asset group is not recoverable, we recognize an impairment loss based on the excess of the carrying amount of the long-lived asset or asset group over its respective fair value, which is generally determined as either the present value of estimated future cash flows or the appraised value. The impairment analysis is based on significant assumptions of future results made by management, including revenue and cash flow projections. Circumstances that may lead to impairment of property, plant and equipment include unforeseen decreases in future performance or industry demand and the restructuring of our operations resulting from a change in our business strategy or adverse economic conditions.
We have recorded intangible assets, including goodwill, in connection with business acquisitions. Estimated useful lives of amortizable intangible assets are determined by management based on an assessment of the period over which the asset is expected to contribute to future cash flows. The fair value of acquired amortizable intangible assets impacts the amounts recorded as goodwill.
30

Table of Contents
We perform a goodwill impairment analysis using the two-step method on an annual basis and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. The Company may elect to perform a qualitative assessment to determine whether it is more likely than not that a reporting unit is impaired. If the qualitative assessment is not performed or if the Company determines that it is not more likely than not that the fair value of the reporting unit exceeds the carrying value, the recoverability of goodwill is measured at the reporting unit level by comparing the reporting unit’s carrying amount, including goodwill, to the fair value of the reporting unit. We determine the fair value of our reporting units based on an average weighting of both projected discounted future results and the use of comparative market multiples. If the carrying amount of the reporting unit exceeds its fair value, goodwill is considered impaired and a second test is performed to measure the amount of loss, if any.
We perform an indefinite-lived intangible asset impairment analysis on an annual basis and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. The Company may elect to perform a qualitative assessment to determine whether it is more likely than not that an indefinite-lived intangible is impaired. If the qualitative assessment is not performed or if the Company determines that it is not more likely than not that the fair value of an indefinite-lived intangible exceeds the carrying value, the recoverability is measured by comparing the carrying amount to the fair value. We determine the fair value of our indefinite-lived intangible assets principally based on a variation of the income approach, known as the relief from royalty method. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, the indefinite-lived intangible asset is considered impaired.
We completed our annual impairment test for goodwill and indefinite-lived intangible assets during the fourth quarter of fiscal year 2020 and determined that the fair values of our reporting units and the indefinite-lived intangible assets are in excess of the carrying values and that no impairment existed as of the date of the impairment test. Significant judgments inherent in this analysis included assumptions regarding appropriate revenue and operating income growth rates, discount rates and royalty rates.

Income Taxes
We estimate our income tax provision in each of the jurisdictions in which we operate, a process that includes estimating exposures related to examinations by taxing authorities. We must also make judgments regarding the ability to realize deferred tax assets. The carrying value of our net deferred tax assets is based on our belief that it is more likely than not that we will generate sufficient future taxable income in certain jurisdictions to realize these deferred tax assets. A valuation allowance has been established for deferred tax assets that we do not believe meet the “more likely than not” criteria. We assess whether an uncertain tax position taken or expected to be taken in a tax return meets the threshold for recognition and measurement in the Consolidated Financial Statements. Our judgments regarding future taxable income as well as tax positions taken or expected to be taken in a tax return may change due to changes in market conditions, changes in tax laws or other factors. If our assumptions and consequently our estimates change in the future, the valuation allowances and/or tax reserves established may be increased or decreased, resulting in a respective increase or decrease in income tax expense. For further discussion related to our income taxes, refer to Note 15 — “Income Taxes” to the Consolidated Financial Statements.
Recent Accounting Pronouncements
See Note 19 – “New Accounting Guidance” to the Consolidated Financial Statements for a discussion of recent accounting guidance.
31

Table of Contents
Results of Operations
Refer to Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" section contained in our Annual Report on Form 10-K for the fiscal year ended August 31, 2019 for the results of operations discussion for the fiscal year ended August 31, 2019 compared to the fiscal year ended August 31, 2018.
Net Revenue
Generally, we assess revenue on a global customer basis regardless of whether the growth is associated with organic growth or as a result of an acquisition. Accordingly, we do not differentiate or separately report revenue increases generated by acquisitions as opposed to existing business. In addition, the added cost structures associated with our acquisitions have historically been relatively insignificant when compared to our overall cost structure.
The distribution of revenue across our segments has fluctuated, and will continue to fluctuate, as a result of numerous factors, including the following: fluctuations in customer demand; efforts to diversify certain portions of our business; business growth from new and existing customers; specific product performance; and any potential termination, or substantial winding down, of significant customer relationships.

| Fiscal Year Ended August 31, |  | Change
(dollars in millions) | 2020 |  | 2019 |  | 2018 |  | 2020 vs. 2019 |  | 2019 vs. 2018
Net revenue | $ | 27,266.4 |  |  | $ | 25,282.3 |  |  | $ | 22,095.4 |  |  | 7.8 | % |  | 14.4 | %

2020 vs. 2019
Net revenue increased during the fiscal year ended August 31, 2020 compared to the fiscal year ended August 31, 2019. Specifically, the EMS segment revenues increased 8% primarily due to (i) a 10% increase in revenues from existing customers within our cloud business and (ii) a 2% increase in revenues from existing customers within our capital equipment business. The increase is partially offset by (i) a 3% decrease from existing customers within our networking and telecommunications business and (ii) a 1% decrease in revenues from existing customers within our print and retail business. DMS segment revenues increased 8% due to an 11% increase in revenues from new and existing customers in our healthcare business. The increase is partially offset by a 3% decrease in revenue from customers within our edge devices and accessories businesses.
During fiscal year 2021, we expect lower revenue than fiscal year 2020 as approximately $1.0 billion in components that we procure and integrate for our cloud business will shift from a purchase and resale model to a consignment service model. As a result of this transition, we expect higher gross margins and lower cash used in this business.
The following table sets forth, for the periods indicated, revenue by segment expressed as a percentage of net revenue:

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
EMS | 61 | % |  | 61 | % |  | 56 | %
DMS | 39 | % |  | 39 | % |  | 44 | %
Total | 100 | % |  | 100 | % |  | 100 | %

The following table sets forth, for the periods indicated, foreign source revenue expressed as a percentage of net revenue:

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Foreign source revenue | 82.6 | % |  | 87.7 | % |  | 91.7 | %

Gross Profit

| Fiscal Year Ended August 31,
(dollars in millions) | 2020 |  | 2019 |  | 2018
Gross profit | $ | 1,930.8 |  |  | $ | 1,913.4 |  |  | $ | 1,706.8 |
Percent of net revenue | 7.1 | % |  | 7.6 | % |  | 7.7 | %

2020 vs. 2019
32

Table of Contents
Gross profit as a percentage of net revenue decreased for the fiscal year ended August 31, 2020 compared to the fiscal year ended August 31, 2019, primarily due to an increase of $108.8 million in incremental and idle labor costs associated with travel disruptions and governmental restrictions, largely related to the COVID-19 outbreak. This increase in costs was partially offset by governmental subsidies, such as lower payroll taxes or social insurance in certain countries, related to COVID-19 incentives.
Additionally, gross profit as a percent of revenue decreased for the EMS segment largely due to product mix. The decrease was partially offset by an increase in the DMS segment due to improved profitability across the various businesses.
Selling, General and Administrative

| Fiscal Year Ended August 31, |  | Change
(dollars in millions) | 2020 |  | 2019 |  | 2018 |  | 2020 vs. 2019 |  | 2019 vs. 2018
Selling, general and administrative | $ | 1,174.7 |  |  | $ | 1,111.3 |  |  | $ | 1,050.7 |  |  | $ | 63.4 |  |  | $ | 60.6 |

2020 vs. 2019
Selling, general and administrative expenses increased during the fiscal year ended August 31, 2020 compared to the fiscal year ended August 31, 2019. The increase is predominantly due to (i) $33.1 million in costs related to the COVID-19 outbreak, including personal protection equipment for our employees globally, (ii) a $41.6 million increase in salary and salary related expenses and other costs primarily due to our strategic collaboration with a healthcare company and (iii) a $21.7 million increase in stock-based compensation expense due to a higher stock price for awards granted during fiscal year 2020. The increase is partially offset by (i) a $20.5 million decrease in acquisition and integration charges related to our strategic collaboration with a healthcare company and (ii) a $12.5 million decrease due to lower salary and salary related expense across the Company and lower travel expenses related to the pandemic.
Research and Development

| Fiscal Year Ended August 31,
(dollars in millions) | 2020 |  | 2019 |  | 2018
Research and development | $ | 44.1 |  |  | $ | 42.9 |  |  | $ | 38.5 |
Percent of net revenue | 0.2 | % |  | 0.2 | % |  | 0.2 | %

2020 vs. 2019
Research and development expenses remained consistent as a percent of net revenue during the fiscal year ended August 31, 2020 compared to the fiscal year ended August 31, 2019.
Amortization of Intangibles

| Fiscal Year Ended August 31, |  | Change
(dollars in millions) | 2020 |  | 2019 |  | 2018 |  | 2020 vs. 2019 |  | 2019 vs. 2018
Amortization of intangibles | $ | 55.5 |  |  | $ | 31.9 |  |  | $ | 38.5 |  |  | $ | 23.6 |  |  | $ | (6.6 | )

2020 vs. 2019
Amortization of intangibles increased during the fiscal year ended August 31, 2020 compared to the fiscal year ended August 31, 2019 primarily driven by amortization related to the Nypro trade name, which was reclassified to a definite-lived intangible asset during fiscal year 2019 as a result of our decision that the indefinite-lived trade name of $72.5 million acquired during the acquisition of Nypro would be phased out by 2023. As such, this trade name was assigned a four-year estimated useful life and is being amortized on an accelerated basis.
Restructuring, Severance and Related Charges
Following is a summary of our restructuring, severance and related charges:
33

Table of Contents

|  | Fiscal Year Ended August 31,
(dollars in millions) |  | 2020(2) |  | 2019(3) |  | 2018(3)
Employee severance and benefit costs |  | $ | 94.0 |  |  | $ | 16.0 |  |  | $ | 16.3 |
Lease costs |  | 7.7 |  |  | — |  |  | 1.6 |
Asset write-off costs |  | 32.9 |  |  | (3.6 | ) |  | 16.2 |
Other costs |  | 22.0 |  |  | 13.5 |  |  | 2.8 |
Total restructuring, severance and related charges(1) |  | $ | 156.6 |  |  | $ | 25.9 |  |  | $ | 36.9 |

(1) | Includes $61.9 million, $21.5 million and $16.3 million recorded in the EMS segment, $75.6 million, $2.6 million and $16.6 million recorded in the DMS segment and $19.1 million, $1.8 million and $4.0 million of non-allocated charges for the fiscal years ended August 31, 2020, 2019 and 2018, respectively. Except for asset write-off costs, all restructuring, severance and related charges are cash settled.

(2) | As the Company continues to optimize its cost structure and improve operational efficiencies, $56.6 million of employee severance and benefit costs was incurred in connection with a reduction in the worldwide workforce during the fiscal year ended August 31, 2020. The remaining amount primarily relates to the 2020 Restructuring Plan.

(3) | Primarily relates to the 2017 Restructuring Plan, which was complete as of August 31, 2019.

2020 Restructuring Plan
On September 20, 2019, our Board of Directors formally approved a restructuring plan to realign our global capacity support infrastructure, particularly in our mobility footprint in China, in order to optimize organizational effectiveness. This action includes headcount reductions and capacity realignment (the “2020 Restructuring Plan”). The 2020 Restructuring Plan reflects our intention only and restructuring decisions, and the timing of such decisions, at certain locations are still subject to consultation with our employees and their representatives.
Upon completion of the 2020 Restructuring Plan, the Company expects to recognize approximately $85.0 million in restructuring and other related costs. The Company incurred $76.9 million of costs during fiscal year 2020 and anticipates incurring the remaining costs during fiscal year 2021 for employee severance and benefit costs, asset write-off costs, and other related costs.
The 2020 Restructuring Plan, once complete, is expected to yield annualized cost savings beginning in fiscal year 2021 of approximately $40.0 million. During fiscal year 2020, we realized cost savings of approximately $25.0 million.
See Note 14 – “Restructuring, Severance and Related Charges” to the Consolidated Financial Statements for further discussion of restructuring, severance and related charges for the 2020 Restructuring Plans.

Loss on Securities

| Fiscal Year Ended August 31, |  | Change
(dollars in millions) | 2020 |  | 2019 |  | 2018 |  | 2020 vs. 2019 |  | 2019 vs. 2018
Loss on securities | $ | 48.6 |  |  | $ | 29.6 |  |  | $ | — |  |  | $ | 19.0 |  |  | $ | 29.6 |

2020 vs. 2019
The increase in loss on securities during the fiscal year ended August 31, 2020 compared to the fiscal year ended August 31, 2019, is due to: (i) an impairment charge of $36.4 million during the fiscal year ended August 31, 2020, related to our investment in the Senior Non-Convertible Preferred Stock of iQor Holdings, Inc. (“iQor”) as a result of iQor’s bankruptcy filing; (ii) an impairment charge of $12.2 million during the fiscal year ended August 31, 2020, in connection with the sale of an investment in the optical networking segment; partially offset by (iii) a $29.6 million due to the restructuring of securities during the fiscal year ended August 31, 2019 due to the exchange of preferred stock of iQor in association with iQor’s previously announced sale of its international logistics and product service assets.
Other Expense

| Fiscal Year Ended August 31, |  | Change
(dollars in millions) | 2020 |  | 2019 |  | 2018 |  | 2020 vs. 2019 |  | 2019 vs. 2018
Other expense | $ | 31.2 |  |  | $ | 53.8 |  |  | $ | 37.6 |  |  | $ | (22.6 | ) |  | $ | 16.2 |

34

Table of Contents
2020 vs. 2019
Other expense decreased during the fiscal year ended August 31, 2020 compared to the fiscal year ended August 31, 2019, primarily due to: (i) an $18.2 million decrease in fees associated with the utilization of trade accounts receivable sales programs during fiscal year 2020 and fees incurred for the amended and new asset-backed securitization programs in fiscal year 2019 and (ii) a $14.6 million decrease driven primarily by the expected return on plan assets and actuarial gain related to the Company's pension plans. The decrease was partially offset by $7.3 million of costs incurred during the fiscal year ended August 31, 2020 as a result of the early redemption of the 5.250% Senior Notes due 2020.
Interest Income

| Fiscal Year Ended August 31, |  | Change
(dollars in millions) | 2020 |  | 2019 |  | 2018 |  | 2020 vs. 2019 |  | 2019 vs. 2018
Interest income | $ | 14.6 |  |  | $ | 21.5 |  |  | $ | 17.8 |  |  | $ | (6.9 | ) |  | $ | 3.7 |

2020 vs. 2019
Interest income decreased during the fiscal year ended August 31, 2020 compared to the fiscal year ended August 31, 2019, due to lower interest rates, partially offset by increased interest income on cash equivalents (investments that are readily convertible to cash with maturity dates of 90 days or less).
Interest Expense

| Fiscal Year Ended August 31, |  | Change
(dollars in millions) | 2020 |  | 2019 |  | 2018 |  | 2020 vs. 2019 |  | 2019 vs. 2018
Interest expense | $ | 173.9 |  |  | $ | 188.7 |  |  | $ | 149.0 |  |  | $ | (14.8 | ) |  | $ | 39.7 |

2020 vs. 2019
Interest expense decreased during the fiscal year ended August 31, 2020, compared to the fiscal year ended August 31, 2019, due to lower interest rates, partially offset by additional borrowings on our credit facilities, commercial paper program and senior debt issuances.
Income Tax Expense

| Fiscal Year Ended August 31, |  | Change
| 2020 |  | 2019 |  | 2018 |  | 2020 vs. 2019 |  | 2019 vs. 2018
Effective income tax rate | 78.2 | % |  | 35.8 | % |  | 76.6 | % |  | 42.4 | % |  | (40.8 | )%

2020 vs. 2019
The effective income tax rate increased for the fiscal year ended August 31, 2020, compared to the fiscal year ended August 31, 2019, primarily due to: (i) lower income before income tax for the fiscal year ended August 31, 2020, driven in part by increased restructuring charges with minimal related tax benefit; (ii) a $21.2 million income tax expense associated with the re-measurement of deferred tax assets related to the extension of a non-U.S. tax incentive recorded during the fiscal year ended August 31, 2020; and (iii) a $19.1 million income tax benefit related to the Tax Cuts and Jobs Act of 2017 (the “Tax Act”) adjustments for the fiscal year ended August 31, 2019.
Non-GAAP (Core) Financial Measures
The following discussion and analysis of our financial condition and results of operations include certain non-GAAP financial measures as identified in the reconciliation below. The non-GAAP financial measures disclosed herein do not have standard meaning and may vary from the non-GAAP financial measures used by other companies or how we may calculate those measures in other instances from time to time. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with U.S. GAAP. Also, our “core” financial measures should not be construed as an inference by us that our future results will be unaffected by those items that are excluded from our “core” financial measures.
Management believes that the non-GAAP “core” financial measures set forth below are useful to facilitate evaluating the past and future performance of our ongoing manufacturing operations over multiple periods on a comparable basis by
35

Table of Contents
excluding the effects of the amortization of intangibles, stock-based compensation expense and related charges, restructuring, severance and related charges, distressed customer charges, acquisition and integration charges, loss on disposal of subsidiaries, settlement of receivables and related charges, impairment of notes receivable and related charges, goodwill impairment charges, business interruption and impairment charges, net, loss on securities, income (loss) from discontinued operations, gain (loss) on sale of discontinued operations and certain other expenses, net of tax and certain deferred tax valuation allowance charges. Among other uses, management uses non-GAAP “core” financial measures to make operating decisions, assess business performance and as a factor in determining certain employee performance when evaluating incentive compensation.
We determine the tax effect of the items excluded from “core” earnings and “core” diluted earnings per share based upon evaluation of the statutory tax treatment and the applicable tax rate of the jurisdiction in which the pre-tax items were incurred, and for which realization of the resulting tax benefit, if any, is expected. In certain jurisdictions where we do not expect to realize a tax benefit (due to existing tax incentives or a history of operating losses or other factors resulting in a valuation allowance related to deferred tax assets), a reduced or 0% tax rate is applied.
We are reporting “core” operating income, “core” earnings and cash flows to provide investors with an additional method for assessing operating income and earnings, by presenting what we believe are our “core” manufacturing operations. A significant portion (based on the respective values) of the items that are excluded for purposes of calculating “core” operating income and “core” earnings also impacted certain balance sheet assets, resulting in a portion of an asset being written off without a corresponding recovery of cash we may have previously spent with respect to the asset. In the case of restructuring, severance and related charges, we may make associated cash payments in the future. In addition, although, for purposes of calculating “core” operating income and “core” earnings, we exclude stock-based compensation expense (which we anticipate continuing to incur in the future) because it is a non-cash expense, the associated stock issued may result in an increase in our outstanding shares of stock, which may result in the dilution of our stockholders’ ownership interest. We encourage you to consider these matters when evaluating the utility of these non-GAAP financial measures.
Adjusted free cash flow is defined as net cash provided by (used in) operating activities plus cash receipts on sold receivables less net capital expenditures (acquisition of property, plant and equipment less proceeds and advances from the sale of property, plant and equipment). We report adjusted free cash flow as we believe this non-GAAP financial measure is useful to investors in measuring our ability to generate cash internally and fund future growth and to provide a return to shareholders.
Included in the tables below are a reconciliation of the non-GAAP financial measures to the most directly comparable U.S. GAAP financial measures as provided in our Consolidated Financial Statements:
36

Table of Contents
Reconciliation of U.S. GAAP Financial Results to Non-GAAP Measures

| Fiscal Year Ended August 31,
(in thousands, except for per share data) | 2020 |  | 2019 |  | 2018
Operating income (U.S. GAAP) | $ | 499,846 |  |  | $ | 701,356 |  |  | $ | 542,153 |
Amortization of intangibles | 55,544 |  |  | 31,923 |  |  | 38,490 |
Stock-based compensation expense and related charges | 83,084 |  |  | 61,346 |  |  | 98,511 |
Restructuring, severance and related charges(1) | 156,586 |  |  | 25,914 |  |  | 36,902 |
Distressed customer charge(2) | 14,963 |  |  | 6,235 |  |  | 32,710 |
Net periodic benefit cost(3) | 16,078 |  |  | — |  |  | — |
Business interruption and impairment charges, net(4) | 5,785 |  |  | (2,860 | ) |  | 11,299 |
Acquisition and integration charges(5) | 32,167 |  |  | 52,697 |  |  | 8,082 |
Adjustments to operating income | 364,207 |  |  | 175,255 |  |  | 225,994 |
Core operating income (Non-GAAP) | $ | 864,053 |  |  | $ | 876,611 |  |  | $ | 768,147 |
Net income attributable to Jabil Inc. (U.S. GAAP) | $ | 53,912 |  |  | $ | 287,111 |  |  | $ | 86,330 |
Adjustments to operating income | 364,207 |  |  | 175,255 |  |  | 225,994 |
Loss on securities(6) | 48,625 |  |  | 29,632 |  |  | — |
Net periodic benefit cost(3) | (16,078 | ) |  | — |  |  | — |
Adjustment for taxes(7) | (1,093 | ) |  | (18,633 | ) |  | 146,206 |
Core earnings (Non-GAAP) | $ | 449,573 |  |  | $ | 473,365 |  |  | $ | 458,530 |
Diluted earnings per share (U.S. GAAP) | $ | 0.35 |  |  | $ | 1.81 |  |  | $ | 0.49 |
Diluted core earnings per share (Non-GAAP) | $ | 2.90 |  |  | $ | 2.98 |  |  | $ | 2.62 |
Diluted weighted average shares outstanding (U.S. GAAP and Non-GAAP) | 155,274 |  |  | 158,647 |  |  | 175,044 |

(1) | As the Company continues to optimize its cost structure and improve operational efficiencies, $56.6 million of employee severance and benefit costs was incurred in connection with a reduction in the worldwide workforce during fiscal year 2020. The remaining amount primarily relates to the 2020 Restructuring Plan.

(2) | Relates to accounts receivable and inventory charges for certain distressed customers in the: (i) renewable energy sector during fiscal year 2020 and (ii) networking and consumer wearables sectors during fiscal years 2019 and 2018.

(3) | Following the adoption of Accounting Standards Update 2017-07, Compensation - Retirement Benefits (Topic 715) (“ASU 2017-07”), pension service cost is recognized in cost of revenue and all other components of net periodic benefit cost, including return on plan assets, are presented in other expense. We are reclassifying the pension components in other expense to core operating income as we assess operating performance, inclusive of all components of net periodic benefit cost, with the related revenue. There is no impact to core earnings or diluted core earnings per share for this adjustment.

(4) | Charges for the fiscal year ended August 31, 2020, relate to a flood that impacted our facility in Huangpu, China. Charges, net of insurance proceeds of $2.9 million and $24.9 million, for the fiscal years ended August 31, 2019 and 2018, respectively, relate to costs associated with damage from Hurricane Maria, which impacted our operations in Cayey, Puerto Rico.

(5) | Charges related to our strategic collaboration with Johnson & Johnson Medical Devices Companies (“JJMD”).

(6) | Relates to: (i) an impairment of an investment with iQor and the sale of an investment in the optical networking segment during fiscal year 2020 and (ii) a restructuring of securities loss on the exchange of an investment with iQor during fiscal year 2019.

(7) | The fiscal year ended August 31, 2019 includes a $13.3 million income tax benefit for the effects of the Tax Act recorded during the three months ended November 30, 2018. The fiscal year ended August 31, 2018 includes a $142.3 million provisional estimate to account for the effects of the Tax Act.

Adjusted Free Cash Flow

| Fiscal Year Ended August 31,
(in thousands) | 2020 |  | 2019 (1) |  | 2018
Net cash provided by (used in) operating activities (U.S. GAAP) | $ | 1,257,275 |  |  | $ | 1,193,066 |  |  | $ | (1,105,448 | )
Cash receipts on sold receivables | — |  |  | 96,846 |  |  | 2,039,298 |
Acquisition of property, plant and equipment | (983,035 | ) |  | (1,005,480 | ) |  | (1,036,651 | )
Proceeds and advances from sale of property, plant and equipment | 186,655 |  |  | 218,708 |  |  | 350,291 |
Adjusted free cash flow (Non-GAAP) | $ | 460,895 |  |  | $ | 503,140 |  |  | $ | 247,490 |

(1) | In fiscal year 2019, the adoption of Accounting Standards Update ("ASU") 2016-15, "Classification of Certain Cash Receipts and Cash Payments" resulted in a reclassification of cash flows from operating activities to investing activities for cash receipts for the deferred purchase price receivable on asset-backed securitization transactions. The adoption of this standard does not reflect a change in the underlying business or activities. The effects of this change are applied retrospectively to all prior periods.

Quarterly Results (Unaudited)
The following table sets forth certain unaudited quarterly financial information for the 2020 and 2019 fiscal years. In the opinion of management, this information has been presented on the same basis as the audited consolidated financial statements appearing elsewhere, and all necessary adjustments (consisting primarily of normal recurring accruals) have been included in the amounts stated below to present fairly the unaudited quarterly results when read in conjunction with the audited consolidated financial statements and related notes thereto. The operating results for any quarter are not necessarily indicative of results for any future period.
37

Table of Contents

Fiscal Year 2020 | Three Months Ended
(in thousands, except for per share data) | August 31, 2020 |  | May 31, 2020 |  | February 29, 2020 |  | November 30, 2019
Net revenue | $ | 7,300,015 |  |  | $ | 6,335,642 |  |  | $ | 6,125,083 |  |  | $ | 7,505,698 |
Gross profit(1) | 490,701 |  |  | 456,148 |  |  | 430,125 |  |  | 553,839 |
Operating income(1)(2)(3)(4) | 197,053 |  |  | 59,384 |  |  | 90,630 |  |  | 152,779 |
Net income (loss)(1)(2)(3)(4)(5) | 68,909 |  |  | (50,263 | ) |  | (2,581 | ) |  | 40,714 |
Net income (loss) attributable to Jabil Inc.(1)(2)(3)(4)(5) | $ | 67,731 |  |  | $ | (50,958 | ) |  | $ | (3,283 | ) |  | $ | 40,422 |
Earnings (loss) per share attributable to the stockholders of Jabil Inc. |  |  |  |  |  |  |
Basic | $ | 0.45 |  |  | $ | (0.34 | ) |  | $ | (0.02 | ) |  | $ | 0.26 |
Diluted | $ | 0.44 |  |  | $ | (0.34 | ) |  | $ | (0.02 | ) |  | $ | 0.26 |

Fiscal Year 2019 | Three Months Ended
(in thousands, except for per share data) | August 31, 2019 |  | May 31, 2019 |  | February 28, 2019 |  | November 30, 2018
Net revenue | $ | 6,573,453 |  |  | $ | 6,135,602 |  |  | $ | 6,066,990 |  |  | $ | 6,506,275 |
Gross profit(1) | 495,078 |  |  | 443,799 |  |  | 454,874 |  |  | 519,650 |
Operating income(1)(4) | 189,745 |  |  | 140,918 |  |  | 153,983 |  |  | 216,710 |
Net income(1)(4)(5)(6) | 53,761 |  |  | 44,032 |  |  | 67,607 |  |  | 124,074 |
Net income attributable to Jabil Inc.(1)(4)(5)(6) | $ | 52,675 |  |  | $ | 43,482 |  |  | $ | 67,354 |  |  | $ | 123,600 |
Earnings per share attributable to the stockholders of Jabil Inc. |  |  |  |  |  |  |
Basic | $ | 0.34 |  |  | $ | 0.28 |  |  | $ | 0.44 |  |  | $ | 0.77 |
Diluted | $ | 0.34 |  |  | $ | 0.28 |  |  | $ | 0.43 |  |  | $ | 0.76 |

(1) | Includes a distressed customer charge of $15.0 million and $6.2 million during the three months ended November 30, 2019 and August 31, 2019, respectively.

(2) | Includes direct costs related to the COVID-19 pandemic of $21.5 million, $67.4 million and $53.0 million for the three months ended August 31, 2020, May 31, 2020, and February 29, 2020, respectively.

(3) | Includes employee severance and benefit costs incurred in connection with a reduction in the worldwide workforce of $4.3 million and $52.3 million for the three months ended August 31, 2020 and May 31, 2020, respectively.

(4)Includes acquisition and integration charges related to our strategic collaboration with JJMD as follows (in millions):

| Three Months Ended
| August 31, 2020 |  | May 31, 2020 |  | February 29, 2020 |  | November 30, 2019
Acquisition and integration charges | $ | 2.2 |  |  | $ | 6.1 |  |  | $ | 7.8 |  |  | $ | 16.1 |
| Three Months Ended
| August 31, 2019 |  | May 31, 2019 |  | February 28, 2019 |  | November 30, 2018
Acquisition and integration charges | $ | 17.6 |  |  | $ | 13.4 |  |  | $ | 12.8 |  |  | $ | 8.9 |

(5) | Relates to: (i) an impairment of an investment with iQor during the three months ended August 31, 2020 and the sale of an investment in the optical networking segment during the three months ended February 29, 2020 and (ii) a restructuring of securities loss on the exchange of an investment with iQor during the three months ended August 31, 2019.

(6) | Includes $13.3 million of income tax benefit for the three months ended November 30, 2018 related to the Tax Act.

Acquisitions and Expansion
During fiscal year 2018, the Company and JJMD entered into a Framework Agreement to form a strategic collaboration and expand our existing relationship. The strategic collaboration expands our medical device manufacturing portfolio, diversification and capabilities.
On February 25, 2019 and April 29, 2019, under the terms of the Framework Agreement, we completed the initial and second closings, respectively, of our acquisition of certain assets of JJMD. The aggregate purchase price paid for both the initial and second closings was approximately $167.4 million in cash. For the initial and second closings, total assets acquired of $173.5 million and total liabilities assumed of $6.1 million were recorded at their estimated fair values as of the acquisition dates.
38

Table of Contents
On September 30, 2019, under the terms of the Framework Agreement, the Company completed the third closing of its acquisition of certain assets of JJMD. The aggregate purchase price paid for the third closing was approximately $113.1 million in cash. For the third closing, total assets acquired of $196.2 million, including $80.7 million in contract assets, $34.0 million in inventory and $56.0 million in goodwill, and total liabilities assumed of $83.1 million, including $73.5 million of pension obligations, were recorded at their estimated fair values as of the acquisition date. There were no intangible assets identified in this acquisition and the goodwill is primarily attributable to the assembled workforce. The majority of the goodwill is currently not expected to be deductible for income tax purposes.
The acquisitions of the JJMD assets have been accounted for as separate business combinations for each closing using the acquisition method of accounting. The results of operations were included in the Company’s consolidated financial results beginning on February 25, 2019 for the initial closing, April 29, 2019 for the second closing and September 30, 2019 for the third closing. The Company believes it is impracticable to provide pro forma information for the acquisitions of the JJMD assets.
Refer to Note 16 – “Business Acquisitions” to the Consolidated Financial Statements for further discussion.
Liquidity and Capital Resources
We believe that our level of liquidity sources, which includes available borrowings under our revolving credit facilities and commercial paper program, additional proceeds available under our asset-backed securitization programs and under our uncommitted trade accounts receivable sale programs, cash on hand, funds provided by operations and the access to the capital markets, will be adequate to fund our capital expenditures, the payment of any declared quarterly dividends, any share repurchases under the approved program, any potential acquisitions and our working capital requirements for the next 12 months. We continue to assess our capital structure and evaluate the merits of redeploying available cash.
Certain of our trade accounts receivable sale programs expire or are subject to termination provisions within the 2020 calendar year. While we expect to renew such trade accounts receivable sale programs, market conditions, including the implications of the COVID-19 pandemic, at the time our current programs expire may create challenges in doing so, such as incurring a higher cost of capital.
Cash and Cash Equivalents
As of August 31, 2020, we had approximately $1.4 billion in cash and cash equivalents. As our growth remains predominantly outside of the United States, a significant portion of such cash and cash equivalents are held by our foreign subsidiaries. Most of our cash and cash equivalents as of August 31, 2020 could be repatriated to the United States without potential tax expense.
Notes Payable and Credit Facilities
Following is a summary of principal debt payments and debt issuance for our notes payable and credit facilities:
39

Table of Contents

(in thousands) | 5.625% Senior Notes |  | 4.700% Senior Notes |  | 4.900% Senior Notes |  | 3.950% Senior Notes |  | 3.600% Senior Notes(1) |  | 3.000% Senior Notes(2) |  | Borrowings under revolving credit facilities(3)(4)(5) |  | Borrowings under commercial paper program(5) |  | Borrowings under loans(3) |  | Total notes payable and credit facilities
Balance as of August 31, 2018 | $ | 397,995 |  |  | $ | 497,350 |  |  | $ | 298,814 |  |  | $ | 494,208 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 830,332 |  |  | $ | 2,518,699 |
Borrowings | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 11,985,978 |  |  | — |  |  | — |  |  | 11,985,978 |
Payments | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (11,985,259 | ) |  | — |  |  | (25,134 | ) |  | (12,010,393 | )
Other | 891 |  |  | 654 |  |  | 243 |  |  | 617 |  |  | — |  |  | — |  |  | (719 | ) |  | — |  |  | 495 |  |  | 2,181 |
Balance as of August 31, 2019 | 398,886 |  |  | 498,004 |  |  | 299,057 |  |  | 494,825 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 805,693 |  |  | 2,496,465 |
Borrowings | — |  |  | — |  |  | — |  |  | — |  |  | 499,165 |  |  | 595,668 |  |  | 11,094,561 |  |  | 237,661 |  |  | 350,000 |  |  | 12,777,055 |
Payments | (399,555 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (11,094,561 | ) |  | (237,661 | ) |  | (806,437 | ) |  | (12,538,214 | )
Other | 669 |  |  | 655 |  |  | 243 |  |  | 615 |  |  | (4,409 | ) |  | (5,506 | ) |  | — |  |  | — |  |  | 909 |  |  | (6,824 | )
Balance as of August 31, 2020 | $ | — |  |  | $ | 498,659 |  |  | $ | 299,300 |  |  | $ | 495,440 |  |  | $ | 494,756 |  |  | $ | 590,162 |  |  | $ | — |  |  | $ | — |  |  | $ | 350,165 |  |  | $ | 2,728,482 |
Maturity Date | Dec 15, 2020 |  | Sep 15, 2022 |  | Jul 14, 2023 |  | Jan 12, 2028 |  | Jan 15, 2030 |  | Jan 15, 2031 |  | Apr 23, 2021, Jan 22, 2023 and Jan 22, 2025(3)(4)(5) |  | (5) |  | Jan 22, 2025(3) |  |
Original Facility/ Maximum Capacity | $400.0 million |  | $500.0 million |  | $300.0 million |  | $500.0 million |  | $500.0 million |  | $600.0 million |  | $3.7 billion(3)(4)(5) |  | (5) |  | $351.9 million(3) |  |

(1) | On January 15, 2020, we issued $500.0 million of publicly registered 3.600% Senior Notes due 2030 (the “3.600% Senior Notes”). The net proceeds from the offering were used for the repayment of term loan indebtedness.

(2) | On July 13, 2020, the Company issued $600.0 million of publicly registered 3.000% Senior Notes due 2031 (the “3.000% Senior Notes”). The net proceeds from the offering were used for general corporate purposes, including to redeem the $400.0 million aggregate principal amount of our 5.625% Senior Notes due 2020 and pay the applicable “make-whole” premium.

(3) | On January 22, 2020, we entered into a senior unsecured credit agreement which provides for: (i) a Revolving Credit Facility in the initial amount of $2.7 billion, of which $700.0 million expires on January 22, 2023 and $2.0 billion expires on January 22, 2025 and (ii) a $300.0 million Term Loan Facility which expires on January 22, 2025, (collectively the “Credit Facility”). Interest and fees on the Credit Facility advances are based on our non-credit enhanced long-term senior unsecured debt rating as determined by Standard & Poor’s Ratings Service, Moody’s Investors Service and Fitch Ratings. In connection with our entry into the Credit Facility, we terminated our amended and restated five-year credit agreement dated November 8, 2017 and the credit agreement dated August 24, 2018.

During the fiscal year ended August 31, 2020, the interest rates on the Revolving Credit Facility ranged from 1.2% to 4.3% and the Term Loan Facility ranged from 1.6% to 2.9%. Interest is charged at a rate equal to (a) for the Revolving Credit Facility, either 0.000% to 0.450% above the base rate or 0.975% to 1.450% above the Eurocurrency rate and (b) for the Term Loan Facility, either 0.125% to 0.750% above the base rate or 1.125% to 1.750% above the Eurocurrency rate. The base rate represents the greatest of: (i) Citibank, N.A.’s prime rate, (ii) 0.50% above the federal funds rate, and (iii) 1.0% above one-month LIBOR, but not less than zero. The Eurocurrency rate represents adjusted LIBOR or adjusted CDOR, as applicable, for the applicable interest period, but not less than zero. Fees include a facility fee based on the revolving credit commitments of the lenders and a letter of credit fee based on the amount of outstanding letters of credit.
Additionally, our foreign subsidiaries have various additional credit facilities that finance their future growth and any corresponding working capital needs.

(4) | On April 24, 2020, we entered into an unsecured 364-day revolving credit agreement up to an initial aggregate amount of $375.0 million, which was increased to $425.0 million on May 29, 2020 (the “364-Day Revolving Credit Agreement”). The 364-Day Revolving Credit Agreement expires on April 23, 2021. Interest and fees on the 364-Day

40

Table of Contents
Revolving Credit Agreement advances are based on our non-credit enhanced long-term senior unsecured debt rating as determined by Standard & Poor’s Ratings Service, Moody’s Investors Service and Fitch Ratings.
As of August 31, 2020, no draws were made on the 364-Day Revolving Credit Agreement. Interest is charged at a rate equal to either (i) 0.450%, 0.525% or 0.800% above the base rate or (ii) 1.450%, 1.525% or 1.800% above the Eurodollar rate. The base rate represents the greatest of: (i) Mizuho’s base rate, (ii) 0.50% above the federal funds rate, and (iii) 1.0% above one-month LIBOR, subject to a floor of 0.75%. The Eurodollar rate represents adjusted LIBOR for the applicable interest period, subject to a floor of 0.75%. Fees include a facility fee based on the revolving credit commitments of the lenders.

(5) | As of August 31, 2020, we had $3.7 billion in available unused borrowing capacity under our revolving credit facilities. The Revolving Credit Facility under the Credit Facility acts as the back-up facility for commercial paper outstanding, if any. We have a borrowing capacity of up to $1.8 billion under our commercial paper program.

In the ordinary course of business, we have letters of credit and surety bonds with banks and insurance companies outstanding of $120.3 million as of August 31, 2020. Unused letters of credit were $94.0 million as of August 31, 2020. Letters of credit and surety bonds are generally available for draw down in the event we do not perform.
We have a shelf registration statement with the SEC registering the potential sale of an indeterminate amount of debt and equity securities in the future to augment our liquidity and capital resources.
Our Senior Notes and our credit facilities contain various financial and nonfinancial covenants. A violation of these covenants could negatively impact our liquidity by restricting our ability to borrow under the notes payable and credit facilities and potentially causing acceleration of amounts due under these notes payable and credit facilities. As of August 31, 2020 and 2019, we were in compliance with our debt covenants. Refer to Note 7 – “Notes Payable and Long-Term Debt” to the Consolidated Financial Statements for further details.
Asset-Backed Securitization Programs
We continuously sell designated pools of trade accounts receivable, at a discount, under our foreign asset-backed securitization program and our North American asset-backed securitization program to special purpose entities, which in turn sell certain of the receivables under the foreign program to an unaffiliated financial institution and a conduit administered by an unaffiliated financial institution and certain of the receivables under the North American program to conduits administered by an unaffiliated financial institution on a monthly basis.
The foreign asset-backed securitization program contains a guarantee of payment by the special purpose entity, in an amount approximately equal to the net cash proceeds under the program. No liability has been recorded for obligations under the guarantee as of August 31, 2020.
Certain unsold receivables covering the maximum amount of net cash proceeds available under the North American asset-backed securitization program are pledged as collateral to the unaffiliated financial institution as of August 31, 2020.
Following is a summary of our asset-backed securitization programs and key terms:

| Maximum Amount of Net Cash Proceeds (in millions)(1) | Expiration Date
North American | $ | 390.0 |  | November 22, 2021
Foreign | $ | 400.0 |  | September 30, 2021

(1) | Maximum amount available at any one time.

In connection with our asset-backed securitization programs, during the fiscal year ended August 31, 2020, we sold $4.3 billion of trade accounts receivable and we received cash proceeds of $4.3 billion. As of August 31, 2020, we had up to $49.0 million in available liquidity under our asset-backed securitization programs.
Our asset-backed securitization programs contain various financial and nonfinancial covenants. As of August 31, 2020 and 2019, we were in compliance with all covenants under our asset-backed securitization programs. Refer to Note 8 – “Asset-Backed Securitization Programs” to the Consolidated Financial Statements for further details on the programs.
Trade Accounts Receivable Sale Programs
41

Table of Contents
Following is a summary of the trade accounts receivable sale programs with unaffiliated financial institutions. Under the programs we may elect to sell receivables and the unaffiliated financial institutions may elect to purchase, at a discount, on an ongoing basis:

Program | Maximum Amount (in millions)(1) |  |  | Type of Facility |  | Expiration Date |
A | $ | 600.0 |  |  |  | Uncommitted |  | December 5, 2020 | (2)
B | $ | 150.0 |  |  |  | Uncommitted |  | November 30, 2020 | (3)
C | 400.0 |  | CNY |  | Uncommitted |  | August 31, 2023 |
D | $ | 150.0 |  |  |  | Uncommitted |  | May 4, 2023 | (4)
E | $ | 150.0 |  |  |  | Uncommitted |  | January 25, 2021 | (5)
F | $ | 50.0 |  |  |  | Uncommitted |  | February 23, 2023 | (6)
G | $ | 100.0 |  |  |  | Uncommitted |  | August 10, 2021 | (7)
H | $ | 100.0 |  |  |  | Uncommitted |  | July 21, 2021 | (8)
I | $ | 650.0 |  |  |  | Uncommitted |  | December 4, 2020 | (9)
J | $ | 135.0 |  |  |  | Uncommitted |  | April 11, 2021 | (10)
K | 100.0 |  | CHF |  | Uncommitted |  | December 5, 2020 | (2)

(1) | Maximum amount of trade accounts receivable that may be sold under a facility at any one time.

(2) | The program will be automatically extended through December 5, 2025 unless either party provides 30 days’ notice of termination.

(3) | The program will automatically extend for one year at each expiration date unless either party provides 10 days’ notice of termination.

(4) | Any party may elect to terminate the agreement upon 30 days’ prior notice.

(5) | The program will be automatically extended through January 25, 2023 unless either party provides 30 days’ notice of termination.

(6) | Any party may elect to terminate the agreement upon 15 days’ prior notice.

(7) | The program will be automatically extended through August 10, 2023 unless either party provides 30 days’ notice of termination.

(8) | The program will be automatically extended through August 21, 2023 unless either party provides 30 days’ notice of termination.

(9) | The program will be automatically extended through December 5, 2024 unless either party provides 30 days’ notice of termination.

(10) | The program will be automatically extended each year through April 11, 2025 unless either party provides 30 days’ notice of termination.

During the fiscal year ended August 31, 2020, we sold $8.5 billion of trade accounts receivable under these programs and we received cash proceeds of $8.4 billion. As of August 31, 2020, we had up to $1.4 billion in available liquidity under our trade accounts receivable sale programs.
Capital Expenditures
For Fiscal Year 2021, we anticipate our net capital expenditures will be approximately $800.0 million. In general, our capital expenditures support ongoing maintenance in our DMS and EMS segments and investments in capabilities and targeted end markets. The amount of actual capital expenditures may be affected by general economic, financial, competitive, legislative and regulatory factors, among other things.
Cash Flows
The following table sets forth selected consolidated cash flow information (in thousands):
42

Table of Contents

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Net cash provided by (used in) operating activities | $ | 1,257,275 |  |  | $ | 1,193,066 |  |  | $ | (1,105,448 | )
Net cash (used in) provided by investing activities | (921,113 | ) |  | (872,454 | ) |  | 1,240,914 |
Net cash used in financing activities | (65,123 | ) |  | (415,772 | ) |  | (47,044 | )
Effect of exchange rate changes on cash and cash equivalents | (40,825 | ) |  | 554 |  |  | (20,392 | )
Net increase (decrease) in cash and cash equivalents | $ | 230,214 |  |  | $ | (94,606 | ) |  | $ | 68,030 |

Operating Activities
Net cash provided by operating activities during the fiscal year ended August 31, 2020 was primarily due to increased accounts payable, accrued expenses and other liabilities, partially offset by increased prepaid expenses and other current assets, accounts receivable, contract assets and inventories. The increase in accounts payable, accrued expenses and other liabilities is primarily due to the timing of purchases and cash payments and the third closing of the acquisition of JJMD. The increase in prepaid expenses and other current assets is primarily due to an increase in value added tax receivables and forward contract assets. The increase in accounts receivable is primarily driven by higher sales and the timing of collections. The increase in contract assets is primarily driven by the third closing of the acquisition of JJMD and due to the timing of revenue recognition for over time customers. The increase in inventories is primarily to support expected sales levels in the first quarter of fiscal year 2021.
Investing Activities
Net cash used in investing activities during the fiscal year ended August 31, 2020 consisted primarily of: (i) capital expenditures principally to support ongoing business in the DMS and EMS segments, (ii) expenditures for assets acquired in connection with the third closing of the acquisition of certain assets of JJMD and (iii) purchase price adjustments for the first and second closing of certain assets of JJMD, partially offset by (iv) proceeds and advances from the sale of property, plant and equipment.
Financing Activities
Net cash used in financing activities during the fiscal year ended August 31, 2020 was primarily due to (i) payments for debt agreements, (ii) the repurchase of our common stock, (iii) dividend payments and (iv) treasury stock minimum tax withholding related to vesting of restricted stock. Net cash used in financing activities was partially offset by (i) borrowings under debt agreements and (ii) net proceeds from the exercise of stock options and issuance of common stock under the employee stock purchase plan.
Dividends and Share Repurchases
Following is a summary of the dividends and share repurchases for the fiscal years indicated below (in thousands):

| Dividends Paid(1) |  | Share Repurchases(2) |  | Total
Fiscal year 2016 | $ | 62,436 |  |  | $ | 148,185 |  |  | $ | 210,621 |
Fiscal year 2017 | $ | 59,959 |  |  | $ | 306,397 |  |  | $ | 366,356 |
Fiscal year 2018 | $ | 57,833 |  |  | $ | 450,000 |  |  | $ | 507,833 |
Fiscal year 2019 | $ | 52,004 |  |  | $ | 350,000 |  |  | $ | 402,004 |
Fiscal year 2020 | $ | 50,462 |  |  | $ | 213,925 |  |  | $ | 264,387 |
Total | $ | 282,694 |  |  | $ | 1,468,507 |  |  | $ | 1,751,201 |

(1) | The difference between dividends declared and dividends paid is due to dividend equivalents for unvested restricted stock units that are paid at the time the awards vest.

(2) | Excludes commissions.

We currently expect to continue to declare and pay regular quarterly dividends of an amount similar to our past declarations. However, the declaration and payment of future dividends are discretionary and will be subject to determination by our Board each quarter following its review of our financial performance and global economic conditions.
43

Table of Contents
In September 2019, the Board authorized the repurchase of up to $600.0 million of our common stock as part of a two-year capital allocation framework (“the 2020 Share Repurchase Program”). As of August 31, 2020, 6.0 million shares had been repurchased for $213.9 million and $386.1 million remains available under the 2020 Share Repurchase Program.
Contractual Obligations
Our contractual obligations as of August 31, 2020 are summarized below. As disclosed below, while we have certain non-cancelable purchase order obligations for property, plant and equipment, we generally do not enter into non-cancelable purchase orders for materials until we receive a corresponding purchase commitment from our customer. Non-cancelable purchase orders do not typically extend beyond the normal lead time of several weeks, at most. Purchase orders beyond this time frame are typically cancelable.

| Payments due by period (in thousands)
| Total |  | Less than 1 year |  | 1-3 years |  | 3-5 years |  | After 5 years
Notes payable and long-term debt | $ | 2,728,482 |  |  | $ | 50,194 |  |  | $ | 828,261 |  |  | $ | 269,667 |  |  | $ | 1,580,360 |
Future interest on notes payable and long-term debt(1) | 609,607 |  |  | 98,544 |  |  | 171,639 |  |  | 116,964 |  |  | 222,460 |
Operating lease obligations(2) | 457,167 |  |  | 121,196 |  |  | 157,095 |  |  | 93,077 |  |  | 85,799 |
Finance lease obligations(3) | 194,411 |  |  | 12,383 |  |  | 25,227 |  |  | 55,690 |  |  | 101,111 |
Non-cancelable purchase order obligations(4) | 529,307 |  |  | 425,335 |  |  | 72,464 |  |  | 31,508 |  |  | — |
Pension and postretirement contributions and payments(5) | 41,112 |  |  | 25,109 |  |  | 2,120 |  |  | 2,988 |  |  | 10,895 |
Other(6) | 72,503 |  |  | 33,820 |  |  | 13,600 |  |  | 15,267 |  |  | 9,816 |
Total contractual obligations(7) | $ | 4,632,589 |  |  | $ | 766,581 |  |  | $ | 1,270,406 |  |  | $ | 585,161 |  |  | $ | 2,010,441 |

(1) | Consists of interest on notes payable and long-term debt outstanding as of August 31, 2020. Certain of our notes payable and long-term debt pay interest at variable rates. We have applied estimated interest rates to determine the value of these expected future interest payments.

(2) | Excludes $137.8 million of payments related to leases signed but not yet commenced. Additionally, certain leases signed but not yet commenced contain residual value guarantees and purchase options not deemed probable.

(3) | The amount payable after five years includes $75.1 million in purchase requirements at the end of the respective leases.

(4) | Consists of purchase commitments entered into as of August 31, 2020 primarily for property, plant and equipment and software pursuant to legally enforceable and binding agreements.

(5) | Includes the estimated company contributions to funded pension plans during fiscal year 2021 and the expected benefit payments for unfunded pension and postretirement plans from fiscal years 2021 through 2030. These future payments are not recorded on the Consolidated Balance Sheets but will be recorded as incurred.

(6) | Includes (i) a $27.0 million capital commitment, (ii) a $12.5 million obligation related to a new human resource system and (iii) $33.0 million related to the one-time transition tax as a result of the Tax Act that will be paid in annual installments through fiscal year 2026.

(7) | As of August 31, 2020, we have $0.4 million and $118.8 million recorded as a current and a long-term liability, respectively, for uncertain tax positions. We are not able to reasonably estimate the timing of payments, or the amount by which our liability for these uncertain tax positions will increase or decrease over time, and accordingly, this liability has been excluded from the above table.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Foreign Currency Exchange Risks
We transact business in various foreign countries and are, therefore, subject to risk of foreign currency exchange rate fluctuations. We enter into forward contracts to economically hedge transactional exposure associated with commitments arising from trade accounts receivable, trade accounts payable, intercompany transactions and fixed purchase obligations denominated in a currency other than the functional currency of the respective operating entity. We do not, and do not intend to use derivative financial instruments for speculative or trading purposes. All derivative instruments are recorded on our Consolidated Balance Sheets at their respective fair values.
The forward contracts (both those that are designated and not designated as accounting hedging instruments) will generally expire in less than three months, with 12 months being the maximum term of the contracts outstanding as of August 31, 2020. The change in fair value related to contracts designated as accounting hedging instruments is initially reported as a component of AOCI and subsequently reclassified to the revenue or expense line in which the underlying transaction occurs within our Consolidated Statements of Operations. The change in fair value related to contracts not designated as
44

Table of Contents
accounting hedging instruments will be reflected in cost of revenue within our Consolidated Statements of Operations. The forward contracts are primarily denominated in Chinese yuan renminbi, Euros, Malaysian ringgit, Mexican pesos and Swiss francs.
Based on our overall currency rate exposures as of August 31, 2020, including the derivative financial instruments intended to hedge the nonfunctional currency-denominated monetary assets and liabilities, an immediate 10% hypothetical change of foreign currency exchange rates would not have a material effect on our Consolidated Financial Statements. See Note 11 — “Derivative Financial Instruments and Hedging Activities” to the Consolidated Financial Statements for additional information.
Interest Rate Risk
Our exposure to market risk includes changes in interest rates that could affect the Consolidated Balance Sheet, Consolidated Statement of Operations, and the Consolidated Statement of Cash Flows. We are exposed to interest rate risk primarily on variable rate borrowings under the Credit Facility. There were $349.5 million in borrowings outstanding under debt facilities with variable interest rates as of August 31, 2020.
We utilize valuation models to estimate the effects of sudden interest rate changes. Primarily due to the current low interest rates, the impact of a hypothetical change of 10.0% in variable interest rates would not have a material effect on our Consolidated Financial Statements. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources” and Note 7 — “Notes Payable and Long-Term Debt” to the Consolidated Financial Statements for additional information regarding our outstanding debt obligations.
To manage our exposure to market risk, we use derivative financial instruments and hybrid instruments when deemed appropriate. We have interest rate swap agreements with a notional value of $200.0 million, with mandatory termination dates from August 15, 2020 to February 15, 2022 (the “2020 Extended Interest Rate Swaps”). In addition, we have entered into interest rate swaps to offset future exposures of fluctuations in the fair value of the 2020 Extended Interest Rate Swaps. See Note 11 — “Derivative Financial Instruments and Hedging Activities” to the Consolidated Financial Statements for additional information regarding our interest rate swap transactions. We do not, and do not intend to, use derivative financial instruments for speculative or trading purposes.
We are monitoring developments related to LIBOR; see “Risk Factors” for additional information.
Item 8. Financial Statements and Supplementary Data
Certain information required by this item is included in Item 7 of Part II of this Report under the heading “Quarterly Results” and is incorporated into this item by reference. All other information required by this item is included in Item 15 of Part IV of this Report and is incorporated into this item by reference.
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
There have been no changes in or disagreements with our accountants on accounting and financial disclosure.
45

Table of Contents
Item 9A. Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures
We carried out an evaluation required by Rules 13a-15 and 15d-15 under the Exchange Act (the “Evaluation”), under the supervision and with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15 and 15d-15 under the Exchange Act as of August 31, 2020. Based on the Evaluation, our CEO and CFO concluded that the design and operation of our disclosure controls were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) accumulated and communicated to our senior management, including our CEO and CFO, to allow timely decisions regarding required disclosure.
(b) Management’s Report on Internal Control over Financial Reporting
We assessed the effectiveness of our internal control over financial reporting as of August 31, 2020. Management’s report on internal control over financial reporting as of August 31, 2020 is incorporated herein at Item 15. Ernst & Young LLP, our independent registered public accounting firm, issued an audit report on the effectiveness of our internal control over financial reporting as of August 31, 2020, which is incorporated herein at Item 15.
Our management, including our CEO and CFO, does not expect that our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls may be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control.
The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, a control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
Notwithstanding the foregoing limitations on the effectiveness of controls, we have reached the conclusions set forth in Management’s report on internal control over financial reporting as of August 31, 2020.
The SEC’s general guidance permits the exclusion of an assessment of the effectiveness of a registrant’s controls and procedures as they relate to its internal control over financial reporting for an acquired business during the first year following such acquisition if, among other circumstances and factors, there is not an adequate amount of time between the acquisition date and the date of assessment. On September 30, 2019, we completed the third closing of our acquisition of certain assets of Johnson & Johnson Medical Devices Companies (“JJMD”). In accordance with the SEC guidance, the scope of our evaluation of internal controls over financial reporting as of August 31, 2020 did not include the internal control over financial reporting of these acquired operations. Assets acquired from JJMD during the third closing represent 2.1% of our total consolidated assets at August 31, 2020. Net revenue generated by these assets subsequent to the date of acquisition represents 1.9% of our consolidated net revenue for the fiscal year ended August 31, 2020. We continue to evaluate internal controls over financial reporting for these acquired operations. From the acquisition date to August 31, 2020, the processes and systems of the acquired operations did not significantly impact our internal control over financial reporting.
(c) Changes in Internal Control over Financial Reporting
For our fiscal quarter ended August 31, 2020, we did not identify any modifications to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Item 9B. Other Information
46

Table of Contents
None.
47

Table of Contents
PART III
Item 10. Directors, Executive Officers and Corporate Governance
Information regarding our executive officers is included in Item 1 of Part I of this Report under the heading “Information about our Executive Officers.”
The other information required by this item is incorporated by reference to the information set forth under the captions “Election of Directors”, “Beneficial Ownership – Delinquent Section 16(a) Reports”, “Corporate Governance”, “Board of Directors” and “Audit Committee Matters” in our Proxy Statement for the Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of our fiscal year ended August 31, 2020 (“Proxy Statement”).
Item 11. Executive Compensation
The information required by this item is incorporated by reference to the information set forth under the captions “Compensation Matters”, “Board of Directors – Director Compensation” and “Corporate Governance – Compensation Committee Interlocks and Insider Participation” in our Proxy Statement.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information required by this item is incorporated by reference to the information set forth under the captions “Beneficial Ownership – Share Ownership by Principal Stockholders and Management” and “Compensation Matters – Equity Compensation Plan Information” in our Proxy Statement.
Item 13. Certain Relationships and Related Transactions, and Director Independence
The information required by this item is incorporated by reference to the information set forth under the captions “Corporate Governance – Related Party Transactions – Certain Related Party Transactions”, “Corporate Governance –Determinations of Director Independence” in our Proxy Statement.
Item 14. Principal Accounting Fees and Services
The information required by this item is incorporated by reference to the information set forth under the captions “Audit Committee Matters – Principal Accounting Fees and Services”, “– Policy on Audit Committee Pre-Approval of Audit, Audit-Related and Permissible Non-Audit Services” and “Ratification of Appointment of Independent Registered Public Accounting Firm” in our Proxy Statement.
48

Table of Contents
PART IV
Item 15. Exhibits and Financial Statement Schedules

(a) | The following documents are filed as part of this Report:

1 | Financial Statements. Our consolidated financial statements, and related notes thereto, with the independent registered public accounting firm reports thereon are included in Part IV of this report on the pages indicated by the Index to Consolidated Financial Statements and Schedule.

2 | Financial Statement Schedule. Our financial statement schedule is included in Part IV of this report on the page indicated by the Index to Consolidated Financial Statements and Schedule. This financial statement schedule should be read in conjunction with our consolidated financial statements, and related notes thereto.

Schedules not listed in the Index to Consolidated Financial Statements and Schedule have been omitted because they are not applicable, not required, or the information required to be set forth therein is included in the consolidated financial statements or notes thereto.

3 | Exhibits. See Item 15(b) below.

(b) | Exhibits. The following exhibits are included as part of, or incorporated by reference into, this Report.

EXHIBIT LIST

|  |  |  | Incorporated by Reference Herein
Exhibit No. |  | Description |  | Form |  | Exhibit |  | Filing Date/ Period End
3.1 |  |  | Registrant’s Certificate of Incorporation, as amended. |  | 10-Q |  | 3.1 |  | 5/31/2017
3.2 |  |  | Registrant’s Bylaws, as amended. |  | 10-Q |  | 3.2 |  | 5/31/2017
4.1 |  |  | Form of Certificate for Shares of the Registrant’s Common Stock. (P) |  | S-1 |  | 1 |  | 3/17/1993
4.2 |  |  | Indenture, dated January 16, 2008, with respect to Senior Debt Securities of the Registrant, between the Registrant and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee. |  | 8-K |  | 4.2 |  | 1/17/2008
4.3 |  |  | Form of 4.700% Registered Senior Notes issued on August 3, 2012 |  | 8-K |  | 4.1 |  | 8/6/2012
4.4 |  |  | Officers’ Certificate of the Registrant pursuant to the Indenture, dated August 3, 2012. |  | 8-K |  | 4.3 |  | 8/6/2012
4.5 |  |  | Officers’ Certificate, dated as of January 17, 2018, establishing the 3.950% Senior Notes due 2028. |  | 8-K |  | 4.1 |  | 1/17/2018
4.6 |  |  | Officers’ Certificate, dated as of January 15, 2020, establishing the 3.600% Senior Notes due 2030. |  | 8-K |  | 4.1 |  | 1/15/2020
4.7 |  |  | Officers’ Certificate, dated as of July 13, 2020, establishing the 3.000% Senior Notes due 2031. |  | 8-K |  | 4.1 |  |  | 7/13/2020
4.8 |  |  | Description of Jabil Securities |  | 10-K |  | 4.8 |  |  | 8/31/2019
10.1† |  | Restated cash or deferred profit sharing plan under section 401(k). (P) |  | S-1 |  |  |  | 3/3/1993
10.2† |  | Form of Indemnification Agreement between the Registrant and its Officers and Directors. (P) |  | S-1 |  |  |  | 3/3/1993
10.3† |  | Jabil 2011 Stock Award and Incentive Plan, as Amended and Restated. |  | 14A |  | A |  | 12/9/2016
10.3a |  | Form of Performance-Based Restricted Stock Unit Award Agreement (PBRSU EPS Officer - EU5). |  | 10-K |  | 10.6m |  | 8/31/2016
10.3b |  | Form of Performance-Based Restricted Stock Unit Award Agreement (PBRSU EPS Officer - Non-EU5). |  | 10-K |  | 10.6n |  | 8/31/2016

49

Table of Contents

10.3c |  | Form of Performance-Based Restricted Stock Unit Award Agreement (PBRSU EPS Non-Officer5). |  | 10-K |  | 10.6o |  | 8/31/2016
10.3d |  | Form of Performance-Based Restricted Stock Unit Award Agreement (PBRSU TSR Officer - EU). |  | 10-K |  | 10.6m |  | 8/31/2015
10.3e |  | Form of Performance-Based Restricted Stock Unit Award Agreement (PBRSU TSR Officer - Non-EU). |  | 10-K |  | 10.6n |  | 8/31/2015
10.3f |  | Form of Time-Based Restricted Stock Unit Award Agreement (TBRSU DIR). |  | 10-Q |  | 10.4 |  | 5/31/2011
10.3g |  | Form of Time-Based Restricted Stock Unit Award Agreement (TBRSU NON). |  | 10-Q |  | 10.5 |  | 5/31/2011
10.3h |  | Form of Time-Based Restricted Stock Unit Award Agreement (TBRSU OEU). |  | 10-Q |  | 10.6 |  | 5/31/2011
10.3i |  | Form of Time-Based Restricted Stock Unit Award Agreement (TBRSU ONEU). |  | 10-Q |  | 10.7 |  | 5/31/2011
10.3j |  | Form of Time-Based Restricted Stock Unit Award Agreement (ACQ TBRSU). |  | 10-Q |  | 10.1 |  | 5/31/2015
10.3k |  | Form of Stock Appreciation Right Award Agreement (SAR Officer - Non EU). |  | 10-K |  | 10.7q |  | 8/31/2014
10.4† |  | Jabil Inc. 2011 Employee Stock Purchase Plan, as amended |  | 10-Q |  | 10.8 |  | 11/30/2018
10.4a |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (PBRSU EPS - Executive - EU) |  | 10-Q |  | 10.1 |  | 11/30/2018
10.4b |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (PBRSU EPS - Executive - Non-EU) |  | 10-Q |  | 10.2 |  | 11/30/2018
10.4c |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (PBRSU TSR - ONEU). |  | 10-Q |  | 10.3 |  | 11/30/2018
10.4d |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (PBRSU TSR - OEU). |  | 10-Q |  | 10.4 |  | 11/30/2018
10.4e |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (TBRSU-ONEU) |  | 10-Q |  | 10.5 |  | 11/30/2018
10.4f |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (TBRSU-OEU) |  | 10-Q |  | 10.6 |  | 11/30/2018
10.4g |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (TBRSU-DIR) |  | 10-Q |  | 10.7 |  | 11/30/2018
10.4h |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (PBRSU EPS - Executive-EU). |  | 10-Q |  | 10.1 |  | 11/30/2019
10.4i |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (PBRSU EPS - Executive - Non-EU). |  | 10-Q |  | 10.2 |  | 11/30/2019
10.4j |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (PBRSU TSR - ONEU). |  | 10-Q |  | 10.3 |  | 11/30/2019
10.4k |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (PBRSU TSR - OEU). |  | 10-Q |  | 10.4 |  | 11/30/2019
10.4l |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (TBRSU-ONEU). |  | 10-Q |  | 10.5 |  | 11/30/2019
10.4m |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (TBRSU-OEU). |  | 10-Q |  | 10.6 |  | 11/30/2019
10.4n |  | Form of Jabil Inc. Restricted Stock Unit Award Agreement (TBRSU-DIR). |  | 10-Q |  | 10.7 |  | 11/30/2019
10.5† |  | Executive Deferred Compensation Plan. |  | S-8 |  | 4.1 |  | 2/25/2011

50

Table of Contents

10.6 |  | Credit Agreement dated as of January 22, 2020 among Jabil Inc.; the initial lenders named in the Agreement; Citibank, N.A., as administrative agent; JPMorgan Chase Bank, N.A. and Bank of America, N.A., as co-syndication agents; BNP Paribas, Mizuho Bank, Ltd., MUFG Bank, Ltd. and Sumitomo Mitsui Banking Corporation, as documentation agents; and Citibank, N.A., JPMorgan Chase Bank, N.A., BofA Securities, Inc., BNP Paribas Securities Corp., Mizuho Bank, Ltd., MUFG Bank, Ltd., and Sumitomo Mitsui BankingCorporation, as joint lead arrangers and joint bookrunners. |  | 8-K |  | 10.1 |  | 1/28/2020
10.7 |  | Credit Agreement dated as of April 24, 2020 among Jabil Inc.; the initial lenders named in the Credit Agreement; Mizuho Bank, Ltd. (“Mizuho”), as administrative agent; BNP Paribas and Sumitomo Mitsui Banking Corporation (“SMBC”), as co-syndication agents; Credit Agricole Corporate and Investment Bank, MUFG Union Bank, N.A. and U.S. Bank National Association as Documentation Agents; and Mizuho, BNP Paribas Securities Corp. and SMBC as joint lead arrangers and joint bookrunners. |  | 8-K |  | 10.1 |  | 4/29/2020
21.1* |  | List of Subsidiaries. |  |  |  |  |  |
23.1* |  | Consent of Independent Registered Public Accounting Firm. |  |  |  |  |  |
24.1* |  | Power of Attorney (See Signature page). |  |  |  |  |  |
31.1* |  | Rule 13a-14(a)/15d-14(a) Certification by the Chief Executive Officer of the Registrant. |  |  |  |  |  |
31.2* |  | Rule 13a-14(a)/15d-14(a) Certification by the Chief Financial Officer of the Registrant. |  |  |  |  |  |
32.1* |  | Section 1350 Certification by the Chief Executive Officer of the Registrant. |  |  |  |  |  |
32.2* |  | Section 1350 Certification by the Chief Financial Officer of the Registrant. |  |  |  |  |  |
101 |  | The following financial information from Jabil’s Annual Report on Form 10-K for the fiscal period ended August 31, 2020, formatted in Inline XBRL: (i) Consolidated Balance Sheets as of August 31, 2020 and August 31, 2019; (ii) Consolidated Statement of Operations for the fiscal years ended August 31, 2020, 2019 and 2018; (iii) Consolidated Statements of Comprehensive Income for the fiscal years ended August 31, 2020, 2019 and 2018; (iv) Consolidated Statements of Comprehensive Stockholders’ Equity for the fiscal years ended August 31, 2020, 2019 and 2018; (v) Consolidated Statements of Cash Flows for the fiscal years ended August 31, 2020, 2019 and 2018; and (vi) Notes to Consolidated Financial Statements. |  |  |  |  |  |
104 |  | Cover Page Interactive Data File - Embedded within the inline XBRL Document. |  |  |  |  |  |
† |  | Indicates management compensatory plan, contract of arrangement. |  |  |  |  |  |
* |  | Filed or furnished herewith. |  |  |  |  |  |

Certain instruments with respect to long-term debt of the Company and its consolidated subsidiaries are not filed herewith pursuant to Item 601(b)(4)(iii) of Regulation S-K since the total amount of securities authorized under each such instrument does not exceed 10% of the total assets of the Company and its subsidiaries on a consolidated basis. The Company agrees to furnish a copy of any such instrument to the SEC upon request.

(c) | Financial Statement Schedules. See Item 15(a) above.

51

Table of Contents
JABIL INC. AND SUBSIDIARIES
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND SCHEDULE

Management’s Report on Internal Control over Financial Reporting | 53
Reports of Independent Registered Public Accounting Firm (Ernst & Young LLP) | 54
Consolidated Financial Statements: |
Consolidated Balance Sheets – August 31, 2020 and 2019 | 57
Consolidated Statements of Operations – Fiscal years ended August 31, 2020, 2019, and 2018 | 58
Consolidated Statements of Comprehensive Income – Fiscal years ended August 31, 2020, 2019, and 2018 | 59
Consolidated Statements of Stockholders’ Equity – Fiscal years ended August 31, 2020, 2019, and 2018 | 60
Consolidated Statements of Cash Flows – Fiscal years ended August 31, 2020, 2019 and 2018 | 61
Notes to Consolidated Financial Statements | 62
Financial Statement Schedule: |
Schedule II – Valuation and Qualifying Accounts | 97

52

Table of Contents
MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Management of Jabil Inc. (the “Company”) is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule13a-15(f) of the Securities Exchange Act of 1934, as amended.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Under the supervision of and with the participation of the Chief Executive Officer and the Chief Financial Officer, the Company’s management conducted an assessment of the effectiveness of the Company’s internal control over financial reporting as of August 31, 2020. Management based this assessment on the framework as established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Management’s assessment included an evaluation of the design of the Company’s internal control over financial reporting and testing of the effectiveness of its internal control over financial reporting.
The SEC’s general guidance permits the exclusion of an assessment of the effectiveness of a registrant’s controls and procedures as they relate to its internal control over financial reporting for an acquired business during the first year following such acquisition if, among other circumstances and factors, there is not an adequate amount of time between the acquisition date and the date of assessment. On September 30, 2019, we completed the third closing of our acquisition of certain assets of Johnson & Johnson Medical Devices Companies (“JJMD”). In accordance with the SEC guidance, the scope of our evaluation of internal controls over financial reporting as of August 31, 2020 did not include the internal control over financial reporting of these acquired operations. Assets acquired from JJMD during the third closing represent 2.1% of our total consolidated assets at August 31, 2020. Net revenue generated by these assets subsequent to the date of acquisition represents 1.9% of our
consolidated net revenue for the fiscal year ended August 31, 2020. We continue to evaluate internal controls over financial reporting for these acquired operations. From the acquisition date to August 31, 2020, the processes and systems of the acquired operations did not significantly impact our internal control over financial reporting.
Based on this assessment, management has concluded that, as of August 31, 2020, the Company maintained effective internal control over financial reporting.
Ernst & Young LLP, the Company’s independent registered public accounting firm, issued an audit report on the effectiveness of the Company’s internal control over financial reporting which follows this report.
October 22, 2020
53

Table of Contents
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders of Jabil Inc.
Opinion on Internal Control over Financial Reporting
We have audited Jabil Inc. and subsidiaries’ internal control over financial reporting as of August 31, 2020, based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Jabil Inc. and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of August 31, 2020, based on the COSO criteria.
As indicated in the accompanying Management’s Report on Internal Control over Financial Reporting, management’s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of the operations acquired in the third closing of the Company’s acquisition of certain assets of Johnson & Johnson Medical Devices Companies (JJMD), which are included in the 2020 consolidated financial statements of the Company and constituted 2.1% of consolidated total assets as of August 31, 2020 and 1.9% of consolidated net revenue for the year then ended. Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of the operations acquired in the third closing of the Company’s acquisition of certain assets of JJMD.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of August 31, 2020 and 2019, and the related consolidated statements of operations, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended August 31, 2020, and the related notes and financial statement schedule listed in the Index at Item 15(a), and our report dated October 22, 2020 expressed an unqualified opinion thereon.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ ERNST & YOUNG LLP

Tampa, Florida
October 22, 2020
54

Table of Contents
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders of Jabil Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Jabil Inc. and subsidiaries (the Company) as of August 31, 2020 and 2019, the related consolidated statements of operations, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended August 31, 2020, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at August 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended August 31, 2020, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of August 31, 2020, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated October 22, 2020 expressed an unqualified opinion thereon.
Adoption of New Accounting Standard
As discussed in Note 13 to the consolidated financial statements, the Company changed its method of accounting for revenue from contracts with customers and certain fulfillment costs in 2019 due to the adoption of ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606).
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
55

Table of Contents

| Uncertain Tax Positions
Description of the Matter | As disclosed in Note 15 to the consolidated financial statements, the Company operates in a complex multinational tax environment and is subject to laws and regulations in various jurisdictions regarding intercompany transactions. Uncertain tax positions may arise from interpretations and judgments made by the Company in the application of the relevant laws, regulations and tax rulings. The Company uses significant judgment in (1) determining whether the technical merits of tax positions for certain intercompany transactions are more-likely-than-not to be sustained and (2) measuring the related amount of tax benefit that qualifies for recognition. Auditing the tax positions related to certain intercompany transactions was challenging because the recognition and measurement of the tax positions is highly judgmental and is based on interpretations of laws, regulations and tax rulings.
How We Addressed the Matter in Our Audit | We tested controls over the Company’s process to assess the technical merits of tax positions related to certain intercompany transactions and also tested controls over the Company’s process to determine the application of the relevant laws, regulations and tax rulings, including management’s process to recognize and measure the related tax positions. In testing the recognition and measurement criteria, we involved tax professionals to assist in assessing the technical merits of the Company’s tax positions. In addition, we used our knowledge of and experience with the application of domestic and international income tax laws by the relevant tax authorities to evaluate the Company’s accounting for those tax positions. We also assessed the Company’s assumptions and data used to measure the amount of tax benefit that qualifies for recognition, and tested the clerical accuracy of the calculations. Lastly, we evaluated the Company’s income tax disclosures included in Note 15 in relation to the Company’s uncertain tax positions.

/s/ ERNST & YOUNG LLP

We have served as the Company’s auditor since 2010.
Tampa, Florida
October 22, 2020
56

Table of Contents
JABIL INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except for share data)

| August 31, 2020 |  | August 31, 2019
ASSETS |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 1,393,557 |  |  | $ | 1,163,343 |
Accounts receivable, net of allowance for doubtful accounts | 2,847,743 |  |  | 2,745,226 |
Contract assets | 1,104,700 |  |  | 911,940 |
Inventories, net of reserve for excess and obsolete inventory | 3,131,783 |  |  | 3,023,003 |
Prepaid expenses and other current assets | 657,102 |  |  | 501,573 |
Total current assets | 9,134,885 |  |  | 8,345,085 |
Property, plant and equipment, net of accumulated depreciation | 3,665,312 |  |  | 3,333,750 |
Operating lease right-of-use asset | 362,847 |  |  | — |
Goodwill | 696,853 |  |  | 622,255 |
Intangible assets, net of accumulated amortization | 209,870 |  |  | 256,853 |
Deferred income taxes | 165,407 |  |  | 198,827 |
Other assets | 162,242 |  |  | 213,705 |
Total assets | $ | 14,397,416 |  |  | $ | 12,970,475 |
LIABILITIES AND EQUITY |  |  |
Current liabilities: |  |  |
Current installments of notes payable and long-term debt | $ | 50,194 |  |  | $ | 375,181 |
Accounts payable | 5,687,038 |  |  | 5,166,780 |
Accrued expenses | 3,211,528 |  |  | 2,990,144 |
Current operating lease liabilities | 110,723 |  |  | — |
Total current liabilities | 9,059,483 |  |  | 8,532,105 |
Notes payable and long-term debt, less current installments | 2,678,288 |  |  | 2,121,284 |
Other liabilities | 268,925 |  |  | 163,821 |
Non-current operating lease liabilities | 302,035 |  |  | — |
Income tax liabilities | 148,629 |  |  | 136,689 |
Deferred income taxes | 114,657 |  |  | 115,818 |
Total liabilities | 12,572,017 |  |  | 11,069,717 |
Commitments and contingencies |  |  |
Equity: |  |  |
Jabil Inc. stockholders’ equity: |  |  |
Preferred stock, $0.001 par value, authorized 10,000,000 shares; no shares issued and outstanding | — |  |  | — |
Common stock, $0.001 par value, authorized 500,000,000 shares; 263,830,270 and 260,406,796 shares issued and 150,330,358 and 153,520,380 shares outstanding at August 31, 2020 and August 31, 2019, respectively | 264 |  |  | 260 |
Additional paid-in capital | 2,413,616 |  |  | 2,304,552 |
Retained earnings | 2,040,922 |  |  | 2,037,037 |
Accumulated other comprehensive loss | (34,168 | ) |  | (82,794 | )
Treasury stock at cost, 113,499,912 and 106,886,416 shares as of August 31, 2020 and August 31, 2019, respectively | (2,609,250 | ) |  | (2,371,612 | )
Total Jabil Inc. stockholders’ equity | 1,811,384 |  |  | 1,887,443 |
Noncontrolling interests | 14,015 |  |  | 13,315 |
Total equity | 1,825,399 |  |  | 1,900,758 |
Total liabilities and equity | $ | 14,397,416 |  |  | $ | 12,970,475 |

See accompanying notes to Consolidated Financial Statements.
57

Table of Contents
JABIL INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except for per share data)

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Net revenue | $ | 27,266,438 |  |  | $ | 25,282,320 |  |  | $ | 22,095,416 |
Cost of revenue | 25,335,625 |  |  | 23,368,919 |  |  | 20,388,624 |
Gross profit | 1,930,813 |  |  | 1,913,401 |  |  | 1,706,792 |
Operating expenses: |  |  |  |  |
Selling, general and administrative | 1,174,694 |  |  | 1,111,347 |  |  | 1,050,716 |
Research and development | 44,143 |  |  | 42,861 |  |  | 38,531 |
Amortization of intangibles | 55,544 |  |  | 31,923 |  |  | 38,490 |
Restructuring, severance and related charges | 156,586 |  |  | 25,914 |  |  | 36,902 |
Operating income | 499,846 |  |  | 701,356 |  |  | 542,153 |
Loss on securities | 48,625 |  |  | 29,632 |  |  | — |
Other expense | 31,165 |  |  | 53,750 |  |  | 37,563 |
Interest income | (14,559 | ) |  | (21,460 | ) |  | (17,813 | )
Interest expense | 173,877 |  |  | 188,730 |  |  | 149,002 |
Income before income tax | 260,738 |  |  | 450,704 |  |  | 373,401 |
Income tax expense | 203,959 |  |  | 161,230 |  |  | 285,860 |
Net income | 56,779 |  |  | 289,474 |  |  | 87,541 |
Net income attributable to noncontrolling interests, net of tax | 2,867 |  |  | 2,363 |  |  | 1,211 |
Net income attributable to Jabil Inc. | $ | 53,912 |  |  | $ | 287,111 |  |  | $ | 86,330 |
Earnings per share attributable to the stockholders of Jabil Inc.: |  |  |  |  |
Basic | $ | 0.36 |  |  | $ | 1.85 |  |  | $ | 0.50 |
Diluted | $ | 0.35 |  |  | $ | 1.81 |  |  | $ | 0.49 |
Weighted average shares outstanding: |  |  |  |  |
Basic | 151,613 |  |  | 155,613 |  |  | 172,237 |
Diluted | 155,274 |  |  | 158,647 |  |  | 175,044 |

See accompanying notes to Consolidated Financial Statements.
58

Table of Contents
JABIL INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Net income | $ | 56,779 |  |  | $ | 289,474 |  |  | $ | 87,541 |
Other comprehensive (loss) income: |  |  |  |  |
Change in foreign currency translation | (22,297 | ) |  | (21,729 | ) |  | (50,151 | )
Change in derivative instruments: |  |  |  |  |
Change in fair value of derivatives | (6,004 | ) |  | (67,773 | ) |  | 1,225 |
Adjustment for net losses (gains) realized and included in net income | 14,406 |  |  | 20,259 |  |  | (23,076 | )
Total change in derivative instruments | 8,402 |  |  | (47,514 | ) |  | (21,851 | )
Change in available for sale securities: |  |  |  |  |
Unrealized (loss) gain on available for sale securities | (35,963 | ) |  | (24,508 | ) |  | (8,679 | )
Adjustment for net losses realized and included in net income | 36,420 |  |  | 33,333 |  |  | — |
Total change in available for sale securities | 457 |  |  | 8,825 |  |  | (8,679 | )
Actuarial gain (loss) | 62,126 |  |  | (3,012 | ) |  | 8,194 |
Prior service (cost) credit | (62 | ) |  | 35 |  |  | (1,532 | )
Total other comprehensive income (loss) | 48,626 |  |  | (63,395 | ) |  | (74,019 | )
Comprehensive income | $ | 105,405 |  |  | $ | 226,079 |  |  | $ | 13,522 |
Comprehensive income attributable to noncontrolling interests | 2,867 |  |  | 2,363 |  |  | 1,211 |
Comprehensive income attributable to Jabil Inc. | $ | 102,538 |  |  | $ | 223,716 |  |  | $ | 12,311 |

See accompanying notes to Consolidated Financial Statements.
59

Table of Contents
JABIL INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands, except for share data)

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Total stockholders’ equity, beginning balances | $ | 1,900,758 |  |  | $ | 1,963,380 |  |  | $ | 2,368,344 |
Common stock: |  |  |  |  |
Beginning balances | 260 |  |  | 257 |  |  | 253 |
Shares issued under employee stock purchase plan | 2 |  |  | 1 |  |  | 1 |
Vesting of restricted stock | 2 |  |  | 2 |  |  | 3 |
Ending balances | 264 |  |  | 260 |  |  | 257 |
Additional paid-in capital: |  |  |  |  |
Beginning balances | 2,304,552 |  |  | 2,218,673 |  |  | 2,104,203 |
Shares issued under employee stock purchase plan | 30,118 |  |  | 26,999 |  |  | 24,865 |
Vesting of restricted stock | (2 | ) |  | (2 | ) |  | (3 | )
Recognition of stock-based compensation | 78,948 |  |  | 58,882 |  |  | 89,608 |
Ending balances | 2,413,616 |  |  | 2,304,552 |  |  | 2,218,673 |
Retained earnings: |  |  |  |  |
Beginning balances | 2,037,037 |  |  | 1,760,097 |  |  | 1,730,893 |
Declared dividends | (50,027 | ) |  | (51,026 | ) |  | (57,126 | )
Cumulative effect adjustment for adoption of new accounting standards | — |  |  | 40,855 |  |  | — |
Net income attributable to Jabil Inc. | 53,912 |  |  | 287,111 |  |  | 86,330 |
Ending balances | 2,040,922 |  |  | 2,037,037 |  |  | 1,760,097 |
Accumulated other comprehensive loss: |  |  |  |  |
Beginning balances | (82,794 | ) |  | (19,399 | ) |  | 54,620 |
Other comprehensive income (loss) | 48,626 |  |  | (63,395 | ) |  | (74,019 | )
Ending balances | (34,168 | ) |  | (82,794 | ) |  | (19,399 | )
Treasury stock: |  |  |  |  |
Beginning balances | (2,371,612 | ) |  | (2,009,371 | ) |  | (1,536,455 | )
Purchases of treasury stock under employee stock plans | (23,128 | ) |  | (11,918 | ) |  | (22,597 | )
Treasury shares purchased | (214,510 | ) |  | (350,323 | ) |  | (450,319 | )
Ending balances | (2,609,250 | ) |  | (2,371,612 | ) |  | (2,009,371 | )
Noncontrolling interests: |  |  |  |  |
Beginning balances | 13,315 |  |  | 13,123 |  |  | 14,830 |
Net income attributable to noncontrolling interests | 2,867 |  |  | 2,363 |  |  | 1,211 |
Acquisition of noncontrolling interests | — |  |  | 1,112 |  |  | — |
Disposition of noncontrolling interests | — |  |  | (1,785 | ) |  | — |
Declared dividends to noncontrolling interests | (2,002 | ) |  | (1,500 | ) |  | (2,920 | )
Foreign currency adjustments attributable to noncontrolling interests | (165 | ) |  | — |  |  | 2 |
Other | — |  |  | 2 |  |  | — |
Ending balances | 14,015 |  |  | 13,315 |  |  | 13,123 |
Total stockholders’ equity, ending balances | $ | 1,825,399 |  |  | $ | 1,900,758 |  |  | $ | 1,963,380 |

See accompanying notes to Consolidated Financial Statements.
60

Table of Contents
JABIL INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Cash flows provided by (used in) operating activities: |  |  |  |  |
Net income | $ | 56,779 |  |  | $ | 289,474 |  |  | $ | 87,541 |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |  |  |  |  |
Depreciation and amortization | 794,581 |  |  | 771,833 |  |  | 773,704 |
Restructuring and related charges | 41,356 |  |  | (3,566 | ) |  | 16,264 |
Recognition of stock-based compensation expense and related charges | 83,084 |  |  | 61,346 |  |  | 90,664 |
Deferred income taxes | 29,209 |  |  | 20,998 |  |  | 52,705 |
Loss (gain) on sale of property, plant and equipment | 29,393 |  |  | (2,522 | ) |  | — |
Provision for allowance for doubtful accounts and notes receivable | 32,066 |  |  | 15,867 |  |  | 38,030 |
Loss on securities | 48,625 |  |  | 29,632 |  |  | — |
Other, net | 21,925 |  |  | 39,539 |  |  | (13,600 | )
Change in operating assets and liabilities, exclusive of net assets acquired: |  |  |  |  |
Accounts receivable | (135,973 | ) |  | (586,511 | ) |  | (2,334,367 | )
Contract assets | (104,601 | ) |  | (878,469 | ) |  | — |
Inventories | (77,320 | ) |  | 483,074 |  |  | (499,105 | )
Prepaid expenses and other current assets | (144,152 | ) |  | 28,897 |  |  | (97,795 | )
Other assets | (10,669 | ) |  | (38,188 | ) |  | (34,747 | )
Accounts payable, accrued expenses and other liabilities | 592,972 |  |  | 961,662 |  |  | 815,258 |
Net cash provided by (used in) operating activities | 1,257,275 |  |  | 1,193,066 |  |  | (1,105,448 | )
Cash flows (used in) provided by investing activities: |  |  |  |  |
Acquisition of property, plant and equipment | (983,035 | ) |  | (1,005,480 | ) |  | (1,036,651 | )
Proceeds and advances from sale of property, plant and equipment | 186,655 |  |  | 218,708 |  |  | 350,291 |
Cash paid for business and intangible asset acquisitions, net of cash | (146,909 | ) |  | (153,239 | ) |  | (109,664 | )
Cash receipts on sold receivables | — |  |  | 96,846 |  |  | 2,039,298 |
Other, net | 22,176 |  |  | (29,289 | ) |  | (2,360 | )
Net cash (used in) provided by investing activities | (921,113 | ) |  | (872,454 | ) |  | 1,240,914 |
Cash flows used in financing activities: |  |  |  |  |
Borrowings under debt agreements | 12,777,055 |  |  | 11,985,978 |  |  | 9,677,424 |
Payments toward debt agreements | (12,544,456 | ) |  | (12,013,004 | ) |  | (9,206,016 | )
Payments to acquire treasury stock | (214,510 | ) |  | (350,323 | ) |  | (450,319 | )
Dividends paid to stockholders | (50,462 | ) |  | (52,004 | ) |  | (57,833 | )
Net proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan | 30,117 |  |  | 26,999 |  |  | 24,865 |
Treasury stock minimum tax withholding related to vesting of restricted stock | (23,128 | ) |  | (11,918 | ) |  | (22,597 | )
Other, net | (39,739 | ) |  | (1,500 | ) |  | (12,568 | )
Net cash used in financing activities | (65,123 | ) |  | (415,772 | ) |  | (47,044 | )
Effect of exchange rate changes on cash and cash equivalents | (40,825 | ) |  | 554 |  |  | (20,392 | )
Net increase (decrease) in cash and cash equivalents | 230,214 |  |  | (94,606 | ) |  | 68,030 |
Cash and cash equivalents at beginning of period | 1,163,343 |  |  | 1,257,949 |  |  | 1,189,919 |
Cash and cash equivalents at end of period | $ | 1,393,557 |  |  | $ | 1,163,343 |  |  | $ | 1,257,949 |
Supplemental disclosure information: |  |  |  |  |
Interest paid, net of capitalized interest | $ | 182,946 |  |  | $ | 185,696 |  |  | $ | 167,278 |
Income taxes paid, net of refunds received | $ | 163,571 |  |  | $ | 168,053 |  |  | $ | 180,423 |

See accompanying notes to Consolidated Financial Statements.
61

Table of Contents
JABIL INC. AND SUBSIDIARIES
Notes to Consolidated Financial Statements
1. Description of Business and Summary of Significant Accounting Policies
Jabil Inc. (together with its subsidiaries, herein referred to as the “Company”) is one of the leading providers of manufacturing services and solutions. The Company provides comprehensive electronics design, production and product management services to companies in various industries and end markets. The Company’s services combine a highly automated, continuous flow manufacturing approach with advanced electronic design and design for manufacturability technologies. The Company is headquartered in St. Petersburg, Florida and has manufacturing operations principally in the Americas, Europe and Asia.
Significant accounting policies followed by the Company are as follows:
Principles of Consolidation and Basis of Presentation
The consolidated financial statements include the accounts and operations of the Company, and its wholly-owned and majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in preparing the consolidated financial statements. The Company has made certain reclassification adjustments to conform prior periods’ Consolidated Financial Statements and Notes to the Consolidated Financial Statements to the current presentation.
Use of Accounting Estimates
Management is required to make estimates and assumptions during the preparation of the consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”). These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from these estimates and assumptions.
Cash and Cash Equivalents
Cash equivalents consist of investments that are readily convertible to cash with original maturities of 90 days or less.
Accounts Receivable
Accounts receivable consist of trade receivables and other miscellaneous receivables. The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. Bad debts are charged to this allowance after all attempts to collect the balance are exhausted. Allowances of $25.8 million and $17.2 million were recorded as of August 31, 2020 and 2019, respectively. As the financial condition and circumstances of the Company’s customers change, adjustments to the allowance for doubtful accounts are made as necessary.
Contract Balances
Timing of revenue recognition may differ from the timing of invoicing to customers. The Company records an asset when revenue is recognized prior to invoicing a customer (“contract assets”) while a liability is recognized when a customer pays an invoice prior to the Company transferring control of the goods or services (“contract liabilities”). Amounts recognized as contract assets are generally transferred to receivables in the succeeding quarter due to the short-term nature of the manufacturing cycle. Contract assets are classified separately on the Consolidated Balance Sheets and transferred to receivables when right to payment becomes unconditional.
The Company reviews contract assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable after considering factors such as the age of the balances and the financial stability of the customer.
Inventories
Inventories are stated at the lower of cost (on a first in, first out (FIFO) basis) and net realizable value. Inventory is valued based on current and forecasted usage, customer inventory-related contractual obligations and other lower of cost and net realizable value considerations. If actual market conditions or customer product demands are less favorable than those projected, additional valuation adjustments may be necessary.
Fulfillment Costs
62

Table of Contents
The Company capitalizes costs incurred to fulfill its contracts that i) relate directly to the contract or anticipated contracts, ii) are expected to generate or enhance the Company’s resources that will be used to satisfy the performance obligation under the contract, and iii) are expected to be recovered through revenue generated from the contract. Capitalized fulfillment costs are amortized to cost of revenue as the Company satisfies the related performance obligations under the contract with approximate lives ranging from 1 year to 3 years. These costs, which are included in prepaid expenses and other current assets and other assets on the Consolidated Balance Sheets, generally represent upfront costs incurred to prepare for manufacturing activities.
The Company assesses the capitalized fulfillment costs for impairment at the end of each reporting period. The Company will recognize an impairment loss to the extent the carrying amount of the capitalized costs exceeds the recoverable amount. Recoverability is assessed by considering the capitalized fulfillment costs in relation to the forecasted profitability of the related manufacturing performance obligations.
As of August 31, 2020 and 2019, capitalized costs to fulfill were $85.3 million and $67.1 million, respectively. Amortization of fulfillment cost were $56.6 million and $48.6 million during the fiscal years ended August 31, 2020 and 2019, respectively. Immaterial or no impairments for fulfillments costs were recognized during the fiscal years ended August 31, 2020 and 2019, respectively.
Property, Plant and Equipment, net
Property, plant and equipment is capitalized at cost and depreciated using the straight-line depreciation method over the estimated useful lives of the respective assets. Estimated useful lives for major classes of depreciable assets are as follows:

Asset Class | Estimated Useful Life
Buildings | Up to 35 years
Leasehold improvements | Shorter of lease term or useful life of the improvement
Machinery and equipment | 2 to 10 years
Furniture, fixtures and office equipment | 5 years
Computer hardware and software | 3 to 7 years
Transportation equipment | 3 years

Maintenance and repairs are expensed as incurred. The cost and related accumulated depreciation of assets sold or retired is removed from the accounts and any resulting gain or loss is reflected in the Consolidated Statements of Operations as a component of operating income.
Leases
Effective September 1, 2019, the Company’s lease accounting policies changed in conjunction with the adoption of Accounting Standards Update No. 2016-02 (“ASU 2016-02”), Leases (Topic 842). For further discussion, refer to Note 5—“Leases” to the Consolidated Financial Statements.
The Company elected to apply the package of practical expedients, which among other things, allows entities to maintain the historical lease classification for existing leases. The Company has lease agreements that contain both lease and non-lease components. For lease agreements entered into or reassessed after the adoption of ASU 2016-02, the Company has elected the practical expedient to combine lease and non-lease components for building and real estate leases.
The Company primarily has leases for buildings and real estate with lease terms ranging from 1 year to 36 years. Leases for other classes of assets are not significant. For any leases with an initial term in excess of 12 months, the Company determines whether an arrangement is a lease at contract inception by evaluating if the contract conveys the right to use and control the specific property or equipment. Certain lease agreements contain purchase or renewal options. These options are included in the lease term when it is reasonably certain that the Company will exercise that option. Generally, the Company's lease agreements do not contain material residual value guarantees or material restrictive covenants.
Right-of-use assets represent the right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized based on the present value of future lease payments over the lease term at the lease commencement date. When determining the present value of future payment, the Company uses the incremental borrowing rate when the implicit rate is not readily determinable. Any payment deemed probable under residual value guarantees is included in lease payments. Any variable payments, other than those that depend on an index or rate, are excluded from right-of-use assets and lease liabilities.
63

Table of Contents
Leases with an initial term of 12 months or less are not recorded as right-of-use assets and lease liabilities in the Consolidated Balance Sheet. Lease expense for these leases is recognized on a straight-line basis over the lease term.
Certain equipment and buildings held under finance leases are classified as property, plant and equipment and the related obligation is recorded as accrued expenses and other liabilities on the Consolidated Balance Sheets. Amortization of assets held under finance leases is included in depreciation expense in the Consolidated Statements of Operations.
Goodwill and Other Intangible Assets
The Company accounts for goodwill in a business combination as the excess of the cost over the fair value of net assets acquired and is assigned to the reporting unit in which the acquired business will operate. The Company tests goodwill and indefinite-lived intangible assets for impairment during the fourth quarter of each fiscal year or whenever events or changes in circumstances indicate the carrying amount may not be recoverable.
The recoverability of goodwill is measured at the reporting unit level by comparing the reporting unit’s carrying amount, including goodwill, to the fair value of the reporting unit. The Company may elect to perform a qualitative assessment to determine whether it is more likely than not that a reporting unit is impaired. If the qualitative assessment is not performed or if the Company determines that it is not more likely than not that the fair value of the reporting unit exceeds the carrying value, the Company determines the fair value of its reporting units based on an average weighting of both projected discounted future results and the use of comparative market multiples. If the carrying amount of the reporting unit exceeds its fair value, goodwill is considered impaired and a second step is performed to measure the amount of loss, if any.
The recoverability of indefinite-lived intangible assets is measured by comparing the carrying amount to the fair value. The Company may elect to perform a qualitative assessment to determine whether it is more likely than not that an indefinite-lived intangible is impaired. If the qualitative assessment is not performed or if the Company determines that it is not more likely than not that the fair value of an indefinite-lived intangible exceeds the carrying value, the Company determines the fair value principally based on a variation of the income approach, known as the relief from royalty method. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, the indefinite-lived intangible asset is considered impaired.
Business combinations can also result in other intangible assets being recognized. Finite-lived intangible assets are amortized on either a straight-line or accelerated basis over their estimated useful life and include contractual agreements and customer relationships, tradenames and intellectual property. No significant residual values are estimated for the amortizable intangible assets.
Long-lived Assets
Long-lived assets, such as property, plant and equipment, and finite-lived intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of the asset or asset group is measured by comparing its carrying amount to the undiscounted future net cash flows the asset is expected to generate. If the carrying amount of an asset or asset group is not recoverable, the Company recognizes an impairment loss based on the excess of the carrying amount of the long-lived asset or asset group over its respective fair value, which is generally determined as the present value of estimated future cash flows or as the appraised value.
Derivative Instruments
All derivative instruments are recorded gross on the Consolidated Balance Sheets at their respective fair values. The accounting for changes in the fair value of a derivative instrument depends on the intended use and designation of the derivative instrument. For derivative instruments that are designated and qualify as a fair value hedge, the gain or loss on the derivative and the offsetting gain or loss on the hedged item attributable to the hedged risk are recognized in current earnings. For derivative instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative instrument is initially reported as a component of accumulated other comprehensive income (“AOCI”), net of tax, and is subsequently reclassified into the line item within the Consolidated Statements of Operations in which the hedged items are recorded in the same period in which the hedged item affects earnings. The ineffective portion of the gain or loss is recognized immediately in current earnings. For derivative instruments that are not designated as hedging instruments, gains and losses from changes in fair values are recognized in earnings. Cash receipts and cash payments related to derivative instruments are recorded in the same category as the cash flows from the items being hedged on the Consolidated Statements of Cash Flows.
Accumulated Other Comprehensive Income
64

Table of Contents
The following table sets forth the changes in AOCI, net of tax, by component during the fiscal year ended August 31, 2020 (in thousands):

| Foreign Currency Translation Adjustment |  | Derivative Instruments |  | Actuarial (Loss) Gain |  | Prior Service Cost |  | Available for Sale Securities |  | Total
Balance as of August 31, 2019 | $ | (14,298 | ) |  | $ | (39,398 | ) |  | $ | (28,033 | ) |  | $ | (608 | ) |  | $ | (457 | ) |  | $ | (82,794 | )
Other comprehensive (loss) income before reclassifications | (22,297 | ) |  | (6,004 | ) |  | 66,285 |  |  | (17 | ) |  | (35,963 | ) |  | 2,004 |
Amounts reclassified from AOCI | — |  |  | 14,406 |  |  | (4,159 | ) |  | (45 | ) |  | 36,420 |  |  | 46,622 |
Other comprehensive (loss) income(1) | (22,297 | ) |  | 8,402 |  |  | 62,126 |  |  | (62 | ) |  | 457 |  |  | 48,626 |
Balance as of August 31, 2020 | $ | (36,595 | ) |  | $ | (30,996 | ) |  | $ | 34,093 |  |  | $ | (670 | ) |  | $ | — |  |  | $ | (34,168 | )

(1) | Actuarial (loss) gain is net of tax of $(12.0) million. Amounts for other components of AOCI are net of tax, which are immaterial.

The following table sets forth the amounts reclassified from AOCI into the Consolidated Statements of Operations, and the associated financial statement line item, net of tax, for the periods indicated (in thousands):

|  |  |  | Fiscal Year Ended August 31,
Comprehensive Income Components |  | Financial Statement Line Item |  | 2020 |  | 2019 |  | 2018
Realized losses (gains) on derivative instruments:(1) |  |  |  |  |  |  |  |
Foreign exchange contracts |  | Cost of revenue |  | $ | 15,507 |  |  | $ | 21,982 |  |  | $ | (9,379 | )
Interest rate contracts |  | Interest expense |  | (1,101 | ) |  | (1,723 | ) |  | (13,697 | )
Actuarial (gain) loss |  | (2) |  | (4,159 | ) |  | 741 |  |  | 1,127 |
Prior service credit |  | (2) |  | (45 | ) |  | (44 | ) |  | (88 | )
Available for sale securities |  | Loss on securities |  | 36,420 |  |  | 33,333 |  |  | — |
Total amounts reclassified from AOCI(3) |  |  |  | $ | 46,622 |  |  | $ | 54,289 |  |  | $ | (22,037 | )

(1) | The Company expects to reclassify $4.7 million into earnings during the next twelve months, which will primarily be classified as a component of cost of revenue.

(2) | Amounts are included in the computation of net periodic benefit pension cost. Refer to Note 10 – “Postretirement and Other Employee Benefits” for additional information.

(3) | Amounts are net of tax, which are immaterial for the fiscal years ended August 31, 2020 and 2019. The amount for the fiscal year ended August 31, 2018 includes a reduction to income tax expense related to derivative instruments of $14.8 million.

Foreign Currency Transactions
For the Company’s foreign subsidiaries that use a currency other than the U.S. dollar as their functional currency, the assets and liabilities are translated at exchange rates in effect at the balance sheet date, and revenues and expenses are translated at the average exchange rate for the period. The effects of these translation adjustments are reported in accumulated other comprehensive income. Gains and losses arising from transactions denominated in a currency other than the functional currency of the entity involved are included in operating income.
Revenue Recognition
The Company provides comprehensive electronics design, production and product management services to companies in various industries and end markets. The Company derives substantially all of its revenue from production and product management services (collectively referred to as “manufacturing services”), which encompasses the act of producing tangible products that are built to customer specifications, which are then provided to the customer.
65

Table of Contents
The Company generally enters into manufacturing service contracts with its customers that provide the framework under which business will be conducted and customer purchase orders will be received for specific quantities and with predominantly fixed pricing. As a result, the Company considers its contract with a customer to be the combination of the manufacturing service contract and the purchase order, or any agreements or other similar documents.
The majority of the Company's manufacturing service contracts relate to manufactured products which have no alternative use and for which the Company has an enforceable right to payment for the work completed to date. As a result, revenue is recognized over time when or as the Company transfers control of the promised products or services (known as performance obligations) to its customers. For certain other contracts with customers that do not meet the over time revenue recognition criteria, transfer of control occurs at a point in time which generally occurs upon delivery and transfer of risk and title to the customer.
Most of the Company's contracts have a single performance obligation as the promise to transfer the individual manufactured product or service is capable of being distinct and is distinct within the context of the contract. For the majority of customers, performance obligations are satisfied over time based on the continuous transfer of control as manufacturing services are performed and are generally completed in less than one year.
The Company also derives revenue to a lesser extent from electronic design services to certain customers. Revenue from electronic design services is generally recognized over time as the services are performed.
For the Company’s over time customers, it believes the measure of progress which best depicts the transfer of control is based on costs incurred to date, relative to total estimated cost at completion (i.e., an input method). This method is a faithful depiction of the transfer of goods or services because it results in the recognition of revenue on the basis of the Company's to-date efforts in the satisfaction of a performance obligation relative to the total expected efforts in the satisfaction of the performance obligation. The Company believes that the use of an input method best depicts the transfer of control to the customer, which occurs as the Company incurs costs on its contracts. The transaction price of each performance obligation is generally based upon the contractual stand-alone selling price of the product or service.
Certain contracts with customers include variable consideration, such as periodic cost of materials adjustments, rebates, discounts, or returns. The Company recognizes estimates of this variable consideration that are not expected to result in a significant revenue reversal in the future, primarily based on the most likely level of consideration to be paid to the customer under the specific terms of the underlying programs.
Taxes collected from the Company’s customers and remitted to governmental authorities are presented within the Company’s Consolidated Statement of Operations on a net basis and are excluded from the transaction price. The Company has elected to account for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the goods. Accordingly, the Company records customer payments of shipping and handling costs as a component of net revenue, and classifies such costs as a component of cost of revenue.
Stock-Based Compensation
The Company recognizes stock-based compensation expense, reduced for estimated forfeitures, on a straight-line basis over the requisite service period of the award, which is generally the vesting period for outstanding stock awards.
The stock-based compensation expense for time-based and performance-based restricted stock unit awards (“restricted stock units”) is measured at fair value on the date of grant based on the number of shares expected to vest and the quoted market price of the Company’s common stock. For restricted stock units with performance conditions, stock-based compensation expense is originally based on the number of shares that would vest if the Company achieved 100% of the performance goal, which is the intended outcome at the grant date. Throughout the requisite service period, management monitors the probability of achievement of the performance condition. If it becomes probable, based on the Company’s performance, that more or less than the current estimate of the awarded shares will vest, an adjustment to stock-based compensation expense will be recognized as a change in accounting estimate in the period that such probability changes.
The stock-based compensation expense for market-based restricted stock units is measured at fair value on the date of grant. The market conditions are considered in the grant date fair value using a Monte Carlo valuation model, which utilizes multiple input variables to determine the probability of the Company achieving the specified market conditions. Stock-based compensation expense related to an award with a market condition will be recognized over the requisite service period regardless of whether the market condition is satisfied, provided that the requisite service period has been completed.
66

Table of Contents
The Company currently expects to satisfy share-based awards with registered shares available to be issued.
See Note 12 – “Stockholders’ Equity” for further discussion of stock-based compensation expense.
Income Taxes
Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in the tax rate is recognized in income in the period that includes the enactment date of the rate change. The Company records a valuation allowance to reduce its deferred tax assets to the amount that is more likely than not to be realized. The Company considers future taxable income and ongoing feasible tax planning strategies in assessing the need for the valuation allowance.
The Company applies the incremental cash tax savings approach when analyzing the impact Global Intangible Low-Taxed Income (“GILTI”) could have on its U.S. valuation allowance. The incremental cash tax savings approach considers the realizable benefit of a net operating loss and deferred tax assets by comparing the incremental cash taxes in the calculation of GILTI with and without the net operating loss and other DTAs.
Earnings Per Share
The Company calculates its basic earnings per share by dividing net income attributable to Jabil Inc. by the weighted average number of shares of common stock outstanding during the period. The Company’s diluted earnings per share is calculated in a similar manner, but includes the effect of dilutive securities. The difference between the weighted average number of basic shares outstanding and the weighted average number of diluted shares outstanding is primarily due to dilutive unvested restricted stock units and dilutive stock appreciation rights.
Potential shares of common stock are excluded from the computation of diluted earnings per share when their effect would be antidilutive. Performance-based restricted stock units are considered dilutive when the related performance criterion have been met assuming the end of the reporting period represents the end of the performance period. All potential shares of common stock are antidilutive in periods of net loss. Potential shares of common stock not included in the computation of earnings per share because their effect would have been antidilutive or because the performance criterion was not met were as follows (in thousands):

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Restricted stock units | 728 |  |  | 796 |  |  | 2,426 |

Fair Value of Financial Instruments
Fair value is categorized in one of three levels based on the lowest level of significant input used. Level 1 – quoted market prices in active markets for identical assets and liabilities; Level 2 – inputs other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – unobservable inputs for the asset or liability.
2. Trade Accounts Receivable Sale Programs
The Company regularly sells designated pools of high credit quality trade accounts receivable under uncommitted trade accounts receivable sale programs to unaffiliated financial institutions without recourse. As these accounts receivable are sold without recourse, the Company does not retain the associated risks following the transfer of such accounts receivable to the respective financial institutions. The Company continues servicing the receivables sold and in exchange receives a servicing fee under each of the trade accounts receivable sale programs. Servicing fees related to each of the trade accounts receivable sale programs recognized during the fiscal years ended August 31, 2020, 2019 and 2018 were not material. The Company does not record a servicing asset or liability on the Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities.
Transfers of the receivables under the trade accounts receivable sale programs are accounted for as sales and, accordingly, net receivables sold under the trade accounts receivable sale programs are excluded from accounts receivable on the Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Consolidated Statements of Cash Flows.
67

Table of Contents
The following is a summary of the trade accounts receivable sale programs with unaffiliated financial institutions where the Company may elect to sell receivables and the unaffiliated financial institution may elect to purchase, at a discount, on an ongoing basis:

Program | Maximum Amount (in millions)(1) |  |  | Type of Facility |  | Expiration Date |
A | $ | 600.0 |  |  |  | Uncommitted |  | December 5, 2020 | (2)
B | $ | 150.0 |  |  |  | Uncommitted |  | November 30, 2020 | (3)
C | 400.0 |  | CNY |  | Uncommitted |  | August 31, 2023 |
D | $ | 150.0 |  |  |  | Uncommitted |  | May 4, 2023 | (4)
E | $ | 150.0 |  |  |  | Uncommitted |  | January 25, 2021 | (5)
F | $ | 50.0 |  |  |  | Uncommitted |  | February 23, 2023 | (6)
G | $ | 100.0 |  |  |  | Uncommitted |  | August 10, 2021 | (7)
H | $ | 100.0 |  |  |  | Uncommitted |  | July 21, 2021 | (8)
I | $ | 650.0 |  |  |  | Uncommitted |  | December 4, 2020 | (9)
J | $ | 135.0 |  |  |  | Uncommitted |  | April 11, 2021 | (10)
K | $ | 100.0 |  | CHF |  | Uncommitted |  | December 5, 2020 | (2)

(1) | Maximum amount of trade accounts receivable that may be sold under a facility at any one time.

(2) | The program will be automatically extended through December 5, 2025 unless either party provides 30 days’ notice of termination.

(3) | The program will automatically extend for one year at each expiration date unless either party provides 10 days’ notice of termination.

(4) | Any party may elect to terminate the agreement upon 30 days’ prior notice.

(5) | The program will be automatically extended through January 25, 2023 unless either party provides 30 days’ notice of termination.

(6) | Any party may elect to terminate the agreement upon 15 days’ prior notice.

(7) | The program will be automatically extended through August 10, 2023 unless either party provides 30 days’ notice of termination.

(8) | The program will be automatically extended through August 21, 2023 unless either party provides 30 days’ notice of termination.

(9) | The program will be automatically extended through December 5, 2024 unless either party provides 30 days’ notice of termination.

(10) | The program will be automatically extended each year through April 11, 2025 unless either party provides 30 days’ notice of termination.

In connection with the trade accounts receivable sale programs, the Company recognized the following (in millions):

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Trade accounts receivable sold | $ | 8,457 |  |  | $ | 6,751 |  |  | $ | 5,480 |
Cash proceeds received | $ | 8,440 |  |  | $ | 6,723 |  |  | $ | 5,463 |
Pre-tax losses on sale of receivables(1) | $ | 17 |  |  | $ | 28 |  |  | $ | 17 |

(1) | Recorded to other expense within the Consolidated Statements of Operations.

3. Inventories
Inventories consist of the following (in thousands):
68

Table of Contents

| August 31, 2020 |  | August 31, 2019
Raw materials | $ | 2,389,719 |  |  | $ | 2,310,081 |
Work in process | 450,781 |  |  | 468,217 |
Finished goods | 376,542 |  |  | 314,258 |
Reserve for excess and obsolete inventory | (85,259 | ) |  | (69,553 | )
Inventories, net | $ | 3,131,783 |  |  | $ | 3,023,003 |

4. Property, Plant and Equipment
Property, plant and equipment consists of the following (in thousands):

| August 31, 2020 |  | August 31, 2019
Land and improvements | $ | 141,715 |  |  | $ | 146,719 |
Buildings | 1,152,204 |  |  | 962,559 |
Leasehold improvements | 1,144,238 |  |  | 1,092,787 |
Machinery and equipment | 4,685,611 |  |  | 4,262,015 |
Furniture, fixtures and office equipment | 221,709 |  |  | 209,257 |
Computer hardware and software | 760,195 |  |  | 671,252 |
Transportation equipment | 9,061 |  |  | 16,423 |
Construction in progress | 76,337 |  |  | 83,234 |
| 8,191,070 |  |  | 7,444,246 |
Less accumulated depreciation and amortization | 4,525,758 |  |  | 4,110,496 |
| $ | 3,665,312 |  |  | $ | 3,333,750 |

Depreciation and maintenance and repair expenses were as follows for the periods indicated (in thousands):

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Depreciation expense | $ | 739,038 |  |  | $ | 739,910 |  |  | $ | 735,213 |
Maintenance and repair expense | $ | 333,772 |  |  | $ | 288,309 |  |  | $ | 266,691 |

As of August 31, 2020 and 2019, the Company had $422.4 million and $235.2 million, respectively, included in accounts payable for the acquisition of property, plant and equipment, which is considered a non-cash investing activity in the Consolidated Statements of Cash Flows.
5. Leases
Effective September 1, 2019, the Company adopted Accounting Standards Update No. 2016-02 (“ASU 2016-02”), Leases (Topic 842) using the modified retrospective approach and also elected to apply the package of practical expedients, which among other things, allows entities to maintain the historical lease classification for existing leases. The Company has lease agreements that contain both lease and non-lease components. For lease agreements entered into or reassessed after the adoption of ASU 2016-02, the Company has elected the practical expedient to combine lease and non-lease components for building and real estate leases.
Upon adoption of ASU 2016-02, the Company recorded $414.6 million and $437.5 million of right-of-use assets and lease liabilities, respectively, related to its existing operating lease portfolio. The accounting for the Company's finance leases remained substantially unchanged and balances were not significant on the adoption date. The adoption of this standard did not have a material impact on the Consolidated Statements of Operations or the Consolidated Statements of Cash Flows.
The following table sets forth the amount of lease assets and lease liabilities included on the Company's Consolidated Balance Sheets, as of the period indicated (in thousands):
69

Table of Contents

|  | Financial Statement Line Item |  | August 31, 2020
Assets |  |  |  |
Operating lease assets (1) |  | Operating lease right-of-use assets |  | $ | 362,847 |
Finance lease assets (2) |  | Property, plant and equipment, net |  | 160,015 |
Total lease assets |  |  |  | $ | 522,862 |
Liabilities |  |  |  |
Current |  |  |  |
Operating lease liabilities |  | Current operating lease liabilities |  | $ | 110,723 |
Finance lease liabilities |  | Accrued expenses |  | 7,465 |
Non-current |  |  |  |  |
Operating lease liabilities |  | Non-current operating lease liabilities |  | 302,035 |
Finance lease liabilities |  | Other liabilities |  | 160,747 |
Total lease liabilities |  |  |  | $ | 580,970 |

(1) | Net of accumulated amortization of $96.2 million.

(2) | Net of accumulated amortization of $12.8 million.

The following table is a summary of expenses related to leases included on the Company's Consolidated Statements of Operations, for the periods indicated (in thousands):

| Fiscal Year Ended August 31,
| 2020
Operating lease cost | $ | 114,290 |
Finance lease cost |
Amortization of leased assets | 5,470 |
Interest on lease liabilities | 4,950 |
Other | 15,038 |
Net lease cost(1) | $ | 139,748 |

(1) | Lease costs are primarily recognized in cost of revenue.

The following table is a summary of the weighted-average remaining lease terms and weighted-average discount rates of the Company's leases, as of the period indicated:

| August 31, 2020
| Weighted-average remaining lease term |  | Weighted-average discount rate
Operating leases | 5.4 years |  | 3.18 | %
Finance leases | 5.7 years |  | 4.28 | %

The following table sets forth other supplemental information related to the Company's lease portfolio (in thousands):
70

Table of Contents

| Fiscal Year Ended August 31,
| 2020
Cash paid for amounts included in the measurement of lease liabilities: |
Operating cash flows for operating leases(1) | $ | 112,267 |
Operating cash flows for finance leases(1) | 4,950 |
Financing activities for finance leases(2) | 6,242 |
Non-cash right-of-use assets obtained in exchange for new lease liabilities: |
Operating leases | 91,350 |
Finance leases | 111,591 |

(1) | Included in accounts payable, accrued expenses and other liabilities in Operating Activities of the Company's Consolidated Statements of Cash Flows.

(2) | Included in payments toward debt agreements in Financing Activities of the Company's Consolidated Statements of Cash Flows.

The future minimum lease payments under operating and finance leases as of August 31, 2020 were as follows (in thousands):

Fiscal Year Ending August 31, | Operating Leases(1) |  | Finance Leases |  | Total
2021 | $ | 121,196 |  |  | $ | 12,383 |  |  | $ | 133,579 |
2022 | 89,143 |  |  | 12,864 |  |  | 102,007 |
2023 | 67,952 |  |  | 12,363 |  |  | 80,315 |
2024 | 56,153 |  |  | 12,505 |  |  | 68,658 |
2025 | 36,924 |  |  | 43,185 |  |  | 80,109 |
Thereafter | 85,799 |  |  | 101,111 |  |  | 186,910 |
Total minimum lease payments | $ | 457,167 |  |  | $ | 194,411 |  |  | $ | 651,578 |
Less: Interest | (44,409 | ) |  | (26,199 | ) |  | (70,608 | )
Present value of lease liabilities | $ | 412,758 |  |  | $ | 168,212 |  |  | $ | 580,970 |

(1) | Excludes $137.8 million of payments related to leases signed but not yet commenced. Additionally, certain leases signed but not yet commenced contain residual value guarantees and purchase options not deemed probable.

As disclosed in the Company’s Form 10-K for the fiscal year ended August 31, 2019, the future minimum lease payments of non-cancelable operating leases prior to the adoption of ASU 2016-02 were as follows (in thousands):

Fiscal Year Ending August 31, | Amount
2020 | $ | 118,312 |
2021 | 102,915 |
2022 | 84,729 |
2023 | 63,206 |
2024 | 51,091 |
Thereafter | 182,932 |
Total minimum lease payments | $ | 603,185 |

Total operating lease expense prior to the adoption of ASU 2016-02 was approximately $125.4 million and $130.2 million for fiscal years 2019 and 2018, respectively.
6. Goodwill and Other Intangible Assets
The Company completed its annual impairment test for goodwill and indefinite-lived intangible assets during the fourth quarter of fiscal year 2020 and determined the fair values of the reporting units and the indefinite-lived intangible assets were in excess of the carrying values and that no impairment existed as of the date of the impairment test.
71

Table of Contents
The following table presents the changes in goodwill allocated to the Company’s reportable segments, Electronics Manufacturing Services (“EMS”) and Diversified Manufacturing Services (“DMS”), during the fiscal years ended August 31, 2020 and 2019 (in thousands):

| EMS |  | DMS |  | Total
Balance as of August 31, 2018 | $ | 82,670 |  |  | $ | 545,075 |  |  | $ | 627,745 |
Change in foreign currency exchange rates | (702 | ) |  | (4,788 | ) |  | (5,490 | )
Balance as of August 31, 2019 | 81,968 |  |  | 540,287 |  |  | 622,255 |
Acquisitions and adjustments | 5,358 |  |  | 55,999 |  |  | 61,357 |
Change in foreign currency exchange rates | (138 | ) |  | 13,379 |  |  | 13,241 |
Balance as of August 31, 2020 | $ | 87,188 |  |  | $ | 609,665 |  |  | $ | 696,853 |

The following table is a summary of the Company’s gross goodwill balances and accumulated impairments as of the periods indicated (in thousands):

| August 31, 2020 |  | August 31, 2019
| Gross Carrying Amount |  | Accumulated Impairment |  | Gross Carrying Amount |  | Accumulated Impairment
Goodwill | $ | 1,716,675 |  |  | $ | 1,019,822 |  |  | $ | 1,642,077 |  |  | $ | 1,019,822 |

The following table presents the Company’s total purchased intangible assets as of August 31, 2020 and 2019 (in thousands):

| Weighted Average Amortization Period (in years) |  | August 31, 2020 |  | August 31, 2019
|  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount
Contractual agreements and customer relationships | 12 |  | $ | 302,314 |  |  | $ | (199,861 | ) |  | $ | 102,453 |  |  | $ | 292,797 |  |  | $ | (175,199 | ) |  | $ | 117,598 |
Intellectual property | 8 |  | 174,373 |  |  | (164,671 | ) |  | 9,702 |  |  | 173,771 |  |  | (157,606 | ) |  | 16,165 |
Finite-lived trade names | Not applicable |  | 77,667 |  |  | (30,542 | ) |  | 47,125 |  |  | 77,536 |  |  | (5,036 | ) |  | 72,500 |
Trade names | Indefinite |  | 50,590 |  |  | — |  |  | 50,590 |  |  | 50,590 |  |  | — |  |  | 50,590 |
Total intangible assets | 12 |  | $ | 604,944 |  |  | $ | (395,074 | ) |  | $ | 209,870 |  |  | $ | 594,694 |  |  | $ | (337,841 | ) |  | $ | 256,853 |

Intangible asset amortization for fiscal years 2020, 2019 and 2018 was approximately $55.5 million, $31.9 million and $38.5 million, respectively. The estimated future amortization expense is as follows (in thousands):

Fiscal Year Ended August 31, |
2021 | $ | 45,246 |
2022 | 30,038 |
2023 | 27,624 |
2024 | 12,724 |
2025 | 10,874 |
Thereafter | 32,774 |
Total | $ | 159,280 |

7. Notes Payable and Long-Term Debt
Notes payable and long-term debt outstanding as of August 31, 2020 and 2019 are summarized below (in thousands):
72

Table of Contents

| Maturity Date |  | August 31, 2020 |  | August 31, 2019
5.625% Senior Notes(1)(2) | Dec 15, 2020 |  | — |  |  | 398,886 |
4.700% Senior Notes(1)(2) | Sep 15, 2022 |  | 498,659 |  |  | 498,004 |
4.900% Senior Notes(1) | Jul 14, 2023 |  | 299,300 |  |  | 299,057 |
3.950% Senior Notes(1)(2) | Jan 12, 2028 |  | 495,440 |  |  | 494,825 |
3.600% Senior Notes(1)(2)(3) | Jan 15, 2030 |  | 494,756 |  |  | — |
3.000% Senior Notes(1)(2)(4) | Jan 15, 2031 |  | 590,162 |  |  | — |
Borrowings under credit facilities(5)(6)(7) | Apr 23, 2021, Jan 22, 2023 and Jan 22, 2025 |  | — |  |  | — |
Borrowings under loans(5) | Jan 22, 2025 |  | 350,165 |  |  | 805,693 |
Total notes payable and long-term debt |  |  | 2,728,482 |  |  | 2,496,465 |
Less current installments of notes payable and long-term debt |  |  | 50,194 |  |  | 375,181 |
Notes payable and long-term debt, less current installments |  |  | $ | 2,678,288 |  |  | $ | 2,121,284 |

(1) | The notes are carried at the principal amount of each note, less any unamortized discount and unamortized debt issuance costs.

(2) | The Senior Notes are the Company’s senior unsecured obligations and rank equally with all other existing and future senior unsecured debt obligations.

(3) | On January 15, 2020, the Company issued $500.0 million of publicly registered 3.600% Senior Notes due 2030 (the “3.600% Senior Notes”). The net proceeds from the offering were used for the repayment of term loan indebtedness.

(4) | On July 13, 2020, the Company issued $600.0 million of publicly registered 3.000% Senior Notes due 2031 (the “3.000% Senior Notes”). The net proceeds from the offering were used for general corporate purposes, including to redeem the $400.0 million aggregate principal amount of the Company’s 5.625% Senior Notes due 2020 and pay the applicable “make-whole” premium.

(5) | On January 22, 2020, the Company entered into a senior unsecured credit agreement which provides for: (i) a Revolving Credit Facility in the initial amount of $2.7 billion, of which $700.0 million expires on January 22, 2023 and $2.0 billion expires on January 22, 2025 and (ii) a $300.0 million Term Loan Facility which expires on January 22, 2025, (collectively the “Credit Facility”). Interest and fees on the Credit Facility advances are based on the Company’s non-credit enhanced long-term senior unsecured debt rating as determined by Standard & Poor’s Ratings Service, Moody’s Investors Service and Fitch Ratings. In connection with the Company’s entry into the Credit Facility, the Company terminated the Company’s amended and restated five-year credit agreement dated November 8, 2017 and the credit agreement dated August 24, 2018.

During the fiscal year ended August 31, 2020, the interest rates on the Revolving Credit Facility ranged from 1.2% to 4.3% and the Term Loan Facility ranged from 1.6% to 2.9%. Interest is charged at a rate equal to (a) for the Revolving Credit Facility, either 0.000% to 0.450% above the base rate or 0.975% to 1.450% above the Eurocurrency rate and (b) for the Term Loan Facility, either 0.125% to 0.750% above the base rate or 1.125% to 1.750% above the Eurocurrency rate. The base rate represents the greatest of: (i) Citibank, N.A.’s prime rate, (ii) 0.50% above the federal funds rate, and (iii) 1.0% above one-month LIBOR, but not less than zero. The Eurocurrency rate represents adjusted LIBOR or adjusted CDOR, as applicable, for the applicable interest period, but not less than zero. Fees include a facility fee based on the revolving credit commitments of the lenders and a letter of credit fee based on the amount of outstanding letters of credit.
Additionally, the Company’s foreign subsidiaries had various additional credit facilities that finance their future growth and any corresponding working capital needs.

(6) | On April 24, 2020, the Company entered into an unsecured 364-day revolving credit agreement up to an initial aggregate amount of $375.0 million, which was increased to $425.0 million on May 29, 2020 (the “364-Day Revolving Credit Agreement”). The 364-Day Revolving Credit Agreement expires on April 23, 2021. Interest and fees on the 364-Day Revolving Credit Agreement advances are based on the Company’s non-credit enhanced long-term senior unsecured debt rating as determined by Standard & Poor’s Ratings Service, Moody’s Investors Service and Fitch Ratings.

73

Table of Contents
As of August 31, 2020, no draws were made on the 364-Day Revolving Credit Agreement. Interest is charged at a rate equal to either (i) 0.450%, 0.525% or 0.800% above the base rate or (ii) 1.450%, 1.525% or 1.800% above the Eurodollar rate. The base rate represents the greatest of: (i) Mizuho’s base rate, (ii) 0.50% above the federal funds rate, and (iii) 1.0% above one-month LIBOR, subject to a floor of 0.75%. The Eurodollar rate represents adjusted LIBOR for the applicable interest period, subject to a floor of 0.75%. Fees include a facility fee based on the revolving credit commitments of the lenders.

(7) | As of August 31, 2020, the Company has $3.7 billion in available unused borrowing capacity under its revolving credit facilities. The Revolving Credit Facility under the Credit Facility acts as the back-up facility for commercial paper outstanding, if any. The Company has a borrowing capacity of up to $1.8 billion under its commercial paper program.

In the ordinary course of business, the Company has letters of credit and surety bonds with banks and insurance companies outstanding of $120.3 million as of August 31, 2020. Unused letters of credit were $94.0 million as of August 31, 2020. Letters of credit and surety bonds are generally available for draw down in the event the Company does not perform.
Debt Maturities
Debt maturities as of August 31, 2020 are as follows (in thousands):

Fiscal Year Ended August 31, |
2021 | $ | 50,194 |
2022 | 7,672 |
2023 | 820,589 |
2024 | 30,130 |
2025 | 239,537 |
Thereafter | 1,580,360 |
Total | $ | 2,728,482 |

Debt Covenants
Borrowings under the Company’s debt agreements are subject to various covenants that limit the Company’s ability to: incur additional indebtedness, sell assets, effect mergers and certain transactions, and effect certain transactions with subsidiaries and affiliates. In addition, the revolving credit facilities and the 4.900% Senior Notes contain debt leverage and interest coverage covenants. The Company is also subject to certain covenants requiring the Company to offer to repurchase the 4.700%, 4.900%, 3.950%, 3.600% or 3.000% Senior Notes upon a change of control. As of August 31, 2020 and 2019, the Company was in compliance with its debt covenants.
Fair Value
Refer to Note 17 – “Fair Value Measurements” for the estimated fair values of the Company’s notes payable and long-term debt.
8. Asset-Backed Securitization Programs
The Company continuously sells designated pools of trade accounts receivable, at a discount, under its foreign asset-backed securitization program and its North American asset-backed securitization program to special purpose entities, which in turn sell certain of the receivables under the foreign program to an unaffiliated financial institution and a conduit administered by an unaffiliated financial institution and certain of the receivables under the North American program to conduits administered by an unaffiliated financial institution on a monthly basis.
The Company continues servicing the receivables sold and in exchange receives a servicing fee under each of the asset-backed securitization programs. Servicing fees related to each of the asset-backed securitization programs recognized during the fiscal years ended August 31, 2020, 2019 and 2018 were not material. The Company does not record a servicing asset or liability on the Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities.
Transfers of the receivables under the asset-backed securitization programs are accounted for as sales and, accordingly, net receivables sold under the asset-backed securitization programs are excluded from accounts receivable on the Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Consolidated Statements of Cash Flows.
74

Table of Contents
The special purpose entity in the foreign asset-backed securitization program is a separate bankruptcy-remote entity whose assets would be first available to satisfy the creditor claims of the unaffiliated financial institution. The Company is deemed the primary beneficiary of this special purpose entity as the Company has both the power to direct the activities of the entity that most significantly impact the entity’s economic performance and the obligation to absorb losses or the right to receive the benefits that could potentially be significant to the entity from the transfer of the trade accounts receivable into the special purpose entity. Accordingly, the special purpose entity associated with the foreign asset-backed securitization program is included in the Company’s Consolidated Financial Statements. As of August 31, 2020, the special purpose entity has liabilities for which creditors do not have recourse to the general credit of the Company (primary beneficiary). The liabilities cannot exceed the maximum amount of net cash proceeds under the foreign asset-backed securitization program.
The foreign asset-backed securitization program contains a guarantee of payment by the special purpose entity, in an amount approximately equal to the net cash proceeds under the program. No liability has been recorded for obligations under the guarantee as of August 31, 2020.
The special purpose entity in the North American asset-backed securitization program is a wholly-owned subsidiary of the Company and is included in the Company’s Consolidated Financial Statements. Certain unsold receivables covering the maximum amount of net cash proceeds available under the North American asset-backed securitization program are pledged as collateral to the unaffiliated financial institution as of August 31, 2020.
Following is a summary of the asset-backed securitization programs and key terms:

| Maximum Amount of Net Cash Proceeds (in millions)(1)(2) |  | Expiration Date
North American | $ | 390.0 |  |  | November 22, 2021
Foreign | $ | 400.0 |  |  | September 30, 2021

(1) | Maximum amount available at any one time.

(2) | As of August 31, 2020, the Company had up to $49.0 million in available liquidity under its asset-backed securitization programs.

In connection with the asset-backed securitization programs, the Company recognized the following (in millions):

| Fiscal Year Ended August 31,
| 2020 |  | 2019(3) |  | 2018
Trade accounts receivable sold | $ | 4,333 |  |  | $ | 4,057 |  |  | $ | 8,386 |
Cash proceeds received(1) | $ | 4,314 |  |  | $ | 4,031 |  |  | $ | 7,838 |
Pre-tax losses on sale of receivables(2) | $ | 19 |  |  | $ | 26 |  |  | $ | 15 |
Deferred purchase price receivables as of August 31 | $ | — |  |  | $ | — |  |  | $ | 533 |

(1) | The amounts primarily represent proceeds from collections reinvested in revolving-period transfers.

(2) | Recorded to other expense within the Consolidated Statements of Operations.

(3) | Excludes $650.3 million of trade accounts receivable sold, $488.1 million of cash and $13.9 million of net cash received prior to the amendment of the foreign asset-backed securitization program and under the previous North American asset-backed securitization program which occurred during the first quarter of fiscal year 2019.

The asset-backed securitization programs require compliance with several covenants. The North American asset-backed securitization program covenants include compliance with the interest ratio and debt to EBITDA ratio of the five-year unsecured credit facility entered into on January 22, 2020 (the “Credit Facility”). The foreign asset-backed securitization program covenants include limitations on certain corporate actions such as mergers and consolidations. As of August 31, 2020 and 2019, the Company was in compliance with all covenants under the asset-backed securitization programs.
9. Accrued Expenses
Accrued expenses consist of the following (in thousands):
75

Table of Contents

| August 31, 2020 |  | August 31, 2019
Contract liabilities(1) | $ | 496,219 |  |  | $ | 511,329 |
Accrued compensation and employee benefits | 703,250 |  |  | 600,907 |
Obligation associated with securitization programs | 494,042 |  |  | 475,251 |
Other accrued expenses | 1,518,017 |  |  | 1,402,657 |
Accrued expenses | $ | 3,211,528 |  |  | $ | 2,990,144 |

(1) | Revenue recognized during the fiscal years ended August 31, 2020 and 2019 that was included in the contract liability balance as of August 31, 2019 and September 1, 2018 was $308.1 million and $404.0 million, respectively.

10. Postretirement and Other Employee Benefits
Postretirement Benefits
The Company has a qualified defined benefit pension plan for employees of Jabil Circuit UK Limited (the “UK plan”). The UK plan, which is closed to new participants, provides benefits based on average employee earnings over a three-year service period preceding retirement and length of employee service. The Company’s policy is to contribute amounts sufficient to meet minimum funding requirements as set forth in UK employee benefit and tax laws plus such additional amounts as are deemed appropriate by the Company.
As a result of the third closing of the JJMD acquisition, the Company assumed a pension obligation for employees in Switzerland (the “Switzerland plan”). The Switzerland plan, which is a qualified defined benefit pension plan, provides benefits based on average employee earnings over an approximately 8 years service period preceding retirement and length of employee service. The Company’s policy is to contribute amounts sufficient to meet minimum funding requirements as set forth in Switzerland employee benefit and tax laws plus such additional amounts as are deemed appropriate by the Company.
Additionally, as a result of acquiring various other operations in Europe, Asia and Mexico the Company assumed both qualified and unfunded nonqualified retirement benefits covering eligible employees who meet age and service requirements (the “other plans”).
The UK plan, Switzerland plan and other plans are collectively referred to herein as the “plans.”
Benefit Obligation and Plan Assets
The benefit obligations and plan assets, changes to the benefit obligation and plan assets and the funded status of the plans as of and for the fiscal years ended August 31 are as follows (in thousands):
76

Table of Contents

| Fiscal Year Ended August 31,
| 2020 |  | 2019
Change in projected benefit obligation |  |  |
Beginning projected benefit obligation | $ | 174,690 |  |  | $ | 161,104 |
Service cost | 24,606 |  |  | 1,437 |
Interest cost | 3,041 |  |  | 3,715 |
Actuarial (gain) loss | (81,409 | ) |  | 19,060 |
Settlements paid from plan assets(1) | (25,749 | ) |  | — |
Total benefits paid | (6,431 | ) |  | (6,568 | )
Plan participants’ contributions | 14,171 |  |  | 35 |
Acquisitions | 404,297 |  |  | 6,040 |
Effect of conversion to U.S. dollars | 51,887 |  |  | (10,133 | )
Ending projected benefit obligation | $ | 559,103 |  |  | $ | 174,690 |
Change in plan assets |  |  |
Beginning fair value of plan assets | 158,101 |  |  | 151,715 |
Actual return on plan assets | 6,952 |  |  | 19,784 |
Acquisitions | 330,793 |  |  | — |
Settlements paid from plan assets(1) | (25,749 | ) |  | — |
Employer contributions | 10,084 |  |  | 1,717 |
Benefits paid from plan assets | (5,765 | ) |  | (5,435 | )
Plan participants’ contributions | 14,171 |  |  | 35 |
Effect of conversion to U.S. dollars | 49,686 |  |  | (9,715 | )
Ending fair value of plan assets | $ | 538,273 |  |  | $ | 158,101 |
Unfunded status | $ | (20,830 | ) |  | $ | (16,589 | )
Amounts recognized in the Consolidated Balance Sheets |  |  |
Accrued benefit liability, current | $ | 646 |  |  | $ | 368 |
Accrued benefit liability, noncurrent | $ | 20,184 |  |  | $ | 16,221 |
Accumulated other comprehensive loss(2) |  |  |
Actuarial (gain) loss, before tax | $ | (49,054 | ) |  | $ | 24,343 |
Prior service cost, before tax | $ | 786 |  |  | $ | 690 |

(1) | The settlements recognized during fiscal year 2020 relate primarily to the Switzerland plan.

(2) | The Company anticipates amortizing $5.1 million and $0.0 million, before tax, of net actuarial gain and prior service costs balances, respectively, to net periodic cost in fiscal year 2021.

Net Periodic Benefit Cost
The following table provides information about the net periodic benefit cost for the plans for fiscal years 2020, 2019 and 2018 (in thousands):

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Service cost | $ | 24,606 |  |  | $ | 1,437 |  |  | $ | 1,063 |
Interest cost | 3,041 |  |  | 3,715 |  |  | 3,807 |
Expected long-term return on plan assets | (14,115 | ) |  | (5,291 | ) |  | (5,954 | )
Recognized actuarial (gain) loss | (4,159 | ) |  | 741 |  |  | 1,127 |
Amortization of prior service credit | (45 | ) |  | (44 | ) |  | (88 | )
Net settlement loss | 230 |  |  | 634 |  |  | 116 |
Net periodic benefit cost | $ | 9,558 |  |  | $ | 1,192 |  |  | $ | 71 |

Assumptions
Weighted-average actuarial assumptions used to determine net periodic benefit cost and projected benefit obligation for the plans for the fiscal years 2020, 2019 and 2018 were as follows:
77

Table of Contents

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Net periodic benefit cost: |  |  |  |  |
Expected long-term return on plan assets(1) | 3.0 | % |  | 3.6 | % |  | 3.8 | %
Rate of compensation increase | 2.0 | % |  | 4.4 | % |  | 3.3 | %
Discount rate | 0.5 | % |  | 2.2 | % |  | 2.1 | %
Projected benefit obligation: |  |  |  |  |
Expected long-term return on plan assets | 2.9 | % |  | 2.0 | % |  | 3.6 | %
Rate of compensation increase | 2.1 | % |  | 4.3 | % |  | 4.4 | %
Discount rate(2) | 0.8 | % |  | 1.7 | % |  | 2.2 | %

(1) | The expected return on plan assets assumption used in calculating net periodic benefit cost is based on historical return experience and estimates of future long-term performance with consideration to the expected investment mix of the plan.

(2) | The discount rate is used to state expected cash flows relating to future benefits at a present value on the measurement date. This rate represents the market rate for high-quality fixed income investments whose timing would match the cash outflow of retirement benefits. Other assumptions include demographic factors such as retirement, mortality and turnover.

Plan Assets
The Company has adopted an investment policy for a majority of plan assets, which was set by plan trustees who have the responsibility for making investment decisions related to the plan assets. The plan trustees oversee the investment allocation, including selecting professional investment managers and setting strategic targets. The investment objectives for the assets are (1) to acquire suitable assets that hold the appropriate liquidity in order to generate income and capital growth that, along with new contributions, will meet the cost of current and future benefits under the plan, (2) to limit the risk of the plan assets from failing to meet the plan liabilities over the long-term and (3) to minimize the long-term costs under the plan by maximizing the return on the plan assets.
Investment policies and strategies governing the assets of the plans are designed to achieve investment objectives with prudent risk parameters. Risk management practices include the use of external investment managers; the maintenance of a portfolio diversified by asset class, investment approach and security holdings; and the maintenance of sufficient liquidity to meet benefit obligations as they come due. Within the equity securities class, the investment policy provides for investments in a broad range of publicly traded securities including both domestic and international stocks. Within the debt securities class, the investment policy provides for investments in corporate bonds as well as fixed and variable interest debt instruments. The Company currently expects to achieve a target mix of 35% equity and 65% debt securities in fiscal year 2021.
Fair Value
The fair values of the plan assets held by the Company by asset category are as follows (in thousands):

|  |  | August 31, 2020 |  | August 31, 2019
| Fair Value Hierarchy |  | Fair Value |  | Asset Allocation |  | Fair Value |  | Asset Allocation
Asset Category |  |  |  |  |  |  |  |  |
Cash and cash equivalents(1) | Level 1 |  | $ | 14,900 |  |  | 3 | % |  | $ | 7,705 |  |  | 5 | %
Equity Securities: |  |  |  |  |  |  |  |  |
Global equity securities(2)(3) | Level 2 |  | 208,384 |  |  | 38 | % |  | 20,215 |  |  | 13 | %
Debt Securities: |  |  |  |  |  |  |  |  |
Corporate bonds(3) | Level 2 |  | 237,812 |  |  | 44 | % |  | 42,522 |  |  | 27 | %
Government bonds(3) | Level 2 |  | 58,095 |  |  | 11 | % |  | 69,880 |  |  | 44 | %
Other Investments: |  |  |  |  |  |  |  |  |
Insurance contracts(4) | Level 3 |  | 19,082 |  |  | 4 | % |  | 17,779 |  |  | 11 | %
Fair value of plan assets |  |  | $ | 538,273 |  |  | 100 | % |  | $ | 158,101 |  |  | 100 | %

(1) | Carrying value approximates fair value.

(2) | Investments in equity securities by companies incorporated, listed or domiciled in developed and/or emerging market countries.

78

Table of Contents

(3) | Investments in global equity securities, corporate bonds, government securities and government bonds are valued using the quoted prices of securities with similar characteristics.

(4) | Consist of an insurance contract that guarantees the payment of the funded pension entitlements, as well as provides a profit share to the Company. The profit share in this contract is not based on actual investments, but, instead on a notional investment portfolio that is expected to return a pre-defined rate. Insurance contract assets are recorded at fair value and is determined based on the cash surrender value of the insured benefits which is the present value of the guaranteed funded benefits. Insurance contracts are valued using unobservable inputs (Level 3 inputs), primarily by discounting expected future cash flows relating to benefits paid from a notional investment portfolio in order to determine the cash surrender value of the policy. The unobservable inputs consist of estimated future benefits to be paid throughout the duration of the policy and estimated discount rates, which both have an immaterial impact on the fair value estimate of the contract.

Accumulated Benefit Obligation
The following table provides information for the plans with an accumulated benefit obligation for fiscal years 2020 and 2019 (in thousands):

| August 31, 2020 |  | August 31, 2019
Projected benefit obligation | $ | 559,103 |  |  | $ | 174,690 |
Accumulated benefit obligation | $ | 535,513 |  |  | $ | 161,729 |
Fair value of plan assets | $ | 538,273 |  |  | $ | 158,101 |

Cash Flows
The Company expects to make cash contributions between $21.7 million and $26.6 million to its funded pension plans during fiscal year 2021. The estimated future benefit payments, which reflect expected future service, are as follows (in thousands):

Fiscal Year Ended August 31, | Amount
2021 | $ | 36,361 |
2022 | 28,541 |
2023 | 27,958 |
2024 | 27,531 |
2025 | 28,942 |
2026 through 2030 | 137,521 |

Profit Sharing, 401(k) Plan and Defined Contribution Plans
The Company provides retirement benefits to its domestic employees who have completed a 30-day period of service through a 401(k) plan that provides a matching contribution by the Company. The Company also has defined contribution benefit plans for certain of its international employees. The Company contributed approximately $56.1 million, $49.0 million and $40.5 million for defined contribution plans for the fiscal years ended August 31, 2020, 2019 and 2018, respectively.
11. Derivative Financial Instruments and Hedging Activities
The Company is directly and indirectly affected by changes in certain market conditions. These changes in market conditions may adversely impact the Company’s financial performance and are referred to as market risks. The Company, where deemed appropriate, uses derivatives as risk management tools to mitigate the potential impact of certain market risks. The primary market risks managed by the Company through the use of derivative instruments are foreign currency risk and interest rate risk.
Foreign Currency Risk Management
Forward contracts are put in place to manage the foreign currency risk associated with the anticipated foreign currency denominated revenues and expenses. A hedging relationship existed with an aggregate notional amount outstanding of $355.2 million and $334.1 million as of August 31, 2020 and 2019, respectively. The related forward foreign exchange contracts have been designated as hedging instruments and are accounted for as cash flow hedges. The forward foreign exchange contract transactions will effectively lock in the value of anticipated foreign currency denominated revenues and expenses against foreign currency fluctuations. The anticipated foreign currency denominated revenues and expenses being hedged are expected to occur between September 1, 2020 and August 31, 2021.
79

Table of Contents
In addition to derivatives that are designated as hedging instruments and qualify for hedge accounting, the Company also enters into forward contracts to economically hedge transactional exposure associated with commitments arising from trade accounts receivable, trade accounts payable, fixed purchase obligations and intercompany transactions denominated in a currency other than the functional currency of the respective operating entity. The aggregate notional amount of these outstanding contracts as of August 31, 2020 and 2019, was $2.9 billion and $2.5 billion, respectively.

Refer to Note 17 – “Fair Value Measurements” for the fair values and classification of the Company’s derivative instruments.

The gains and losses recognized in earnings due to hedge ineffectiveness and the amount excluded from effectiveness testing were not material for all periods presented and are included as components of net revenue, cost of revenue and selling, general and administrative expense, which are the same line items in which the hedged items are recorded.
The following table presents the net gains (losses) from forward contracts recorded in the Consolidated Statements of Operations for the periods indicated (in thousands):

Derivatives Not Designated as Hedging Instruments Under ASC 815 |  | Location of Gain (Loss) on Derivatives Recognized in Net Income |  | Amount of Gain (Loss) Recognized in Net Income on Derivatives
|  |  |  | Fiscal Year Ended August 31,
|  |  |  | 2020 |  | 2019 |  | 2018
Forward foreign exchange contracts(1) |  | Cost of revenue |  | $ | 42,077 |  |  | $ | (29,557 | ) |  | $ | (27,774 | )

(1) | For the fiscal year ended August 31, 2020, the Company recognized $47.4 million of foreign currency losses in cost of revenue, which are offset by the gains from the forward foreign exchange contracts. For the fiscal years ended August 31, 2019 and 2018, the Company recognized $14.9 million and $36.7 million, respectively, of foreign currency gains in cost of revenue, which are offset by the losses from the forward foreign exchange contracts.

Interest Rate Risk Management
The Company periodically enters into interest rate swaps to manage interest rate risk associated with the Company’s borrowings.
Cash Flow Hedges
Contemporaneously with the issuance of our 3.000% Notes in July 2020, the Company amended interest rate swap agreements with a notional value of $200.0 million, with mandatory termination dates from August 15, 2020 to February 15, 2022 and de-designated the interest rate swaps as cash flow hedges (the “2020 Extended Interest Rate Swaps”). No ineffectiveness was recognized in earnings upon the termination of the cash flow hedges. In addition, the Company entered into interest rate swaps to offset future exposures of fluctuations in the fair value of the 2020 Extended Interest Rate Swaps (the “Offsetting Interest Rate Swaps”). The change in the fair value of the 2020 Extended Interest Rate Swaps and the Offsetting Interest Rate Swaps will be recorded in the Consolidated Statements of Income through the maturity date as an adjustment to interest expense.
12. Stockholders’ Equity
The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in thousands):

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Restricted stock units(1) | $ | 73,775 |  |  | $ | 53,766 |  |  | $ | 84,082 |
Employee stock purchase plan | 9,309 |  |  | 7,580 |  |  | 6,891 |
Other(2) | — |  |  | — |  |  | 7,538 |
Total | $ | 83,084 |  |  | $ | 61,346 |  |  | $ | 98,511 |

(1) | As a result of a modification, 0.8 million awards vested during fiscal year 2018, which resulted in approximately $24.9 million of stock-based compensation expense recognized during the fiscal year ended August 31, 2018.

80

Table of Contents

(2) | For the fiscal year ended August 31, 2018, represents a one-time cash-settled stock award that vested on November 30, 2017.

Equity Compensation Plan
The 2011 Stock Award and Incentive Plan (the “2011 Plan”) provides for the grant of restricted stock awards, restricted stock unit awards and other stock-based awards. The maximum aggregate number of shares that may be subject to awards under the 2011 Plan is 23,300,000.
Following is a reconciliation of the shares available to be issued under the 2011 Plan as of August 31, 2020:

| Shares Available for Grant
Balance as of August 31, 2019 | 12,040,581 |
SARS canceled | 601 |
Restricted stock units granted, net of forfeitures(1) | (1,431,674 | )
Balance as of August 31, 2020 | 10,609,508 |

(1) | Represents the maximum number of shares that can be issued based on the achievement of certain performance criteria.

Stock Appreciation Rights (“SARS”)
The following table summarizes SARS activity from August 31, 2019 through August 31, 2020:

| SARS Outstanding |  | Average Intrinsic Value (in thousands) |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Life (years)
Outstanding as of August 31, 2019 | 123,501 |  |  | $ | 1,278 |  |  | $ | 18.46 |  |  | 2.11
SARS canceled | (601 | ) |  |  |  | $ | 14.88 |  |  |
SARS exercised | (107,900 | ) |  |  |  | $ | 18.48 |  |  |
Outstanding and exercisable as of August 31, 2020 | 15,000 |  |  | $ | 235 |  |  | $ | 18.49 |  |  | 1.13

Restricted Stock Units
Certain key employees have been granted time-based, performance-based and market-based restricted stock units. The time-based restricted stock units granted generally vest on a graded vesting schedule over three years. The performance-based restricted stock units generally vest on a cliff vesting schedule over three years and up to a maximum of 150%, depending on the specified performance condition and the level of achievement obtained. The performance-based restricted stock units have a vesting condition that is based upon the Company’s cumulative adjusted core earnings per share during the performance period. The market-based restricted stock units generally vest on a cliff vesting schedule over three years and up to a maximum of 200%, depending on the specified performance condition and the level of achievement obtained. The market-based restricted stock units have a vesting condition that is tied to the Company’s total shareholder return based on the Company’s stock performance in relation to the companies in the Standard and Poor’s (S&P) Super Composite Technology Hardware and Equipment Index excluding the Company.
The following table summarizes restricted stock units activity from August 31, 2019 through August 31, 2020:

| Shares |  | Weighted- Average Grant-Date Fair Value
Outstanding as of August 31, 2019 | 7,165,473 |  |  | $ | 26.27 |
Changes during the period |  |  |
Shares granted(1) | 2,280,625 |  |  | $ | 42.21 |
Shares vested | (2,259,623 | ) |  | $ | 24.69 |
Shares forfeited | (848,951 | ) |  | $ | 25.77 |
Outstanding as of August 31, 2020 | 6,337,524 |  |  | $ | 32.64 |

81

Table of Contents

(1) | For those shares granted that are based on the achievement of certain performance criteria, the amount represents the maximum number of shares that can vest. During the fiscal year ended August 31, 2020, the Company awarded approximately 1.2 million time-based restricted stock units, 0.3 million performance-based restricted stock units and 0.3 million market-based restricted stock units based on target performance criteria.

The following table represents the restricted stock units and SARS stock-based compensation information for the periods indicated (in thousands):

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Intrinsic value of SARS exercised | $ | 2,329 |  |  | $ | 335 |  |  | $ | 909 |
Fair value of restricted stock units vested | $ | 55,799 |  |  | $ | 49,725 |  |  | $ | 62,592 |
Tax benefit for stock compensation expense(1) | $ | 1,159 |  |  | $ | 611 |  |  | $ | 1,122 |
Unrecognized stock-based compensation expense — restricted stock units | $ | 38,909 |  |  |  |  |
Remaining weighted-average period for restricted stock units expense | 1.3 years |  |  |  |  |

(1) | Classified as income tax expense within the Consolidated Statements of Operations.

Employee Stock Purchase Plan
The maximum aggregate number of shares that are available for issuance under the 2011 Employee Stock Purchase Plan (the “ESPP”) is 12,000,000.
Employees are eligible to participate in the ESPP after 90 days of employment with the Company. The ESPP permits eligible employees to purchase common stock through payroll deductions, which may not exceed 10% of an employee’s compensation, as defined in the ESPP, at a price equal to 85% of the fair value of the common stock at the beginning or end of the offering period, whichever is lower. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code. As of August 31, 2020, 2,290,167 shares remained available for issue under the 2011 ESPP.
The fair value of shares issued under the ESPP was estimated on the commencement date of each offering period using the Black-Scholes option pricing model. The following weighted-average assumptions were used in the model for each respective period:

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Expected dividend yield | 0.4 | % |  | 0.6 | % |  | 0.6 | %
Risk-free interest rate | 1.9 | % |  | 2.3 | % |  | 1.4 | %
Expected volatility (1) | 30.7 | % |  | 28.6 | % |  | 23.0 | %
Expected life | 0.5 years |  |  | 0.5 years |  |  | 0.5 years |

(1) | The expected volatility was estimated using the historical volatility derived from the Company’s common stock.

82

Table of Contents
Dividends
The following table sets forth certain information relating to the Company’s cash dividends declared to common stockholders during fiscal years 2020 and 2019:

| Dividend Declaration Date |  | Dividend per Share |  | Total of Cash Dividends Declared |  | Date of Record for Dividend Payment |  | Dividend Cash Payment Date
| (in thousands, except for per share data)
Fiscal Year 2020: | October 17, 2019 |  | $ | 0.08 |  |  | $ | 12,647 |  |  | November 15, 2019 |  | December 2, 2019
| January 23, 2020 |  | $ | 0.08 |  |  | $ | 12,517 |  |  | February 14, 2020 |  | March 4, 2020
| April 15, 2020 |  | $ | 0.08 |  |  | $ | 12,452 |  |  | May 15, 2020 |  | June 3, 2020
| July 16, 2020 |  | $ | 0.08 |  |  | $ | 12,433 |  |  | August 14, 2020 |  | September 2, 2020
Fiscal Year 2019: | October 18, 2018 |  | $ | 0.08 |  |  | $ | 13,226 |  |  | November 15, 2018 |  | December 3, 2018
| January 24, 2019 |  | $ | 0.08 |  |  | $ | 12,706 |  |  | February 15, 2019 |  | March 1, 2019
| April 18, 2019 |  | $ | 0.08 |  |  | $ | 12,681 |  |  | May 15, 2019 |  | June 3, 2019
| July 18, 2019 |  | $ | 0.08 |  |  | $ | 12,724 |  |  | August 15, 2019 |  | September 3, 2019

Common Stock Outstanding
The following represents the common stock outstanding for the fiscal year ended:

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Common stock outstanding: |  |  |  |  |
Beginning balances | 153,520,380 |  |  | 164,588,172 |  |  | 177,727,653 |
Shares issued upon exercise of stock options | 56,999 |  |  | 11,348 |  |  | 30,832 |
Shares issued under employee stock purchase plan | 1,106,852 |  |  | 1,282,042 |  |  | 1,105,400 |
Vesting of restricted stock | 2,259,623 |  |  | 1,983,261 |  |  | 2,727,229 |
Purchases of treasury stock under employee stock plans | (621,250 | ) |  | (489,836 | ) |  | (793,052 | )
Treasury shares purchased(1)(2) | (5,992,246 | ) |  | (13,854,607 | ) |  | (16,209,890 | )
Ending balances | 150,330,358 |  |  | 153,520,380 |  |  | 164,588,172 |

(1) | During fiscal years 2018 and 2017, the Company’s Board of Directors (“the Board”) authorized the repurchase of $350.0 million and $450.0 million, respectively, of the Company’s common stock under share repurchase programs, which were repurchased during fiscal years 2019 and 2018, respectively.

(2) | In September 2019, the Board authorized the repurchase of up to $600.0 million of the Company’s common stock as part of a two-year capital allocation framework (“the 2020 Share Repurchase Program”). As of August 31, 2020, 6.0 million shares had been repurchased for $213.9 million and $386.1 million remains available under the 2020 Share Repurchase Program.

13. Concentration of Risk and Segment Data
Concentration of Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and trade receivables. The Company maintains cash and cash equivalents with various domestic and foreign financial institutions. Deposits held with the financial institutions may exceed the amount of insurance provided on such deposits, but may generally be redeemed upon demand. The Company performs periodic evaluations of the relative credit standing of the financial institutions and attempts to limit exposure with any one institution. For trade receivables, the Company performs ongoing credit evaluations of its customers and generally does not require collateral. The Company maintains an allowance for potential credit losses on trade receivables.
Sales of the Company’s products are concentrated among specific customers. For fiscal year 2020, the Company’s five largest customers accounted for approximately 47% of its net revenue and 73 customers accounted for approximately 90% of its net revenue. As the Company is a provider of manufacturing services and solutions and products are built based on customer specifications, it is impracticable to provide revenues from external customers for each product and service. Sales to the following customer that accounted for 10% or more of the Company’s net revenues, expressed as a percentage of consolidated net revenue, and the percentage of accounts receivable for the customer, were as follows:
83

Table of Contents

|  | Percentage of Net Revenue Fiscal Year Ended August 31, |  | Percentage of Accounts Receivable as of August 31,
|  | 2020 |  | 2019 |  | 2018 |  | 2020 |  | 2019
Apple, Inc.(1) |  | 20 | % |  | 22 | % |  | 28 | % |  | * |  | *
Amazon.com(2) |  | 11 | % |  | * |  |  | * |  |  | * |  | *

* Amount was less than 10% of total.

(1) | Sales to this customer were reported in the DMS operating segment.

(2) | Sales to this customer were reported primarily in the EMS operating segment.

The Company procures components from a broad group of suppliers. Some of the products manufactured by the Company require one or more components that are available from only a single source.
Segment Data
Operating segments are defined as components of an enterprise that engage in business activities from which they may earn revenues and incur expenses; for which separate financial information is available; and whose operating results are regularly reviewed by the chief operating decision maker (“CODM”) to assess the performance of the individual segment and make decisions about resources to be allocated to the segment.
The Company derives its revenue from providing comprehensive electronics design, production and product management services. The CODM evaluates performance and allocates resources on a segment basis. The Company’s operating segments consist of two segments – EMS and DMS, which are also the Company’s reportable segments. The segments are organized based on the economic profiles of the services performed, including manufacturing capabilities, market strategy, margins, return on capital and risk profiles.
The EMS segment is focused around leveraging IT, supply chain design and engineering, technologies largely centered on core electronics, utilizing the Company’s large scale manufacturing infrastructure and the ability to serve a broad range of end markets. The EMS segment is a high volume business that produces products at a quicker rate (i.e. cycle time) and in larger quantities and includes customers primarily in the automotive and transportation, capital equipment, cloud, computing and storage, defense and aerospace, industrial and energy, networking and telecommunications, print and retail, and smart home and appliances industries.
The DMS segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies and healthcare. The DMS segment includes customers primarily in the edge devices and accessories, healthcare, mobility and packaging industries.
Net revenue for the operating segments is attributed to the segment in which the service is performed. An operating segment’s performance is evaluated based on its pre-tax operating contribution, or segment income. Segment income is defined as net revenue less cost of revenue, segment selling, general and administrative expenses, segment research and development expenses and an allocation of corporate manufacturing expenses and selling, general and administrative expenses. Segment income does not include amortization of intangibles, stock-based compensation expense and related charges, restructuring, severance and related charges, distressed customer charges, acquisition and integration charges, loss on disposal of subsidiaries, settlement of receivables and related charges, impairment of notes receivable and related charges, loss on securities, goodwill impairment charges, business interruption and impairment charges, net, income (loss) from discontinued operations, gain (loss) on sale of discontinued operations, other expense (excluding certain components of net periodic benefit cost), interest income, interest expense, income tax expense or adjustment for net income (loss) attributable to noncontrolling interests.
Total segment assets are defined as accounts receivable, inventories, net, customer-related property, plant and equipment, intangible assets net of accumulated amortization and goodwill. All other non-segment assets are reviewed on a global basis by management. Transactions between operating segments are generally recorded at amounts that approximate those at which we would transact with third parties.
As of September 1, 2020, certain customers have been realigned within the Company’s operating segments. As there have been no changes to how the Company’s CODM assesses operating performance and allocates resources, the Company’s operating segments which are the reporting segments continue to consist of the DMS and EMS segments. Beginning in fiscal year 2021, customers within the automotive and transportation and smart home and appliances industries will be presented within the DMS segment. Prior period disclosures will be restated to reflect the realignment.
84

Table of Contents
The following table presents the Company’s revenues disaggregated by segment (in thousands):

| Fiscal Year Ended August 31,
| 2020 |  | 2019
| EMS |  | DMS |  | Total |  | EMS |  | DMS |  | Total
Timing of transfer(1) |  |  |  |  |  |  |  |  |  |  |
Point in time | $ | 4,385,128 |  |  | $ | 6,045,986 |  |  | $ | 10,431,114 |  |  | $ | 2,877,082 |  |  | $ | 6,055,716 |  |  | $ | 8,932,798 |
Over time | 12,226,894 |  |  | 4,608,430 |  |  | 16,835,324 |  |  | 12,553,447 |  |  | 3,796,075 |  |  | 16,349,522 |
Total | $ | 16,612,022 |  |  | $ | 10,654,416 |  |  | $ | 27,266,438 |  |  | $ | 15,430,529 |  |  | $ | 9,851,791 |  |  | $ | 25,282,320 |

(1) | Effective September 1, 2018, the Company adopted ASU 2014-09, Revenue Recognition (Topic 606) using the modified retrospective method by applying the guidance to all open contracts upon adoption and recording a cumulative effect adjustment as of September 1, 2018, net of tax, of $42.6 million. No adjustments were made to prior periods.

The following tables set forth operating segment information (in thousands):

|  | Fiscal Year Ended August 31,
|  | 2020 |  | 2019 |  | 2018
Net revenue |  |  |  |  |  |
EMS |  | $ | 16,612,022 |  |  | $ | 15,430,529 |  |  | $ | 12,268,600 |
DMS |  | 10,654,416 |  |  | 9,851,791 |  |  | 9,826,816 |
|  | $ | 27,266,438 |  |  | $ | 25,282,320 |  |  | $ | 22,095,416 |

|  | Fiscal Year Ended August 31,
|  | 2020 |  | 2019 |  | 2018
Segment income and reconciliation of income before tax |  |  |  |  |  |
EMS |  | $ | 447,284 |  |  | $ | 480,047 |  |  | $ | 451,149 |
DMS |  | 416,769 |  |  | 396,564 |  |  | 316,998 |
Total segment income |  | $ | 864,053 |  |  | $ | 876,611 |  |  | $ | 768,147 |
Reconciling items: |  |  |  |  |  |
Amortization of intangibles |  | (55,544 | ) |  | (31,923 | ) |  | (38,490 | )
Stock-based compensation expense and related charges |  | (83,084 | ) |  | (61,346 | ) |  | (98,511 | )
Restructuring, severance and related charges |  | (156,586 | ) |  | (25,914 | ) |  | (36,902 | )
Distressed customer charges |  | (14,963 | ) |  | (6,235 | ) |  | (32,710 | )
Business interruption and impairment charges, net (1) |  | (5,785 | ) |  | 2,860 |  |  | (11,299 | )
Acquisition and integration charges |  | (32,167 | ) |  | (52,697 | ) |  | (8,082 | )
Loss on securities |  | (48,625 | ) |  | (29,632 | ) |  | — |
Other expense (net of periodic benefit cost) |  | (47,243 | ) |  | (53,750 | ) |  | (37,563 | )
Interest income |  | 14,559 |  |  | 21,460 |  |  | 17,813 |
Interest expense |  | (173,877 | ) |  | (188,730 | ) |  | (149,002 | )
Income before income tax |  | $ | 260,738 |  |  | $ | 450,704 |  |  | $ | 373,401 |

(1) | Charges for the fiscal year ended August 31, 2020, relate to a flood that impacted the Company’s facility in Huangpu, China. Charges, net of insurance proceeds of $2.9 million and $24.9 million, for the fiscal years ended August 31, 2019 and 2018, respectively, relate to business interruption and asset impairment costs associated with damage from Hurricane Maria, which impacted operations in Cayey, Puerto Rico. These charges are classified as a component of cost of revenue and selling, general and administrative expenses in the Consolidated Statements of Operations.

|  | August 31, 2020 |  | August 31, 2019
Total assets |  |  |  |
EMS |  | $ | 4,247,897 |  |  | $ | 4,353,465 |
DMS |  | 5,627,869 |  |  | 4,988,198 |
Other non-allocated assets |  | 4,521,650 |  |  | 3,628,812 |
|  | $ | 14,397,416 |  |  | $ | 12,970,475 |

85

Table of Contents
The Company operates in 31 countries worldwide. Sales to unaffiliated customers are based on the Company location that maintains the customer relationship and transacts the external sale. The following tables set forth external net revenue, net of intercompany eliminations, and long-lived asset information where individual countries represent a material portion of the total (in thousands):

|  | Fiscal Year Ended August 31,
|  | 2020 |  | 2019 |  | 2018
External net revenue: |  |  |  |  |  |
Singapore |  | $ | 6,512,310 |  |  | $ | 6,718,495 |  |  | $ | 7,193,414 |
Mexico |  | 4,685,790 |  |  | 4,526,456 |  |  | 3,533,437 |
China |  | 4,583,089 |  |  | 4,958,462 |  |  | 4,585,355 |
Malaysia |  | 1,903,163 |  |  | 1,681,911 |  |  | 1,389,851 |
Vietnam |  | 921,083 |  |  | 750,367 |  |  | 552,709 |
Other |  | 3,912,536 |  |  | 3,548,062 |  |  | 2,995,956 |
Foreign source revenue |  | 22,517,971 |  |  | 22,183,753 |  |  | 20,250,722 |
U.S. |  | 4,748,467 |  |  | 3,098,567 |  |  | 1,844,694 |
Total |  | $ | 27,266,438 |  |  | $ | 25,282,320 |  |  | $ | 22,095,416 |

|  | August 31, 2020 |  | August 31, 2019
Long-lived assets: |  |  |  |
China |  | $ | 1,670,290 |  |  | $ | 1,579,904 |
Mexico |  | 375,902 |  |  | 418,641 |
Malaysia |  | 232,165 |  |  | 154,386 |
Switzerland |  | 218,851 |  |  | 158 |
Singapore |  | 141,659 |  |  | 156,028 |
Taiwan |  | 114,594 |  |  | 123,608 |
Vietnam |  | 107,857 |  |  | 85,728 |
Hungary |  | 101,437 |  |  | 85,809 |
Other |  | 501,453 |  |  | 462,261 |
Long-lived assets related to foreign operations |  | 3,464,208 |  |  | 3,066,523 |
U.S. |  | 1,107,827 |  |  | 1,146,335 |
Total |  | $ | 4,572,035 |  |  | $ | 4,212,858 |

14. Restructuring, Severance and Related Charges
Following is a summary of the Company’s restructuring, severance and related charges (in thousands):

|  | Fiscal Year Ended August 31,
|  | 2020(2) |  | 2019(3) |  | 2018(3)
Employee severance and benefit costs |  | $ | 94,031 |  |  | $ | 16,029 |  |  | $ | 16,269 |
Lease costs |  | 7,666 |  |  | (41 | ) |  | 1,596 |
Asset write-off costs |  | 32,945 |  |  | (3,566 | ) |  | 16,264 |
Other costs |  | 21,944 |  |  | 13,492 |  |  | 2,773 |
Total restructuring, severance and related charges(1) |  | $ | 156,586 |  |  | $ | 25,914 |  |  | $ | 36,902 |

(1) | Includes $61.9 million, $21.5 million and $16.3 million recorded in the EMS segment, $75.6 million, $2.6 million and $16.6 million recorded in the DMS segment and $19.1 million, $1.8 million and $4.0 million of non-allocated charges for the fiscal years ended August 31, 2020, 2019 and 2018, respectively. Except for asset write-off costs, all restructuring, severance and related charges are cash settled.

(2) | As the Company continues to optimize its cost structure and improve operational efficiencies, $56.6 million of employee severance and benefit costs was incurred in connection with a reduction in the worldwide workforce during the fiscal year ended August 31, 2020. The remaining amount primarily relates to the 2020 Restructuring Plan. The Company’s liability associated with the worldwide workforce reduction is $35.8 million as of August 31, 2020.

(3) | Primarily relates to the 2017 Restructuring Plan, which was complete as of August 31, 2019.

2020 Restructuring Plan
86

Table of Contents
On September 20, 2019, the Company’s Board of Directors formally approved a restructuring plan to realign the Company’s global capacity support infrastructure, particularly in the Company’s mobility footprint in China, in order to optimize organizational effectiveness. This action includes headcount reductions and capacity realignment (the “2020 Restructuring Plan”). The 2020 Restructuring Plan reflects the Company’s intention only and restructuring decisions, and the timing of such decisions, at certain locations are still subject to consultation with the Company’s employees and their representatives.
Upon completion of the 2020 Restructuring Plan, the Company expects to recognize approximately $85.0 million in restructuring and other related costs. The Company incurred $76.9 million of costs during fiscal year 2020 and anticipates incurring the remaining costs during fiscal year 2021 for employee severance and benefit costs, asset write-off costs, and other related costs.

The tables below summarize the Company’s liability activity (in thousands):

|  | Employee Severance and Benefit Costs |  | Lease Costs |  | Asset Write-off Costs |  | Other Related Costs |  | Total
Balance as of August 31, 2018 |  | $ | 18,131 |  |  | $ | 2,684 |  |  | $ | — |  |  | $ | 522 |  |  | $ | 21,337 |
Restructuring related charges |  | 16,029 |  |  | (41 | ) |  | (3,566 | ) |  | 2,071 |  |  | 14,493 |
Asset write-off charge and other non-cash activity |  | (494 | ) |  | — |  |  | 3,566 |  |  | (18 | ) |  | 3,054 |
Cash payments |  | (30,504 | ) |  | (663 | ) |  | — |  |  | (1,786 | ) |  | (32,953 | )
Balance as of August 31, 2019(1) |  | 3,162 |  |  | 1,980 |  |  | — |  |  | 789 |  |  | 5,931 |
Restructuring related charges |  | 37,416 |  |  | 7,666 |  |  | 32,945 |  |  | 617 |  |  | 78,644 |
Asset write-off charge and other non-cash activity |  | (222 | ) |  | (6,435 | ) |  | (32,945 | ) |  | 18 |  |  | (39,584 | )
Cash payments |  | (32,213 | ) |  | (895 | ) |  | — |  |  | (998 | ) |  | (34,106 | )
Balance as of August 31, 2020(2) |  | $ | 8,143 |  |  | $ | 2,316 |  |  | $ | — |  |  | $ | 426 |  |  | $ | 10,885 |

(1) | Balance as of August 31, 2019 primarily relates to the 2017 Restructuring Plan.

(2) | Balance as of August 31, 2020 primarily relates to the 2020 Restructuring Plan.

15. Income Taxes
Provision for Income Taxes
Income (loss) before income tax expense is summarized below (in thousands):

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Domestic(1) | $ | (452,233 | ) |  | $ | (415,707 | ) |  | $ | (426,897 | )
Foreign(1) | 712,971 |  |  | 866,411 |  |  | 800,298 |
| $ | 260,738 |  |  | $ | 450,704 |  |  | $ | 373,401 |

(1) | Includes the elimination of intercompany foreign dividends paid to the U.S.

87

Table of Contents
Income tax expense (benefit) is summarized below (in thousands):

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Current: |  |  |  |  |
Domestic - federal | $ | (3,054 | ) |  | $ | (23,675 | ) |  | $ | 69,080 |
Domestic - state | 1,367 |  |  | 1,383 |  |  | 134 |
Foreign | 179,462 |  |  | 175,993 |  |  | 178,790 |
Total current | 177,775 |  |  | 153,701 |  |  | 248,004 |
Deferred: |  |  |  |  |
Domestic - federal | (9,692 | ) |  | (8,000 | ) |  | (24,342 | )
Domestic - state | 107 |  |  | (2,202 | ) |  | 93 |
Foreign | 35,769 |  |  | 17,731 |  |  | 62,105 |
Total deferred | 26,184 |  |  | 7,529 |  |  | 37,856 |
Total income tax expense | $ | 203,959 |  |  | $ | 161,230 |  |  | $ | 285,860 |

Reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is summarized below:

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
U.S. federal statutory income tax rate | 21.0 | % |  | 21.0 | % |  | 25.7 | %
State income taxes, net of federal tax benefit | (2.6 | ) |  | (1.7 | ) |  | (1.5 | )
Impact of foreign tax rates(1)(2) | (0.9 | ) |  | (9.9 | ) |  | (19.3 | )
Permanent impact of non-deductible cost | 3.2 |  |  | 1.8 |  |  | 5.9 |
Income tax credits(1) | (2.5 | ) |  | (3.1 | ) |  | (2.8 | )
Changes in tax rates on deferred tax assets and liabilities(3) | 10.3 |  |  | 0.2 |  |  | 4.0 |
One-time transition tax related to the Tax Act(4) | — |  |  | (0.5 | ) |  | 62.2 |
Indefinite reinvestment assertion impact(5) | — |  |  | 0.9 |  |  | 5.8 |
Valuation allowance(6) | 16.8 |  |  | 1.3 |  |  | (16.4 | )
Non-deductible equity compensation | 2.2 |  |  | 1.4 |  |  | 5.5 |
Impact of intercompany charges and dividends | 15.0 |  |  | 10.4 |  |  | 7.3 |
Reclassification of stranded tax effects in AOCI | — |  |  | — |  |  | (4.0 | )
Global Intangible Low-Taxed Income(7) | 13.7 |  |  | 10.4 |  |  | — |
Other, net | 2.0 |  |  | 3.6 |  |  | 4.2 |
Effective income tax rate | 78.2 | % |  | 35.8 | % |  | 76.6 | %

(1) | The Company has been granted tax incentives for various subsidiaries in Brazil, China, Malaysia, Singapore and Vietnam, which expire at various dates through fiscal year 2031 and are subject to certain conditions with which the Company expects to comply. These tax incentives resulted in a tax benefit of approximately $42.6 million ($0.28 per basic share), $67.3 million ($0.43 per basic share) and $52.1 million ($0.30 per basic share) during the fiscal years ended August 31, 2020, 2019 and 2018, respectively.

(2) | For the fiscal year ended August 31, 2020, the decrease in the impact of foreign tax rates was primarily related to decreased income in low tax rate jurisdictions. For the fiscal year ended August 31, 2019, the decrease in the impact of foreign tax rates was primarily due to a decrease in the U.S. federal statutory income tax rate due to the Tax Act.

(3) | For the fiscal year ended August 31, 2020, the increase in the changes in tax rates on deferred tax assets and liabilities was primarily due to the re-measurement of deferred tax assets related to an extension of a non-U.S. tax incentive of $21.2 million. For the fiscal year ended August 31, 2018, the changes in tax rates on deferred tax assets and liabilities included changes related to the Tax Act, excluding the impact of the enacted rate change on the U.S. valuation allowance.

(4) | The one-time transition tax impact for the fiscal year ended August 31, 2018 was due to the comprehensive tax legislation enacted on December 22, 2017, commonly referred to as the Tax Cuts and Jobs Act of 2017 (“Tax Act”). The enacted changes included a mandatory income inclusion of the historically untaxed foreign earnings of a U.S. company’s foreign subsidiaries and effectively taxed such income at reduced tax rates (“transition tax”). The calculation of the one-time transition tax is based upon post-1986 earnings and profits, applicable foreign tax credits

88

Table of Contents
and relevant limitations, utilization of U.S. federal net operating losses and tax credits and the amount of foreign earnings held in cash and non-cash assets.

(5) | As a result of the Tax Act, the Company made a change to the indefinite reinvestment assertion for the fiscal year ended August 31, 2018 resulting in foreign withholding taxes that would be incurred upon such future remittances of cash.

(6) | The valuation allowance change for the fiscal year ended August 31, 2020 was primarily due to the increase in deferred tax assets for sites with existing valuation allowances. The valuation allowance change for the fiscal years ended August 31, 2019 and 2018 was primarily due to utilization of domestic federal net operating losses and tax credits against the one-time transition tax and the change in enacted tax rate applied to U.S. deferred tax assets and liabilities for the fiscal year ended August 31, 2018. The increase for the fiscal year ended August 31, 2019 was partially offset by an income tax benefit of $17.5 million for the reversal of a U.S. valuation allowance due to an intangible asset reclassification from indefinite-life to finite-life.

(7) | GILTI, a newly defined category of foreign subsidiary income which is taxable to U.S. shareholders each year, applied beginning in the fiscal year ended August 31, 2019 and primarily results in the utilization of current year U.S. federal operating losses. The Company records the effects of GILTI as a period cost.

Deferred Tax Assets and Liabilities
Significant components of the deferred tax assets and liabilities are summarized below (in thousands):

| Fiscal Year Ended August 31,
| 2020 |  | 2019
Deferred tax assets: |  |  |
Net operating loss carryforwards | $ | 197,516 |  |  | $ | 183,297 |
Receivables | 7,749 |  |  | 6,165 |
Inventories | 10,917 |  |  | 9,590 |
Compensated absences | 12,292 |  |  | 10,401 |
Accrued expenses | 85,363 |  |  | 81,731 |
Property, plant and equipment, principally due to differences in depreciation and amortization | 42,484 |  |  | 66,268 |
Domestic tax credits | 29,426 |  |  | 42,464 |
Foreign jurisdiction tax credits | 15,282 |  |  | 15,345 |
Equity compensation | 11,369 |  |  | 9,796 |
Domestic interest carryforwards | 4,846 |  |  | 5,853 |
Cash flow hedges | 9,064 |  |  | 9,878 |
Capital loss carryforwards | 20,087 |  |  | 7,799 |
Revenue recognition | 43,376 |  |  | 19,195 |
Operating lease liabilities | 89,424 |  |  | — |
Other | 18,120 |  |  | 21,907 |
Total deferred tax assets before valuation allowances | 597,315 |  |  | 489,689 |
Less valuation allowances | (341,200 | ) |  | (287,604 | )
Net deferred tax assets | $ | 256,115 |  |  | $ | 202,085 |
Deferred tax liabilities: |  |  |
Unremitted earnings of foreign subsidiaries | 76,711 |  |  | 75,387 |
Intangible assets | 32,262 |  |  | 39,242 |
Operating lease assets | 83,311 |  |  | — |
Other | 13,081 |  |  | 4,447 |
Total deferred tax liabilities | $ | 205,365 |  |  | $ | 119,076 |
Net deferred tax assets | $ | 50,750 |  |  | $ | 83,009 |

Based on the Company’s historical operating income, projection of future taxable income, scheduled reversal of taxable temporary differences, and tax planning strategies, management believes that it is more likely than not that the Company will realize the benefit of its deferred tax assets, net of valuation allowances recorded.
As of August 31, 2020, the Company intends to indefinitely reinvest the remaining earnings from its foreign subsidiaries for which a deferred tax liability has not already been recorded. The accumulated earnings are the most significant component
89

Table of Contents
of the basis difference which is indefinitely reinvested. As of August 31, 2020, the indefinitely reinvested earnings in foreign subsidiaries upon which taxes had not been provided were approximately $2.4 billion. The estimated amount of the unrecognized deferred tax liability on these reinvested earnings was approximately $0.2 billion.
Tax Carryforwards
The amount and expiration dates of income tax net operating loss carryforwards, tax credit carryforwards, and tax capital loss carryforwards, which are available to reduce future taxes, if any, as of August 31, 2020 are as follows:

(dollars in thousands) | Last Fiscal Year of Expiration |  | Amount
Income tax net operating loss carryforwards:(1) |  |  |
Domestic - state | 2040 or indefinite |  | $ | 57,131 |
Foreign | 2030 or indefinite |  | $ | 667,388 |
Tax credit carryforwards:(1) |  |  |
Domestic - federal | 2030 |  | $ | 26,315 |
Domestic - state | 2027 or indefinite |  | $ | 3,858 |
Foreign(2) | 2027 or indefinite |  | $ | 15,282 |
Tax capital loss carryforwards:(3) |  |  |
Domestic - federal | 2025 |  | $ | 78,700 |

(1) | Net of unrecognized tax benefits.

(2) | Calculated based on the deferral method and includes foreign investment tax credits.

(3) | The tax capital loss carryforwards were primarily from an impairment of an investment that was deemed worthless for tax purposes.

Unrecognized Tax Benefits
Reconciliation of the unrecognized tax benefits is summarized below (in thousands):

| Fiscal Year Ended August 31,
| 2020 |  | 2019 |  | 2018
Beginning balance | $ | 164,383 |  |  | $ | 256,705 |  |  | $ | 201,355 |
Additions for tax positions of prior years | 9,841 |  |  | 20,158 |  |  | 14,465 |
Reductions for tax positions of prior years(1) | (9,346 | ) |  | (106,252 | ) |  | (21,045 | )
Additions for tax positions related to current year(2) | 26,360 |  |  | 35,769 |  |  | 81,866 |
Cash settlements | (510 | ) |  | — |  |  | (1,659 | )
Reductions from lapses in statutes of limitations | (1,054 | ) |  | (2,570 | ) |  | (7,496 | )
Reductions from non-cash settlements with taxing authorities(3) | (2,226 | ) |  | (35,582 | ) |  | (5,928 | )
Foreign exchange rate adjustment | 2,345 |  |  | (3,845 | ) |  | (4,853 | )
Ending balance | $ | 189,793 |  |  | $ | 164,383 |  |  | $ | 256,705 |
Unrecognized tax benefits that would affect the effective tax rate (if recognized) | $ | 108,551 |  |  | $ | 93,237 |  |  | $ | 117,455 |

(1) | The reductions for tax positions of prior years for the fiscal year ended August 31, 2019 are primarily related to a non-U.S. taxing authority ruling related to certain non-U.S. net operating loss carryforwards, offset with a valuation allowance and the impacts of the Tax Act.

(2) | The additions for the fiscal years ended August 31, 2020 are primarily related to taxation of certain intercompany transactions. The additions for the fiscal years ended August 31, 2019 and 2018 are primarily related to the impacts of the Tax Act and taxation of certain intercompany transactions.

(3) | The reductions from settlements with taxing authorities for the fiscal year ended August 31, 2019 are primarily related to the settlement of a U.S. audit.

The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense. The Company’s accrued interest and penalties were approximately $22.8 million and $18.9 million as of August 31, 2020 and 2019,
90

Table of Contents
respectively. The Company recognized interest and penalties of approximately $3.9 million, $(1.5) million and $(6.7) million during the fiscal years ended August 31, 2020, 2019 and 2018, respectively.
It is reasonably possible that the August 31, 2020 unrecognized tax benefits could decrease during the next 12 months by $4.9 million, primarily related to a taxing authority agreement associated with intercompany transactions.
The Company is no longer subject to U.S. federal tax examinations for fiscal years before August 31, 2015. In major non-U.S. and state jurisdictions, the Company is no longer subject to income tax examinations for fiscal years before August 31, 2010 and August 31, 2009, respectively.
16. Business Acquisitions
Fiscal years 2019 and 2020
Acquisitions
During fiscal year 2018, the Company and Johnson & Johnson Medical Devices Companies (“JJMD”) entered into a Framework Agreement to form a strategic collaboration and expand its existing relationship. The strategic collaboration expands the Company’s medical device manufacturing portfolio, diversification and capabilities.
On February 25, 2019 and April 29, 2019, under the terms of the Framework Agreement, the Company completed the initial and second closings, respectively, of its acquisition of certain assets of JJMD. The aggregate purchase price paid for the initial and second closings was approximately $167.4 million in cash. For the initial and second closings, total assets acquired of $173.5 million and total liabilities assumed of $6.1 million were recorded at their estimated fair values as of the acquisition dates.
On September 30, 2019, under the terms of the Framework Agreement, the Company completed the third closing of its acquisition of certain assets of JJMD. The aggregate purchase price paid for the third closing was approximately $113.1 million in cash. For the third closing, total assets acquired of $196.2 million, including $80.7 million in contract assets, $34.0 million in inventory and $56.0 million in goodwill, and total liabilities assumed of $83.1 million, including $73.5 million of pension obligations, were recorded at their estimated fair values as of the acquisition date. There were no intangible assets identified in this acquisition and the goodwill is primarily attributable to the assembled workforce. The majority of the goodwill is currently not expected to be deductible for income tax purposes.
The acquisitions of the JJMD assets have been accounted for as separate business combinations for each closing using the acquisition method of accounting. The results of operations were included in the Company’s consolidated financial results beginning on February 25, 2019 for the initial closing, April 29, 2019 for the second closing and September 30, 2019 for the third closing. The Company believes it is impracticable to provide pro forma information for the acquisitions of the JJMD assets.
Fiscal year 2018
Acquisitions
On September 1, 2017, the Company completed the acquisition of True-Tech Corporation (“True-Tech”) for approximately $95.9 million in cash. True-Tech is a manufacturer specializing in aerospace, semiconductor and medical machined components.
The acquisition of True-Tech assets was accounted for as a business combination using the acquisition method of accounting. Assets acquired of $114.7 million, including $25.9 million in intangible assets and $22.6 million in goodwill, and liabilities assumed of $18.8 million were recorded at their estimated fair values as of the acquisition date. The excess of the purchase price over the fair value of the acquired assets and assumed liabilities was recorded to goodwill and was fully allocated to the EMS segment. The majority of the goodwill is currently expected to be deductible for income tax purposes. The results of operations were included in the Company’s consolidated financial results beginning on September 1, 2017. Pro forma information has not been provided as the acquisition of True-Tech is not deemed to be significant.
17. Fair Value Measurements
Fair Value Measurements on a Recurring Basis
The following table presents the fair value of the Company's financial assets and liabilities measured at fair value by hierarchy level on a recurring basis as of the periods indicated:
91

Table of Contents

(in thousands) |  | Fair Value Hierarchy |  | August 31, 2020 |  | August 31, 2019
Assets: |  |  |  |  |  |
Cash and cash equivalents: |  |  |  |  |  |
Cash equivalents |  | Level 1 | (1) | $ | 33,869 |  |  | $ | 27,804 |
Prepaid expenses and other current assets: |  |  |  |  |  |
Short-term investments |  | Level 1 |  | 16,556 |  |  | 14,088 |
Forward foreign exchange contracts: |  |  |  |  |  |
Derivatives designated as hedging instruments (Note 11) |  | Level 2 | (2) | 11,201 |  |  | 904 |
Derivatives not designated as hedging instruments (Note 11) |  | Level 2 | (2) | 58,893 |  |  | 6,878 |
Other assets: |  |  |  |  |  |
Senior Non-Convertible Preferred Stock |  | Level 3 | (3) | — |  |  | 33,102 |
Liabilities: |  |  |  |  |  |
Accrued expenses: |  |  |  |  |  |
Forward foreign exchange contracts: |  |  |  |  |  |
Derivatives designated as hedging instruments (Note 11) |  | Level 2 | (2) | $ | 1,522 |  |  | $ | 15,999 |
Derivatives not designated as hedging instruments (Note 11) |  | Level 2 | (2) | 9,100 |  |  | 55,391 |
Interest rate swaps: |  |  |  |  |  |
Derivatives designated as hedging instruments (Note 11) |  | Level 2 | (4) | — |  |  | 5,918 |
Derivatives not designated as hedging instruments (Note 11) |  | Level 2 | (4) | 540 |  |  | — |
Extended interest rate swap not designated as a hedging instrument (Note 11) |  | Level 2 | (5) | 26,492 |  |  | — |
Other liabilities: |  |  |  |  |  |
Interest rate swap: |  |  |  |  |  |
Derivatives designated as hedging instruments (Note 11) |  | Level 2 | (4) | — |  |  | 35,045 |
Derivatives not designated as hedging instruments (Note 11) |  | Level 2 | (4) | 329 |  |  | — |
Extended interest rate swap not designated as a hedging instrument (Note 11) |  | Level 2 | (5) | 13,111 |  |  | — |

(1) | Consist of investments that are readily convertible to cash with original maturities of 90 days or less.

(2) | The Company’s forward foreign exchange contracts are measured on a recurring basis at fair value, based on foreign currency spot rates and forward rates quoted by banks or foreign currency dealers.

(3) | During the fourth quarter of fiscal year 2020, the Company recognized an impairment on its investment in the Senior Non-Convertible Preferred Stock of iQor Holdings, Inc. (“iQor”) in connection with iQor’s bankruptcy filing. The Company does not expect to recover any of the investment value and recognized the entire remaining investment of $36.4 million as a loss on securities.

(4) | Fair value measurements are based on the contractual terms of the derivatives and use observable market-based inputs. The interest rate swaps are valued using a discounted cash flow analysis on the expected cash flows of each derivative using observable inputs including interest rate curves and credit spreads.

(5) | The 2020 Extended Interest Rate Swaps are considered a hybrid instrument and the Company elected the fair value option for reporting. Fair value measurements are based on the contractual terms of the contract and use observable market-based inputs. The interest rate swaps are valued using a discounted cash flow analysis on the expected cash flows using observable inputs including interest rate curves and credit spreads.

Assets Held for Sale
The following table presents the assets held for sale (in thousands):

|  | August 31, 2020 |  | August 31, 2019
(in thousands) |  | Carrying Amount |  | Carrying Amount
Assets held for sale (1) |  | $ | 67,380 |  |  | $ | — |

(1) | The fair value of assets held for sale exceeds the carrying value for $30.1 million of assets held for sale. For $37.3 million of assets held for sale, the carrying value approximates the fair value with the asset value measured using Level 2 inputs.

92

Table of Contents
Fair Value of Financial Instruments
The carrying amounts of cash and cash equivalents, trade accounts receivable, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value because of the short-term nature of these financial instruments. The carrying amounts of borrowings under credit facilities and under loans approximates fair value as interest rates on these instruments approximates current market rates.
Notes payable and long-term debt is carried at amortized cost; however, the Company estimates the fair value of notes payable and long-term debt for disclosure purposes. The following table presents the carrying amounts and fair values of the Company's notes payable and long-term debt, by hierarchy level as of the periods indicated:

|  |  |  | August 31, 2020 |  | August 31, 2019
(in thousands) |  | Fair Value Hierarchy |  | Carrying Amount |  | Fair Value |  | Carrying Amount |  | Fair Value
Notes payable and long-term debt: (Note 7) |  |  |  |  |  |  |  |  |  |
5.625% Senior Notes |  | Level 2 | (1) | $ | — |  |  | $ | — |  |  | $ | 398,886 |  |  | $ | 416,000 |
4.700% Senior Notes |  | Level 2 | (1) | 498,659 |  |  | 537,180 |  |  | 498,004 |  |  | 525,890 |
4.900% Senior Notes |  | Level 3 | (2) | 299,300 |  |  | 329,435 |  |  | 299,057 |  |  | 318,704 |
3.950% Senior Notes |  | Level 2 | (1) | 495,440 |  |  | 551,930 |  |  | 494,825 |  |  | 509,845 |
3.600% Senior Notes |  | Level 2 | (1) | 494,756 |  |  | 536,110 |  |  | — |  |  | — |
3.000% Senior Notes |  | Level 2 | (1) | 590,162 |  |  | 611,616 |  |  | — |  |  | — |

(1) | The fair value estimates are based upon observable market data.

(2) | This fair value estimate is based on the Company’s indicative borrowing cost derived from discounted cash flows.

Refer to Note 10 - “Postretirement and Other Employee Benefits” for disclosure surrounding the fair value of the Company’s pension plan assets.
18. Commitments and Contingencies
Lease Agreements
The Company primarily has leases for buildings and real estate with lease terms ranging from 1 year to 36 years. Refer to Note 5 – “Leases” for the future minimum lease payments under operating and finance leases as of August 31, 2020.
Legal Proceedings
The Company is party to certain lawsuits in the ordinary course of business. The Company does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s financial position, results of operations or cash flows.
19. New Accounting Guidance
Recently Adopted Accounting Guidance
During fiscal year 2016, the FASB issued a new accounting standard revising lease accounting, which requires the Company to recognize right-of-use assets and lease liabilities on the Consolidated Balance Sheet and disclose key information regarding leasing arrangements. The accounting standard became effective for the Company in fiscal year 2020. Refer to Note 5 - “Leases” to the Consolidated Financial Statements for further details.
During fiscal year 2017, the FASB issued a new accounting standard to improve the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities by simplifying the application of hedge accounting and improving the related disclosures in its financial statements. This guidance became effective for the Company beginning in fiscal year 2020. The guidance was applied using a modified retrospective approach. The adoption of this standard did not have a material impact on the Company’s Consolidated Financial Statements.
Recently Issued Accounting Guidance
During fiscal year 2016, the FASB issued an accounting standard, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net
93

Table of Contents
amount expected to be collected. This guidance is effective for the Company beginning in the first quarter of fiscal year 2021. This guidance must be applied using a modified retrospective or prospective transition method, depending on the area covered by this accounting standard. The adoption of this standard does not have a material impact on its Consolidated Financial Statements.
During fiscal year 2018, the FASB issued a new accounting standard which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This guidance will be applied prospectively and is effective for the Company beginning in the first quarter of fiscal year 2021. The Company does not expect this new standard to have a material impact on its Consolidated Financial Statements.
During the third quarter of fiscal year 2020, the FASB issued a new accounting standard which provides guidance in accounting for contracts, hedging relationships, and other transactions that reference U.S. dollar LIBOR or another reference rate expected to be discontinued because of reference rate reform. The amendments in this update are elective and were effective for the Company immediately upon issuance. The Company is currently assessing the impact of the transition from U.S. dollar LIBOR to alternative reference rates but does not expect this new standard to have a material impact on its Consolidated Financial Statements.
Recently issued accounting guidance not discussed above is not applicable or did not have, or is not expected to have, a material impact to the Company.
Item 16. Form 10-K Summary
Not applicable.
94

Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| JABIL INC. Registrant
| By: | /s/ MARK T. MONDELLO
|  | Mark T. Mondello Chief Executive Officer

Date: October 22, 2020
95

Table of Contents
POWER OF ATTORNEY
KNOW ALL THESE PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Mark T. Mondello and Michael Dastoor and each of them, jointly and severally, his or her attorneys-in-fact, each with full power of substitution, for him or her in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each said attorneys-in-fact or his substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

| Signature |  | Title | Date
By: | /s/ T IMOTHY L. M AIN |  | Chairman of the Board of Directors | October 22, 2020
| Timothy L. Main |  |  |
By: | /s/ T HOMAS A. S ANSONE |  | Vice Chairman of the Board of Directors | October 22, 2020
| Thomas A. Sansone |  |  |
By: | /s/ M ARK T. M ONDELLO |  | Chief Executive Officer and Director (Principal Executive Officer) | October 22, 2020
| Mark T. Mondello |  |  |
By: | /s/ M ICHAEL D ASTOOR |  | Chief Financial Officer (Principal Financial and Accounting Officer) | October 22, 2020
| Michael Dastoor |  |  |
By: | /s/ A NOUSHEH A NSARI |  | Director | October 22, 2020
| Anousheh Ansari |  |  |
By: | /s/ M ARTHA F. B ROOKS |  | Director | October 22, 2020
| Martha F. Brooks |  |  |
By: | /s/ C HRISTOPHER S. H OLLAND |  | Director | October 22, 2020
| Christopher S. Holland |  |  |
By: | /s/ J OHN C. P LANT |  | Director | October 22, 2020
| John C. Plant |  |  |
By: | /s/ S TEVEN A. R AYMUND |  | Director | October 22, 2020
| Steven A. Raymund |  |  |
By: | /s/ D AVID M. S TOUT |  | Director | October 22, 2020
| David M. Stout |  |  |
By: | /s/ K ATHLEEN A. W ALTERS |  | Director | October 22, 2020
| Kathleen A. Walters |  |  |

96

Table of Contents
SCHEDULE II
JABIL INC. AND SUBSIDIARIES
SCHEDULE OF VALUATION AND QUALIFYING ACCOUNTS
(in thousands)

|  | Balance at Beginning of Period |  | Additions and Adjustments Charged to Costs and Expenses |  | Additions/ (Reductions) Charged to Other Accounts |  | Write-offs |  | Balance at End of Period
Allowance for uncollectible accounts receivable: |  |  |  |  |  |  |  |  |  |
Fiscal year ended August 31, 2020 |  | $ | 17,221 |  |  | $ | 24,574 |  |  | $ | — |  |  | $ | (15,968 | ) |  | $ | 25,827 |
Fiscal year ended August 31, 2019 |  | $ | 15,181 |  |  | $ | 15,867 |  |  | $ | — |  |  | $ | (13,827 | ) |  | $ | 17,221 |
Fiscal year ended August 31, 2018 |  | $ | 14,134 |  |  | $ | 12,545 |  |  | $ | — |  |  | $ | (11,498 | ) |  | $ | 15,181 |

|  | Balance at Beginning of Period |  | Additions and Adjustments Charged to Costs and Expenses |  | Additions/ (Reductions) Charged to Other Accounts |  | Write-offs |  | Balance at End of Period
Reserve for excess and obsolete inventory: |  |  |  |  |  |  |  |  |  |
Fiscal year ended August 31, 2020 |  | $ | 69,553 |  |  | $ | 60,084 |  |  | $ | — |  |  | $ | (44,378 | ) |  | $ | 85,259 |
Fiscal year ended August 31, 2019 |  | $ | 60,940 |  |  | $ | 34,091 |  |  | $ | — |  |  | $ | (25,478 | ) |  | $ | 69,553 |
Fiscal year ended August 31, 2018 |  | $ | 46,013 |  |  | $ | 35,538 |  |  | $ | — |  |  | $ | (20,611 | ) |  | $ | 60,940 |

|  | Balance at Beginning of Period |  | Additions Charged to Costs and Expenses |  | Additions/ (Reductions) Charged to Other Accounts |  | Reductions Charged to Costs and Expenses |  | Balance at End of Period
Valuation allowance for deferred taxes: |  |  |  |  |  |  |  |  |  |
Fiscal year ended August 31, 2020 |  | $ | 287,604 |  |  | $ | 54,249 |  |  | $ | 9,664 |  |  | $ | (10,317 | ) |  | $ | 341,200 |
Fiscal year ended August 31, 2019 |  | $ | 223,487 |  |  | $ | 22,750 |  |  | $ | 58,117 |  |  | $ | (16,750 | ) |  | $ | 287,604 |
Fiscal year ended August 31, 2018 |  | $ | 285,559 |  |  | $ | 18,418 |  |  | $ | (886 | ) |  | $ | (79,604 | ) |  | $ | 223,487 |

See accompanying report of independent registered public accounting firm.
97